"Molecule ChEMBL ID";"Molecule Name";"Molecule Max Phase";"Molecular Weight";"#RO5 Violations";"AlogP";"Compound Key";"Smiles";"Standard Type";"Standard Relation";"Standard Value";"Standard Units";"pChEMBL Value";"Data Validity Comment";"Comment";"Uo Units";"Ligand Efficiency BEI";"Ligand Efficiency LE";"Ligand Efficiency LLE";"Ligand Efficiency SEI";"Potential Duplicate";"Assay ChEMBL ID";"Assay Description";"Assay Type";"BAO Format ID";"BAO Label";"Assay Organism";"Assay Tissue ChEMBL ID";"Assay Tissue Name";"Assay Cell Type";"Assay Subcellular Fraction";"Assay Parameters";"Assay Variant Accession";"Assay Variant Mutation";"Target ChEMBL ID";"Target Name";"Target Organism";"Target Type";"Document ChEMBL ID";"Source ID";"Source Description";"Document Journal";"Document Year";"Cell ChEMBL ID";"Properties";"Action Type";"Standard Text Value"
"CHEMBL3904593";"";"None";"420.49";"0";"2.49";"1";"CC(C)(O)c1coc(S(=O)(=O)NC(=O)Nc2c3c(cc4c2C(O)CC4)CCC3)c1";"IC50";"'='";"232.0";"nM";"6.63";"";"";"UO_0000065";"15.78";"0.31";"4.14";"5.15";"0";"CHEMBL3864034";"Inhibition of NLRP3 inflammasome in LPS-stimulated human monocyte derived macrophages assessed as reduction in NLRP3 inflammasome-induced IL-1beta production preincubated for 30 mins followed by NLRP3 stimulation with ATP for 1 hr by ELISA";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3862040";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"";"";""
"CHEMBL4646548";"";"None";"505.59";"1";"4.49";"15";"CN1CCN(C(=O)c2ccc(/C=C3\SC(=S)N(Cc4cccc(C(F)(F)F)c4)C3=O)cc2)CC1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4628081";"Inhibition of NLRP3 inflammasome (unknown origin) activation in LPS-primed bone marrow derived macrophage cells assessed as effect on IL-1beta production in presence of nigericin by ELISA";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4627283";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"";"";""
"CHEMBL4641183";"";"None";"439.44";"0";"4.68";"18";"O=C(O)c1ccc(/C=C2\SC(=S)N(Cc3cccc(OC(F)(F)F)c3)C2=O)cc1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4628081";"Inhibition of NLRP3 inflammasome (unknown origin) activation in LPS-primed bone marrow derived macrophage cells assessed as effect on IL-1beta production in presence of nigericin by ELISA";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4627283";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"";"";""
"CHEMBL4634472";"";"None";"356.36";"0";"3.30";"13";"O=C(Nc1c2c(cc3c1CCC3)CCC2)NP(=O)(O)c1ccccc1";"IC50";"'>'";"1000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4605569";"Inhibition of NLRP3 inflammasome activation in LPS-primed human THP1 cells assessed as reduction in IL-1beta level preincubated for 1 hr followed by addition of ATP and nigericin further incubated for 1 hrs and measured post ATP addition 1 hr by ELISA method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"THP-1";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4602705";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"CHEMBL3307574";"";"";""
"CHEMBL4786342";"";"None";"316.40";"0";"2.74";"13";"CC(C)OC(=O)CNC(=O)Nc1c2c(cc3c1CCC3)CCC2";"IC50";"'='";"1800.0";"nM";"5.75";"";"";"UO_0000065";"18.16";"0.34";"3.00";"8.52";"0";"CHEMBL4702271";"Inhibition of NLRP3 in human PBMC cells assessed as inhibition of LPS and ATP-induced IL-1beta production";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699510";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"";"INHIBITOR";""
"CHEMBL1518625";"";"None";"377.37";"0";"4.97";"SID24797245";"Br.CCCCCCCCn1c2c(c(=N)c3ccccc31)CCC2";"IC50";"'='";"8750.0";"nM";"5.06";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1738451";"PUBCHEM_BIOASSAY: Dose Response confirmation of inhibitors of NALP3 in yeast using a Caspase-1-ASC counter screen. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2825, AID2832]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL16312";"4'-METHOXYFLAVONE";"None";"252.27";"0";"3.47";"SID26657967";"COc1ccc(-c2cc(=O)c3ccccc3o2)cc1";"IC50";"'='";"5400.0";"nM";"5.27";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1738451";"PUBCHEM_BIOASSAY: Dose Response confirmation of inhibitors of NALP3 in yeast using a Caspase-1-ASC counter screen. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2825, AID2832]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1331770";"";"None";"351.36";"0";"1.63";"SID49730057";"Cc1cccc(C(=O)NNC(=O)c2c(O)c3ccccc3n(C)c2=O)c1";"IC50";"'='";"640.0";"nM";"6.19";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1738451";"PUBCHEM_BIOASSAY: Dose Response confirmation of inhibitors of NALP3 in yeast using a Caspase-1-ASC counter screen. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2825, AID2832]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1363164";"";"None";"419.35";"0";"4.65";"SID17387241";"COc1cc(CNCCc2ccccc2)ccc1OCc1ccc(Cl)nc1.Cl";"IC50";"'='";"4860.0";"nM";"5.31";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1738451";"PUBCHEM_BIOASSAY: Dose Response confirmation of inhibitors of NALP3 in yeast using a Caspase-1-ASC counter screen. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2825, AID2832]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1366588";"";"None";"528.07";"0";"3.35";"SID51090705";"Cl.O=C(CCS(=O)(=O)c1ccccc1)N(CCCN1CCOCC1)c1nc2c(F)cccc2s1";"IC50";"'='";"2070.0";"nM";"5.68";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1737963";"PUBCHEM_BIOASSAY: Dose Response confirmation of uHTS for the identification of inhibitors of NALP3 in yeast using a luminescent assay. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2825, AID2832]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1412902";"";"None";"341.36";"0";"4.50";"SID49643282";"O=C(Nc1scc(-c2ccccc2)c1C(=O)O)c1ccc(F)cc1";"IC50";"'='";"4030.0";"nM";"5.39";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1738451";"PUBCHEM_BIOASSAY: Dose Response confirmation of inhibitors of NALP3 in yeast using a Caspase-1-ASC counter screen. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2825, AID2832]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1076347";"TRICLOCARBAN";"4.0";"315.59";"1";"5.29";"SID85148633";"O=C(Nc1ccc(Cl)cc1)Nc1ccc(Cl)c(Cl)c1";"IC50";"'='";"805.0";"nM";"6.09";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1738451";"PUBCHEM_BIOASSAY: Dose Response confirmation of inhibitors of NALP3 in yeast using a Caspase-1-ASC counter screen. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2825, AID2832]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL2001888";"";"None";"622.45";"1";"3.70";"SID74373544";"CCC1Nc2ncnc(N3CCN(c4ccccn4)CC3)c2N(Cc2ccc(Br)cc2)C1=O.O=C(O)C(F)(F)F";"IC50";"'='";"3300.0";"nM";"5.48";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1738451";"PUBCHEM_BIOASSAY: Dose Response confirmation of inhibitors of NALP3 in yeast using a Caspase-1-ASC counter screen. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2825, AID2832]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL4643208";"";"None";"383.47";"0";"2.66";"8";"Cc1ccc(S(=O)(=O)NC(=O)C(=O)c2c3c(cc4c2CCC4)CCC3)cc1";"IC50";"'>'";"1000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4605569";"Inhibition of NLRP3 inflammasome activation in LPS-primed human THP1 cells assessed as reduction in IL-1beta level preincubated for 1 hr followed by addition of ATP and nigericin further incubated for 1 hrs and measured post ATP addition 1 hr by ELISA method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"THP-1";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4602705";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"CHEMBL3307574";"";"";""
"CHEMBL4636808";"";"None";"331.42";"0";"4.05";"4";"N#CC(NC(=O)Nc1c2c(cc3c1CCC3)CCC2)c1ccccc1";"IC50";"'>'";"1000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4605569";"Inhibition of NLRP3 inflammasome activation in LPS-primed human THP1 cells assessed as reduction in IL-1beta level preincubated for 1 hr followed by addition of ATP and nigericin further incubated for 1 hrs and measured post ATP addition 1 hr by ELISA method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"THP-1";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4602705";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"CHEMBL3307574";"";"";""
"CHEMBL4643062";"";"None";"435.55";"0";"4.59";"21";"Cc1ccc(S(=O)(=Nc2ccn[nH]2)NC(=O)Nc2c3c(cc4c2CCC4)CCC3)cc1";"IC50";"'>'";"1000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4605569";"Inhibition of NLRP3 inflammasome activation in LPS-primed human THP1 cells assessed as reduction in IL-1beta level preincubated for 1 hr followed by addition of ATP and nigericin further incubated for 1 hrs and measured post ATP addition 1 hr by ELISA method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"THP-1";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4602705";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"CHEMBL3307574";"";"";""
"CHEMBL4636825";"";"None";"381.46";"0";"3.10";"33";"N#CN=S(=O)(NC(=O)Nc1c2c(cc3c1CCC3)CCC2)c1cccnc1";"IC50";"'='";"36.3";"nM";"7.44";"";"";"UO_0000065";"19.50";"0.38";"4.34";"6.94";"0";"CHEMBL4605569";"Inhibition of NLRP3 inflammasome activation in LPS-primed human THP1 cells assessed as reduction in IL-1beta level preincubated for 1 hr followed by addition of ATP and nigericin further incubated for 1 hrs and measured post ATP addition 1 hr by ELISA method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"THP-1";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4602705";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"CHEMBL3307574";"";"";""
"CHEMBL4646271";"";"None";"381.46";"0";"3.10";"32";"N#CN=S(=O)(NC(=O)Nc1c2c(cc3c1CCC3)CCC2)c1ccncc1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4605574";"Inhibition of NLRP3 inflammasome activation in LPS-primed human THP1 cells assessed as reduction in TNF alpha level preincubated for 1 hr followed by addition of monosodium urate crystals further incubated for 16 hrs and measured post monosodium urate crystals addition 1 hr by ELISA method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"THP-1";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4602705";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"CHEMBL3307574";"";"";""
"CHEMBL4795253";"";"None";"590.70";"1";"3.39";"6";"CC(=O)c1ccc(S(=O)(=O)N(c2ccc3c(c2)N(S(C)(=O)=O)CCC3)S(=O)(=O)c2ccc(C(C)=O)cc2)cc1";"IC50";"'='";"7810.0";"nM";"5.11";"";"";"UO_0000065";"8.65";"0.18";"1.72";"3.57";"0";"CHEMBL4775286";"Inhibition of NLRP3 in PMA-stimulated human THP-1 cells assessed as reduction in IL-1beta release pre-treated for 24 hrs followed by stimulation with LPS for 3 hrs and ATP for 1 hr by ELISA analysis";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"None";"THP-1";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765468";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 28.0 hr";"INHIBITOR";""
"CHEMBL3183703";"";"None";"404.49";"0";"2.99";"MCC950";"CC(C)(O)c1coc(S(=O)(=O)NC(=O)Nc2c3c(cc4c2CCC4)CCC3)c1";"IC50";"'='";"8.1";"nM";"8.09";"";"";"UO_0000065";"20.00";"0.39";"5.10";"7.45";"1";"CHEMBL4775499";"Inhibition of NLRP3 inflammasome activation in LPS-primed human monocyte derived macrophages assessed as reduction in IL-1beta level preincubated for 30 mins followed by Pam3CSK4 addition and measured after 4 hrs by ELISA method";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"None";"BMDM";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765476";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"TIME = 4.5 hr";"INHIBITOR";""
"CHEMBL4786963";"";"None";"618.84";"2";"5.58";"15";"CC(C)(C)c1ccc(S(=O)(=O)N(c2ccc3c(c2)N(S(C)(=O)=O)CCC3)S(=O)(=O)c2ccc(C(C)(C)C)cc2)cc1";"IC50";"'='";"9860.0";"nM";"5.01";"";"";"UO_0000065";"8.09";"0.17";"-0.57";"4.60";"0";"CHEMBL4775286";"Inhibition of NLRP3 in PMA-stimulated human THP-1 cells assessed as reduction in IL-1beta release pre-treated for 24 hrs followed by stimulation with LPS for 3 hrs and ATP for 1 hr by ELISA analysis";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"None";"THP-1";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765468";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 28.0 hr";"INHIBITOR";""
"CHEMBL4538032";"";"None";"378.88";"0";"2.45";"INF58";"C=C(Cc1ccccc1Cl)C(=O)NCCc1ccc(S(N)(=O)=O)cc1";"IC50";"'='";"74000.0";"nM";"4.13";"";"";"UO_0000065";"10.90";"0.23";"1.68";"4.63";"0";"CHEMBL4324153";"Inhibition of recombinant human NLRP3 ATPase assessed as reduction in ADP formation preincubated for 10 mins followed by ATP addition and measured after 40 mins by ADP-Glo assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4321841";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"";"";""
"CHEMBL1451060";"";"None";"423.25";"0";"2.31";"SID49645365";"O=C(NNC(=S)NC(=O)c1ccc(Br)cc1)c1ccc([N+](=O)[O-])cc1";"IC50";"'>'";"100000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1738451";"PUBCHEM_BIOASSAY: Dose Response confirmation of inhibitors of NALP3 in yeast using a Caspase-1-ASC counter screen. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2825, AID2832]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL4128176";"";"None";"170.16";"0";"0.07";"8";"CC(=O)OC[C@@H]1C=CC(=O)CO1";"IC50";"'='";"4300.0";"nM";"5.37";"";"";"UO_0000065";"31.54";"0.61";"5.30";"10.20";"0";"CHEMBL4125669";"Inhibition of nigericin-induced NLRP3 inflammasome activation in PMA-differentiated human THP1 cells assessed as reduction in LPS-stimulated IL-1beta secretion incubated for 1 hr prior to stimulation with nigericin for 1 hr by quanti-blue based SEAP reporter gene assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4118290";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";"";""
"CHEMBL4127699";"";"None";"128.13";"0";"-0.50";"7";"O=C1C=C[C@@H](CO)OC1";"IC50";"'='";"42000.0";"nM";"4.38";"";"";"UO_0000065";"34.16";"0.66";"4.88";"9.41";"0";"CHEMBL4125669";"Inhibition of nigericin-induced NLRP3 inflammasome activation in PMA-differentiated human THP1 cells assessed as reduction in LPS-stimulated IL-1beta secretion incubated for 1 hr prior to stimulation with nigericin for 1 hr by quanti-blue based SEAP reporter gene assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4118290";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";"";""
"CHEMBL4129407";"";"None";"254.33";"0";"2.41";"10";"CCCCCCCC(=O)OC[C@@H]1C=CC(=O)CO1";"IC50";"'='";"5100.0";"nM";"5.29";"";"";"UO_0000065";"20.81";"0.40";"2.88";"10.06";"0";"CHEMBL4125669";"Inhibition of nigericin-induced NLRP3 inflammasome activation in PMA-differentiated human THP1 cells assessed as reduction in LPS-stimulated IL-1beta secretion incubated for 1 hr prior to stimulation with nigericin for 1 hr by quanti-blue based SEAP reporter gene assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4118290";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";"";""
"CHEMBL4125713";"";"None";"144.10";"0";"0.16";"23";"O=C1C(F)=C[C@@H]2CO[C@H]1O2";"IC50";"'='";"4800.0";"nM";"5.32";"";"";"UO_0000065";"36.91";"0.73";"5.16";"14.97";"0";"CHEMBL4125669";"Inhibition of nigericin-induced NLRP3 inflammasome activation in PMA-differentiated human THP1 cells assessed as reduction in LPS-stimulated IL-1beta secretion incubated for 1 hr prior to stimulation with nigericin for 1 hr by quanti-blue based SEAP reporter gene assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4118290";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";"";""
"CHEMBL1574982";"";"None";"271.71";"0";"3.86";"SID7973985";"N#Cc1ccc(NC(=O)Nc2ccc(Cl)cc2)cc1";"IC50";"'='";"2980.0";"nM";"5.53";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1738451";"PUBCHEM_BIOASSAY: Dose Response confirmation of inhibitors of NALP3 in yeast using a Caspase-1-ASC counter screen. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2825, AID2832]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1596681";"";"None";"381.40";"0";"4.70";"SID14718880";"Br.CCCCCCCCCn1c2c(c(=N)c3c1CCC3)CCC2";"IC50";"'='";"9020.0";"nM";"5.04";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1737963";"PUBCHEM_BIOASSAY: Dose Response confirmation of uHTS for the identification of inhibitors of NALP3 in yeast using a luminescent assay. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2825, AID2832]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1457403";"";"None";"378.91";"0";"4.09";"SID57261334";"CCN(CC)c1ccc2nc3ccc(N)cc3[n+](-c3ccccc3)c2c1.[Cl-]";"IC50";"'='";"4790.0";"nM";"5.32";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1737963";"PUBCHEM_BIOASSAY: Dose Response confirmation of uHTS for the identification of inhibitors of NALP3 in yeast using a luminescent assay. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2825, AID2832]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL2355051";"CLOMIPHENE";"4.0";"405.97";"1";"6.56";"SID11532948";"CCN(CC)CCOc1ccc(C(=C(Cl)c2ccccc2)c2ccccc2)cc1";"IC50";"'='";"29300.0";"nM";"4.53";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1737963";"PUBCHEM_BIOASSAY: Dose Response confirmation of uHTS for the identification of inhibitors of NALP3 in yeast using a luminescent assay. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2825, AID2832]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1412902";"";"None";"341.36";"0";"4.50";"SID49643282";"O=C(Nc1scc(-c2ccccc2)c1C(=O)O)c1ccc(F)cc1";"IC50";"'='";"10300.0";"nM";"4.99";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1737963";"PUBCHEM_BIOASSAY: Dose Response confirmation of uHTS for the identification of inhibitors of NALP3 in yeast using a luminescent assay. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2825, AID2832]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1732520";"";"None";"319.36";"0";"4.08";"SID46500089";"Cc1ccc(C2=NOC(C)(c3nnc(-c4ccccc4)o3)C2)cc1";"IC50";"'='";"41200.0";"nM";"4.38";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1737963";"PUBCHEM_BIOASSAY: Dose Response confirmation of uHTS for the identification of inhibitors of NALP3 in yeast using a luminescent assay. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2825, AID2832]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL4849674";"";"None";"454.55";"0";"3.24";"16";"CC(C)c1cccc2c1CC(=O)NS(=O)(=O)c1cnn(c1)C(C)(C)COc1cc-2ccn1";"IC50";"'<='";"500.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4827632";"Inhibition of NLRP3 inflammasome activation in LPS-primed human whole blood assessed as reduction in nigericin-induced IL-1beta level preincubated for 3 hrs followed by nigericin addition and measured after 1 hrs by AlphaLISA assay";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"Blood";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4825720";"1";"Scientific Literature";"ACS Med Chem Lett";"2021";"None";"TIME = 4.0 hr";"INHIBITOR";""
"CHEMBL4797478";"";"None";"336.82";"0";"3.00";"21";"CCOC(=O)CNC(=O)Nc1c2c(c(Cl)c3c1CCC3)CCC2";"IC50";"'>'";"20000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4702271";"Inhibition of NLRP3 in human PBMC cells assessed as inhibition of LPS and ATP-induced IL-1beta production";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699510";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"";"";""
"CHEMBL4741383";"";"None";"312.37";"0";"2.64";"26";"CCOC(=O)CNC(=O)NC(c1ccccc1)c1ccccc1";"IC50";"'>'";"20000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4702271";"Inhibition of NLRP3 in human PBMC cells assessed as inhibition of LPS and ATP-induced IL-1beta production";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699510";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"";"";""
"CHEMBL4745189";"";"None";"370.47";"0";"2.58";"9";"O=C(CNS(=O)(=O)c1ccccc1)Nc1c2c(cc3c1CCC3)CCC2";"IC50";"'>'";"20000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4702271";"Inhibition of NLRP3 in human PBMC cells assessed as inhibition of LPS and ATP-induced IL-1beta production";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699510";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"";"";""
"CHEMBL4764712";"";"None";"288.35";"0";"1.96";"11";"COC(=O)CNC(=O)Nc1c2c(cc3c1CCC3)CCC2";"IC50";"'='";"6800.0";"nM";"5.17";"";"";"UO_0000065";"17.92";"0.34";"3.21";"7.66";"0";"CHEMBL4702271";"Inhibition of NLRP3 in human PBMC cells assessed as inhibition of LPS and ATP-induced IL-1beta production";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699510";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"";"INHIBITOR";""
"CHEMBL4786071";"";"None";"380.45";"0";"2.36";"41";"COC(=O)[C@@H](Cc1cncnc1)NC(=O)Nc1c2c(cc3c1CCC3)CCC2";"IC50";"'='";"4500.0";"nM";"5.35";"";"";"UO_0000065";"14.05";"0.26";"2.99";"5.74";"0";"CHEMBL4702271";"Inhibition of NLRP3 in human PBMC cells assessed as inhibition of LPS and ATP-induced IL-1beta production";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699510";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"";"INHIBITOR";""
"CHEMBL4790034";"";"None";"394.48";"0";"2.75";"45";"CCOC(=O)[C@@H](Cc1cnccn1)NC(=O)Nc1c2c(cc3c1CCC3)CCC2";"IC50";"'='";"370.0";"nM";"6.43";"";"";"UO_0000065";"16.30";"0.30";"3.68";"6.90";"0";"CHEMBL4702272";"Inhibition of NLRP3 in human whole blood assessed as inhibition of LPS and ATP-induced IL-1beta production";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"Blood";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699510";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"";"INHIBITOR";""
"CHEMBL1596325";"";"None";"363.46";"0";"2.49";"SID49824678";"CCCOc1ccc(C(=O)NNC(=S)NC(=O)c2cccs2)cc1";"IC50";"'='";"8960.0";"nM";"5.05";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1737963";"PUBCHEM_BIOASSAY: Dose Response confirmation of uHTS for the identification of inhibitors of NALP3 in yeast using a luminescent assay. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2825, AID2832]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1336269";"";"None";"251.28";"0";"2.69";"SID47200064";"COc1ccc(NC(=O)C#Cc2ccccc2)cc1";"IC50";"'='";"8010.0";"nM";"5.10";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1737963";"PUBCHEM_BIOASSAY: Dose Response confirmation of uHTS for the identification of inhibitors of NALP3 in yeast using a luminescent assay. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2825, AID2832]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1329507";"";"None";"340.69";"0";"3.97";"SID17411940";"O=c1c2ccc(Cl)cc2nc(-c2cccc(C(F)(F)F)c2)n1O";"IC50";"'='";"11000.0";"nM";"4.96";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1737963";"PUBCHEM_BIOASSAY: Dose Response confirmation of uHTS for the identification of inhibitors of NALP3 in yeast using a luminescent assay. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2825, AID2832]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1411435";"";"None";"333.34";"0";"1.48";"SID49645184";"O=C(NC(=S)NNC(=O)c1ccccc1O)c1ccc(F)cc1";"IC50";"'='";"7940.0";"nM";"5.10";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1737963";"PUBCHEM_BIOASSAY: Dose Response confirmation of uHTS for the identification of inhibitors of NALP3 in yeast using a luminescent assay. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2825, AID2832]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1559889";"";"None";"246.27";"0";"1.78";"SID857404";"CC(C)NC(=O)c1c(O)nc2ccccc2c1O";"IC50";"'='";"13100.0";"nM";"4.88";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1737963";"PUBCHEM_BIOASSAY: Dose Response confirmation of uHTS for the identification of inhibitors of NALP3 in yeast using a luminescent assay. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2825, AID2832]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1507547";"";"None";"360.89";"0";"3.21";"SID26664689";"Cc1cccc(N2CCN(CC(O)COc3ccc(Cl)cc3)CC2)c1";"IC50";"'='";"4780.0";"nM";"5.32";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1738451";"PUBCHEM_BIOASSAY: Dose Response confirmation of inhibitors of NALP3 in yeast using a Caspase-1-ASC counter screen. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2825, AID2832]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1732520";"";"None";"319.36";"0";"4.08";"SID46500089";"Cc1ccc(C2=NOC(C)(c3nnc(-c4ccccc4)o3)C2)cc1";"IC50";"'='";"4290.0";"nM";"5.37";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1738451";"PUBCHEM_BIOASSAY: Dose Response confirmation of inhibitors of NALP3 in yeast using a Caspase-1-ASC counter screen. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2825, AID2832]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1577062";"";"None";"317.41";"0";"3.36";"SID17403510";"COc1ccccc1CNC(=O)c1ccc(SC)cc1OC";"IC50";"'='";"5780.0";"nM";"5.24";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1738451";"PUBCHEM_BIOASSAY: Dose Response confirmation of inhibitors of NALP3 in yeast using a Caspase-1-ASC counter screen. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2825, AID2832]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1541722";"";"None";"383.76";"0";"4.28";"SID17409677";"Cc1onc(-c2ccccc2Cl)c1C(=O)N1C=CC(C(F)(F)F)=NCC1";"IC50";"'='";"6510.0";"nM";"5.19";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1738451";"PUBCHEM_BIOASSAY: Dose Response confirmation of inhibitors of NALP3 in yeast using a Caspase-1-ASC counter screen. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2825, AID2832]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1580883";"";"None";"278.31";"0";"3.36";"SID49645260";"COc1ccc(-c2nn(-c3ccccc3)cc2C=O)cc1";"IC50";"'='";"8260.0";"nM";"5.08";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1738451";"PUBCHEM_BIOASSAY: Dose Response confirmation of inhibitors of NALP3 in yeast using a Caspase-1-ASC counter screen. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2825, AID2832]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL4129636";"";"None";"230.19";"0";"0.69";"24";"CC(=O)OC1=C(F)C(C(C)=O)[C@@H]2CO[C@H]1O2";"IC50";"'='";"3700.0";"nM";"5.43";"";"";"UO_0000065";"23.60";"0.46";"4.74";"8.79";"0";"CHEMBL4125669";"Inhibition of nigericin-induced NLRP3 inflammasome activation in PMA-differentiated human THP1 cells assessed as reduction in LPS-stimulated IL-1beta secretion incubated for 1 hr prior to stimulation with nigericin for 1 hr by quanti-blue based SEAP reporter gene assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4118290";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";"";""
"CHEMBL16312";"4'-METHOXYFLAVONE";"None";"252.27";"0";"3.47";"SID26657967";"COc1ccc(-c2cc(=O)c3ccccc3o2)cc1";"IC50";"'='";"31000.0";"nM";"4.51";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1737963";"PUBCHEM_BIOASSAY: Dose Response confirmation of uHTS for the identification of inhibitors of NALP3 in yeast using a luminescent assay. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2825, AID2832]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1347185";"";"None";"317.69";"0";"2.86";"SID24824347";"O=c1c2cc(Cl)ccc2nc(-c2ccc([N+](=O)[O-])cc2)n1O";"IC50";"'='";"6600.0";"nM";"5.18";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1737963";"PUBCHEM_BIOASSAY: Dose Response confirmation of uHTS for the identification of inhibitors of NALP3 in yeast using a luminescent assay. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2825, AID2832]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1334557";"";"None";"366.87";"0";"4.13";"SID22413246";"CCOC(=O)N1C(=O)C2(CCCCC2)N(c2ccccc2Cl)C1=S";"IC50";"'='";"5920.0";"nM";"5.23";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1737963";"PUBCHEM_BIOASSAY: Dose Response confirmation of uHTS for the identification of inhibitors of NALP3 in yeast using a luminescent assay. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2825, AID2832]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL2001888";"";"None";"622.45";"1";"3.70";"SID74373544";"CCC1Nc2ncnc(N3CCN(c4ccccn4)CC3)c2N(Cc2ccc(Br)cc2)C1=O.O=C(O)C(F)(F)F";"IC50";"'='";"3710.0";"nM";"5.43";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1737963";"PUBCHEM_BIOASSAY: Dose Response confirmation of uHTS for the identification of inhibitors of NALP3 in yeast using a luminescent assay. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2825, AID2832]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL236150";"CLIOXANIDE";"2.0";"541.51";"1";"4.73";"SID50085912";"CC(=O)Oc1c(I)cc(I)cc1C(=O)Nc1ccc(Cl)cc1";"IC50";"'='";"1610.0";"nM";"5.79";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1737963";"PUBCHEM_BIOASSAY: Dose Response confirmation of uHTS for the identification of inhibitors of NALP3 in yeast using a luminescent assay. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2825, AID2832]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1558285";"";"None";"407.30";"0";"3.54";"SID49641834";"CCN(CC)c1ccc2nc3ccccc3[n+](CC)c2c1.[I-]";"IC50";"'='";"6230.0";"nM";"5.21";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1738451";"PUBCHEM_BIOASSAY: Dose Response confirmation of inhibitors of NALP3 in yeast using a Caspase-1-ASC counter screen. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2825, AID2832]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1444685";"";"None";"280.37";"0";"2.71";"SID49734241";"CN(CC(=O)N1CCc2ccccc2C1)c1ccccc1";"IC50";"'='";"2220.0";"nM";"5.65";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1738451";"PUBCHEM_BIOASSAY: Dose Response confirmation of inhibitors of NALP3 in yeast using a Caspase-1-ASC counter screen. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2825, AID2832]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL2000196";"";"None";"310.38";"0";"3.65";"SID14742458";"CC(=O)N(/N=C1\Sc2ccccc2C1=O)c1ccccc1C";"IC50";"'='";"4550.0";"nM";"5.34";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1738451";"PUBCHEM_BIOASSAY: Dose Response confirmation of inhibitors of NALP3 in yeast using a Caspase-1-ASC counter screen. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2825, AID2832]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1596325";"";"None";"363.46";"0";"2.49";"SID49824678";"CCCOc1ccc(C(=O)NNC(=S)NC(=O)c2cccs2)cc1";"IC50";"'='";"2930.0";"nM";"5.53";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1738451";"PUBCHEM_BIOASSAY: Dose Response confirmation of inhibitors of NALP3 in yeast using a Caspase-1-ASC counter screen. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2825, AID2832]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL5268752";"";"None";"333.82";"0";"2.71";"I-8";"Cc1nc(N[C@@H]2CCCN(C)C2)nnc1-c1ccc(Cl)cc1O";"IC50";"'<'";"1.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5260446";"Inhibition of NLRP3 inflammasome activation in PMA-differentiated human THP-1 cells assessed as reduction in IL-1beta secretion preincubated for 20 hrs followed by nigericin addition and measured after 3 hrs by HTRF assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"THP-1";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5257145";"1";"Scientific Literature";"ACS Med Chem Lett";"2023";"None";"TIME = 23.0 hr";"INHIBITOR";""
"CHEMBL1447078";"";"None";"258.36";"0";"4.25";"SID47198483";"CCCC1CCC(c2ccc(OCC)cc2)=CC1=O";"IC50";"'='";"53900.0";"nM";"4.27";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1737963";"PUBCHEM_BIOASSAY: Dose Response confirmation of uHTS for the identification of inhibitors of NALP3 in yeast using a luminescent assay. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2825, AID2832]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1256359";"ALAPROCLATE HYDROCHLORIDE";"None";"292.21";"0";"2.55";"SID56463328";"CC(N)C(=O)OC(C)(C)Cc1ccc(Cl)cc1.Cl";"IC50";"'='";"8020.0";"nM";"5.10";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1737963";"PUBCHEM_BIOASSAY: Dose Response confirmation of uHTS for the identification of inhibitors of NALP3 in yeast using a luminescent assay. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2825, AID2832]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL4795130";"";"None";"302.37";"0";"2.35";"12";"CCOC(=O)CNC(=O)Nc1c2c(cc3c1CCC3)CCC2";"IC50";"'='";"1600.0";"nM";"5.80";"";"";"UO_0000065";"19.17";"0.36";"3.45";"8.60";"0";"CHEMBL4702271";"Inhibition of NLRP3 in human PBMC cells assessed as inhibition of LPS and ATP-induced IL-1beta production";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699510";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"";"INHIBITOR";""
"CHEMBL4754580";"";"None";"287.36";"0";"1.53";"15";"CNC(=O)CNC(=O)Nc1c2c(cc3c1CCC3)CCC2";"IC50";"'>'";"20000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4702271";"Inhibition of NLRP3 in human PBMC cells assessed as inhibition of LPS and ATP-induced IL-1beta production";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699510";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"";"";""
"CHEMBL4784022";"";"None";"301.39";"0";"1.87";"16";"CN(C)C(=O)CNC(=O)Nc1c2c(cc3c1CCC3)CCC2";"IC50";"'>'";"20000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4702271";"Inhibition of NLRP3 in human PBMC cells assessed as inhibition of LPS and ATP-induced IL-1beta production";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699510";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"";"";""
"CHEMBL4789355";"";"None";"316.40";"0";"2.74";"20";"CCOC(=O)CNC(=O)Nc1cc2c(c3c1CCCC3)CCC2";"IC50";"'='";"3100.0";"nM";"5.51";"";"";"UO_0000065";"17.41";"0.33";"2.77";"8.17";"0";"CHEMBL4702271";"Inhibition of NLRP3 in human PBMC cells assessed as inhibition of LPS and ATP-induced IL-1beta production";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699510";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"";"INHIBITOR";""
"CHEMBL1980395";"";"None";"280.37";"0";"1.82";"25";"CCOC(=O)CNC(=O)NC12CC3CC(CC(C3)C1)C2";"IC50";"'>'";"20000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4702271";"Inhibition of NLRP3 in human PBMC cells assessed as inhibition of LPS and ATP-induced IL-1beta production";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699510";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"";"";""
"CHEMBL4649429";"";"None";"399.52";"0";"4.10";"19";"CON=S(=O)(NC(=O)Nc1c2c(cc3c1CCC3)CCC2)c1ccc(C)cc1";"IC50";"'>'";"1000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4605569";"Inhibition of NLRP3 inflammasome activation in LPS-primed human THP1 cells assessed as reduction in IL-1beta level preincubated for 1 hr followed by addition of ATP and nigericin further incubated for 1 hrs and measured post ATP addition 1 hr by ELISA method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"THP-1";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4602705";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"CHEMBL3307574";"";"";""
"CHEMBL4636050";"";"None";"478.52";"0";"4.58";"3";"O=C(c1ccc(/C=C2\SC(=S)N(c3cccc(C(F)(F)F)c3)C2=O)cc1)N1CCOCC1";"IC50";"'='";"2740.0";"nM";"5.56";"";"";"UO_0000065";"11.62";"0.24";"0.98";"11.16";"0";"CHEMBL4628081";"Inhibition of NLRP3 inflammasome (unknown origin) activation in LPS-primed bone marrow derived macrophage cells assessed as effect on IL-1beta production in presence of nigericin by ELISA";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4627283";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"";"";""
"CHEMBL4633580";"";"None";"398.48";"0";"2.42";"12";"Cc1ccc(S(=O)(=O)NC(=O)C(=O)Nc2c3c(cc4c2CCC4)CCC3)cc1";"IC50";"'>'";"1000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4605569";"Inhibition of NLRP3 inflammasome activation in LPS-primed human THP1 cells assessed as reduction in IL-1beta level preincubated for 1 hr followed by addition of ATP and nigericin further incubated for 1 hrs and measured post ATP addition 1 hr by ELISA method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"THP-1";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4602705";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"CHEMBL3307574";"";"";""
"CHEMBL4640804";"";"None";"369.49";"0";"3.02";"10";"Cc1ccc(S(=O)(=O)NC(=O)Cc2c3c(cc4c2CCC4)CCC3)cc1";"IC50";"'>'";"1000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4605569";"Inhibition of NLRP3 inflammasome activation in LPS-primed human THP1 cells assessed as reduction in IL-1beta level preincubated for 1 hr followed by addition of ATP and nigericin further incubated for 1 hrs and measured post ATP addition 1 hr by ELISA method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"THP-1";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4602705";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"CHEMBL3307574";"";"";""
"CHEMBL4642387";"";"None";"484.52";"1";"6.36";"8";"O=C(Nc1ccccc1)c1ccc(/C=C2\SC(=S)N(c3cccc(C(F)(F)F)c3)C2=O)cc1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4628081";"Inhibition of NLRP3 inflammasome (unknown origin) activation in LPS-primed bone marrow derived macrophage cells assessed as effect on IL-1beta production in presence of nigericin by ELISA";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4627283";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"";"";""
"CHEMBL4643594";"";"None";"447.47";"0";"4.29";"12";"O=C1/C(=C/c2ccc(-c3nnn[nH]3)cc2)SC(=S)N1Cc1cccc(C(F)(F)F)c1";"IC50";"'='";"5580.0";"nM";"5.25";"";"";"UO_0000065";"11.74";"0.24";"0.96";"7.03";"0";"CHEMBL4628081";"Inhibition of NLRP3 inflammasome (unknown origin) activation in LPS-primed bone marrow derived macrophage cells assessed as effect on IL-1beta production in presence of nigericin by ELISA";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4627283";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"";"";""
"CHEMBL4649141";"";"None";"381.46";"0";"3.10";"34";"N#CN=S(=O)(NC(=O)Nc1c2c(cc3c1CCC3)CCC2)c1ccccn1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4605574";"Inhibition of NLRP3 inflammasome activation in LPS-primed human THP1 cells assessed as reduction in TNF alpha level preincubated for 1 hr followed by addition of monosodium urate crystals further incubated for 16 hrs and measured post monosodium urate crystals addition 1 hr by ELISA method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"THP-1";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4602705";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"CHEMBL3307574";"";"";""
"CHEMBL1531200";"";"None";"430.51";"0";"3.51";"SID24839703";"Cc1nc2ccc(Nc3nc4cc(S(=O)(=O)N5CCOCC5)ccc4o3)cc2s1";"IC50";"'>'";"100000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1737963";"PUBCHEM_BIOASSAY: Dose Response confirmation of uHTS for the identification of inhibitors of NALP3 in yeast using a luminescent assay. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2825, AID2832]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1577062";"";"None";"317.41";"0";"3.36";"SID17403510";"COc1ccccc1CNC(=O)c1ccc(SC)cc1OC";"IC50";"'='";"24800.0";"nM";"4.61";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1737963";"PUBCHEM_BIOASSAY: Dose Response confirmation of uHTS for the identification of inhibitors of NALP3 in yeast using a luminescent assay. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2825, AID2832]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL4750616";"";"None";"426.47";"0";"2.99";"CP-456,773";"CC(C)(O)c1coc(S(=O)(=O)[N-]C(=O)Nc2c3c(cc4c2CCC4)CCC3)c1.[Na+]";"IC50";"'='";"30.0";"nM";"7.52";"";"";"UO_0000065";"18.60";"0.37";"4.53";"6.92";"0";"CHEMBL4702271";"Inhibition of NLRP3 in human PBMC cells assessed as inhibition of LPS and ATP-induced IL-1beta production";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699510";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"";"INHIBITOR";""
"CHEMBL4748564";"";"None";"259.30";"0";"2.08";"6";"O=C(O)CC(=O)Nc1c2c(cc3c1CCC3)CCC2";"IC50";"'>'";"20000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4702271";"Inhibition of NLRP3 in human PBMC cells assessed as inhibition of LPS and ATP-induced IL-1beta production";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699510";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"";"";""
"CHEMBL4749848";"";"None";"273.33";"0";"2.17";"7";"COC(=O)CC(=O)Nc1c2c(cc3c1CCC3)CCC2";"IC50";"'>'";"20000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4702271";"Inhibition of NLRP3 in human PBMC cells assessed as inhibition of LPS and ATP-induced IL-1beta production";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699510";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"";"";""
"CHEMBL4794211";"";"None";"394.47";"0";"3.28";"32";"COC(=O)C(Cc1ccccc1O)NC(=O)Nc1c2c(cc3c1CCC3)CCC2";"IC50";"'='";"2500.0";"nM";"5.60";"";"";"UO_0000065";"14.20";"0.26";"2.32";"6.39";"0";"CHEMBL4702271";"Inhibition of NLRP3 in human PBMC cells assessed as inhibition of LPS and ATP-induced IL-1beta production";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699510";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"";"INHIBITOR";""
"CHEMBL4748876";"";"None";"394.48";"0";"2.75";"40";"CCOC(=O)C(Cc1ccncn1)NC(=O)Nc1c2c(cc3c1CCC3)CCC2";"IC50";"'='";"6800.0";"nM";"5.17";"";"";"UO_0000065";"13.10";"0.24";"2.42";"5.54";"0";"CHEMBL4702271";"Inhibition of NLRP3 in human PBMC cells assessed as inhibition of LPS and ATP-induced IL-1beta production";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699510";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"";"INHIBITOR";""
"CHEMBL4750616";"";"None";"426.47";"0";"2.99";"CP-456,773";"CC(C)(O)c1coc(S(=O)(=O)[N-]C(=O)Nc2c3c(cc4c2CCC4)CCC3)c1.[Na+]";"IC50";"'='";"2900.0";"nM";"5.54";"";"";"UO_0000065";"13.69";"0.27";"2.55";"5.10";"0";"CHEMBL4702272";"Inhibition of NLRP3 in human whole blood assessed as inhibition of LPS and ATP-induced IL-1beta production";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"Blood";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699510";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"";"INHIBITOR";""
"CHEMBL4742825";"";"None";"447.58";"0";"3.47";"12";"CC(C)(O)c1csc(/C=C/S(=O)(=O)NC(=O)Nc2c3c(cc4c2CCC4)CCC3)n1";"IC50";"'='";"142.0";"nM";"6.85";"";"";"UO_0000065";"15.30";"0.31";"3.38";"6.32";"0";"CHEMBL4671767";"Inhibition of NLRP3 in human THP1 cells assessed as inhibition of IL-1beta production";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"THP-1";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4665838";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"";"INHIBITOR";""
"CHEMBL602526";"";"None";"318.38";"0";"4.03";"SID49819226";"Cc1cccc(C(=O)ONC(=N)Cc2cccc3ccccc23)c1";"IC50";"'='";"1720.0";"nM";"5.76";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1738451";"PUBCHEM_BIOASSAY: Dose Response confirmation of inhibitors of NALP3 in yeast using a Caspase-1-ASC counter screen. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2825, AID2832]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1388722";"";"None";"317.68";"0";"3.73";"SID14728967";"O=c1cc(-c2ccccc2Cl)oc2ccc([N+](=O)[O-])c(O)c12";"IC50";"'='";"9170.0";"nM";"5.04";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1737963";"PUBCHEM_BIOASSAY: Dose Response confirmation of uHTS for the identification of inhibitors of NALP3 in yeast using a luminescent assay. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2825, AID2832]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL2000196";"";"None";"310.38";"0";"3.65";"SID14742458";"CC(=O)N(/N=C1\Sc2ccccc2C1=O)c1ccccc1C";"IC50";"'='";"8340.0";"nM";"5.08";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1737963";"PUBCHEM_BIOASSAY: Dose Response confirmation of uHTS for the identification of inhibitors of NALP3 in yeast using a luminescent assay. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2825, AID2832]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1539913";"";"None";"299.17";"0";"4.30";"SID49674185";"Brc1ccc(-n2cnc(-c3ccccc3)c2)cc1";"IC50";"'='";"35400.0";"nM";"4.45";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1737963";"PUBCHEM_BIOASSAY: Dose Response confirmation of uHTS for the identification of inhibitors of NALP3 in yeast using a luminescent assay. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2825, AID2832]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1507547";"";"None";"360.89";"0";"3.21";"SID26664689";"Cc1cccc(N2CCN(CC(O)COc3ccc(Cl)cc3)CC2)c1";"IC50";"'='";"76600.0";"nM";"4.12";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1737963";"PUBCHEM_BIOASSAY: Dose Response confirmation of uHTS for the identification of inhibitors of NALP3 in yeast using a luminescent assay. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2825, AID2832]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL3193158";"";"None";"415.53";"0";"3.33";"SID4248264";"CCCCCC(=O)N1CCN(CC/N=C/C2=C(O)CC(c3ccco3)CC2=O)CC1";"IC50";"'='";"7300.0";"nM";"5.14";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1737963";"PUBCHEM_BIOASSAY: Dose Response confirmation of uHTS for the identification of inhibitors of NALP3 in yeast using a luminescent assay. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2825, AID2832]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL3192672";"";"None";"282.35";"0";"2.97";"SID14741635";"C=CCc1c(C)nc(C)nc1N/N=C/c1ccccc1O";"IC50";"'='";"45500.0";"nM";"4.34";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1737963";"PUBCHEM_BIOASSAY: Dose Response confirmation of uHTS for the identification of inhibitors of NALP3 in yeast using a luminescent assay. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2825, AID2832]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1427059";"";"None";"298.37";"0";"3.43";"SID49641964";"CCSc1nsc(NC(=O)Nc2cccc(F)c2)n1";"IC50";"'='";"1970.0";"nM";"5.71";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1737963";"PUBCHEM_BIOASSAY: Dose Response confirmation of uHTS for the identification of inhibitors of NALP3 in yeast using a luminescent assay. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2825, AID2832]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1541722";"";"None";"383.76";"0";"4.28";"SID17409677";"Cc1onc(-c2ccccc2Cl)c1C(=O)N1C=CC(C(F)(F)F)=NCC1";"IC50";"'='";"8660.0";"nM";"5.06";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1737963";"PUBCHEM_BIOASSAY: Dose Response confirmation of uHTS for the identification of inhibitors of NALP3 in yeast using a luminescent assay. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2825, AID2832]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1512568";"";"None";"319.39";"0";"2.08";"SID51085724";"O=C(NCCC1=CCCCC1)c1c(O)nc2sccn2c1=O";"IC50";"'='";"3800.0";"nM";"5.42";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1737963";"PUBCHEM_BIOASSAY: Dose Response confirmation of uHTS for the identification of inhibitors of NALP3 in yeast using a luminescent assay. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2825, AID2832]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1363164";"";"None";"419.35";"0";"4.65";"SID17387241";"COc1cc(CNCCc2ccccc2)ccc1OCc1ccc(Cl)nc1.Cl";"IC50";"'='";"30100.0";"nM";"4.52";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1737963";"PUBCHEM_BIOASSAY: Dose Response confirmation of uHTS for the identification of inhibitors of NALP3 in yeast using a luminescent assay. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2825, AID2832]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1444685";"";"None";"280.37";"0";"2.71";"SID49734241";"CN(CC(=O)N1CCc2ccccc2C1)c1ccccc1";"IC50";"'>'";"100000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1737963";"PUBCHEM_BIOASSAY: Dose Response confirmation of uHTS for the identification of inhibitors of NALP3 in yeast using a luminescent assay. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2825, AID2832]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1490692";"";"None";"431.24";"1";"6.27";"SID26666845";"O=C(Nc1cccc(Cl)c1)c1cc(N=Nc2ccc([N+](=O)[O-])cc2Cl)ccc1O";"IC50";"'='";"1340.0";"nM";"5.87";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1737963";"PUBCHEM_BIOASSAY: Dose Response confirmation of uHTS for the identification of inhibitors of NALP3 in yeast using a luminescent assay. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2825, AID2832]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL4636870";"";"None";"437.46";"0";"4.85";"10";"O=C(O)c1ccc(/C=C2\SC(=S)N(CCc3cccc(C(F)(F)F)c3)C2=O)cc1";"IC50";"'='";"5910.0";"nM";"5.23";"";"";"UO_0000065";"11.95";"0.25";"0.38";"9.08";"0";"CHEMBL4628081";"Inhibition of NLRP3 inflammasome (unknown origin) activation in LPS-primed bone marrow derived macrophage cells assessed as effect on IL-1beta production in presence of nigericin by ELISA";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4627283";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"";"";""
"CHEMBL4644329";"";"None";"407.37";"0";"4.64";"16";"O=C(O)c1ccc(/C=C2\SC(=O)N(Cc3cccc(C(F)(F)F)c3)C2=O)cc1";"IC50";"'='";"5960.0";"nM";"5.22";"";"";"UO_0000065";"12.83";"0.25";"0.58";"7.00";"0";"CHEMBL4628081";"Inhibition of NLRP3 inflammasome (unknown origin) activation in LPS-primed bone marrow derived macrophage cells assessed as effect on IL-1beta production in presence of nigericin by ELISA";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4627283";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"";"";""
"CHEMBL2355051";"CLOMIPHENE";"4.0";"405.97";"1";"6.56";"SID11532948";"CCN(CC)CCOc1ccc(C(=C(Cl)c2ccccc2)c2ccccc2)cc1";"IC50";"'='";"2410.0";"nM";"5.62";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1738451";"PUBCHEM_BIOASSAY: Dose Response confirmation of inhibitors of NALP3 in yeast using a Caspase-1-ASC counter screen. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2825, AID2832]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1505307";"";"None";"343.86";"0";"4.00";"SID24792932";"Cc1cccc(NC(=O)N2CCN(Cc3ccc(Cl)cc3)CC2)c1";"IC50";"'='";"3800.0";"nM";"5.42";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1738451";"PUBCHEM_BIOASSAY: Dose Response confirmation of inhibitors of NALP3 in yeast using a Caspase-1-ASC counter screen. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2825, AID2832]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL3191011";"";"None";"450.46";"1";"2.38";"SID24801055";"O=[N+]([O-])c1cccc(/C=N/Nc2nc(NCc3ccccc3)nc(N3CCOCC3)n2)c1O";"IC50";"'='";"6340.0";"nM";"5.20";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1738451";"PUBCHEM_BIOASSAY: Dose Response confirmation of inhibitors of NALP3 in yeast using a Caspase-1-ASC counter screen. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2825, AID2832]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1381195";"";"None";"328.80";"0";"4.44";"SID49670289";"Cl.Nc1ccc(Oc2cc(N)cc(Oc3ccccc3)c2)cc1";"IC50";"'='";"4580.0";"nM";"5.34";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1738451";"PUBCHEM_BIOASSAY: Dose Response confirmation of inhibitors of NALP3 in yeast using a Caspase-1-ASC counter screen. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2825, AID2832]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1709001";"";"None";"372.47";"0";"1.81";"SID51089524";"Cc1cccn2c(O)c(C(=O)NCCCN3CC(C)CC(C)C3)c(=O)nc12";"IC50";"'='";"10300.0";"nM";"4.99";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1738451";"PUBCHEM_BIOASSAY: Dose Response confirmation of inhibitors of NALP3 in yeast using a Caspase-1-ASC counter screen. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2825, AID2832]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL236150";"CLIOXANIDE";"2.0";"541.51";"1";"4.73";"SID50085912";"CC(=O)Oc1c(I)cc(I)cc1C(=O)Nc1ccc(Cl)cc1";"IC50";"'='";"813.0";"nM";"6.09";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1738451";"PUBCHEM_BIOASSAY: Dose Response confirmation of inhibitors of NALP3 in yeast using a Caspase-1-ASC counter screen. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2825, AID2832]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL453974";"";"None";"364.78";"0";"2.69";"SID24841464";"C[C@@H]1C[C@@H]2O[C@H]2/C=C\C=C\C(=O)Cc2c(Cl)c(O)cc(O)c2C(=O)O1";"IC50";"'='";"5660.0";"nM";"5.25";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1738451";"PUBCHEM_BIOASSAY: Dose Response confirmation of inhibitors of NALP3 in yeast using a Caspase-1-ASC counter screen. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2825, AID2832]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL4228911";"";"None";"316.74";"0";"3.91";"5e";"COc1ccc(C/C(=N\O)c2nc3ccc(Cl)cc3o2)cc1";"IC50";"'='";"5720.0";"nM";"5.24";"";"";"UO_0000065";"16.55";"0.33";"1.33";"7.73";"0";"CHEMBL4221123";"Inhibition of NLRP3 inflammasome in human THP1 cells assessed as reduction in MSU-induced IL-1beta production preincubated for 1 hr followed by MSU stimulation measured after 6 hrs";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4219086";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";"";""
"CHEMBL1571123";"";"None";"401.88";"0";"3.66";"SID49721830";"Cc1ccc(NC(=O)c2nc(S(=O)(=O)Cc3ccccc3)ncc2Cl)cc1";"IC50";"'='";"3580.0";"nM";"5.45";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1737963";"PUBCHEM_BIOASSAY: Dose Response confirmation of uHTS for the identification of inhibitors of NALP3 in yeast using a luminescent assay. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2825, AID2832]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1336269";"";"None";"251.28";"0";"2.69";"SID47200064";"COc1ccc(NC(=O)C#Cc2ccccc2)cc1";"IC50";"'='";"1440.0";"nM";"5.84";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1738451";"PUBCHEM_BIOASSAY: Dose Response confirmation of inhibitors of NALP3 in yeast using a Caspase-1-ASC counter screen. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2825, AID2832]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1366588";"";"None";"528.07";"0";"3.35";"SID51090705";"Cl.O=C(CCS(=O)(=O)c1ccccc1)N(CCCN1CCOCC1)c1nc2c(F)cccc2s1";"IC50";"'='";"1050.0";"nM";"5.98";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1738451";"PUBCHEM_BIOASSAY: Dose Response confirmation of inhibitors of NALP3 in yeast using a Caspase-1-ASC counter screen. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2825, AID2832]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1709001";"";"None";"372.47";"0";"1.81";"SID51089524";"Cc1cccn2c(O)c(C(=O)NCCCN3CC(C)CC(C)C3)c(=O)nc12";"IC50";"'='";"14900.0";"nM";"4.83";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1737963";"PUBCHEM_BIOASSAY: Dose Response confirmation of uHTS for the identification of inhibitors of NALP3 in yeast using a luminescent assay. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2825, AID2832]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1574982";"";"None";"271.71";"0";"3.86";"SID7973985";"N#Cc1ccc(NC(=O)Nc2ccc(Cl)cc2)cc1";"IC50";"'='";"3530.0";"nM";"5.45";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1737963";"PUBCHEM_BIOASSAY: Dose Response confirmation of uHTS for the identification of inhibitors of NALP3 in yeast using a luminescent assay. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2825, AID2832]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1505335";"";"None";"346.48";"0";"3.29";"SID24790921";"Cc1ccc(S(=O)(=O)N2CCN=C2SCc2ccccc2)cc1";"IC50";"'='";"41800.0";"nM";"4.38";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1737963";"PUBCHEM_BIOASSAY: Dose Response confirmation of uHTS for the identification of inhibitors of NALP3 in yeast using a luminescent assay. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2825, AID2832]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL601543";"";"None";"610.73";"1";"7.85";"SID24827750";"CCN1/C(=C/C=C/c2oc3ccc(-c4ccccc4)cc3[n+]2CC)Oc2ccc(-c3ccccc3)cc21.CCOS(=O)(=O)[O-]";"IC50";"'='";"8930.0";"nM";"5.05";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1738451";"PUBCHEM_BIOASSAY: Dose Response confirmation of inhibitors of NALP3 in yeast using a Caspase-1-ASC counter screen. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2825, AID2832]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1386774";"";"None";"362.14";"0";"2.97";"SID24824363";"O=c1c2cc(Br)ccc2nc(-c2ccc([N+](=O)[O-])cc2)n1O";"IC50";"'='";"2390.0";"nM";"5.62";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1738451";"PUBCHEM_BIOASSAY: Dose Response confirmation of inhibitors of NALP3 in yeast using a Caspase-1-ASC counter screen. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2825, AID2832]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1585618";"";"None";"375.49";"0";"2.77";"SID14745679";"CN(CCOc1ccccc1)c1ccc(S(=O)(=O)N2CCCCC2)cn1";"IC50";"'>'";"100000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1737963";"PUBCHEM_BIOASSAY: Dose Response confirmation of uHTS for the identification of inhibitors of NALP3 in yeast using a luminescent assay. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2825, AID2832]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1490692";"";"None";"431.24";"1";"6.27";"SID26666845";"O=C(Nc1cccc(Cl)c1)c1cc(N=Nc2ccc([N+](=O)[O-])cc2Cl)ccc1O";"IC50";"'='";"566.0";"nM";"6.25";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1738451";"PUBCHEM_BIOASSAY: Dose Response confirmation of inhibitors of NALP3 in yeast using a Caspase-1-ASC counter screen. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2825, AID2832]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1329507";"";"None";"340.69";"0";"3.97";"SID17411940";"O=c1c2ccc(Cl)cc2nc(-c2cccc(C(F)(F)F)c2)n1O";"IC50";"'='";"2670.0";"nM";"5.57";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1738451";"PUBCHEM_BIOASSAY: Dose Response confirmation of inhibitors of NALP3 in yeast using a Caspase-1-ASC counter screen. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2825, AID2832]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1571123";"";"None";"401.88";"0";"3.66";"SID49721830";"Cc1ccc(NC(=O)c2nc(S(=O)(=O)Cc3ccccc3)ncc2Cl)cc1";"IC50";"'='";"1670.0";"nM";"5.78";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1738451";"PUBCHEM_BIOASSAY: Dose Response confirmation of inhibitors of NALP3 in yeast using a Caspase-1-ASC counter screen. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2825, AID2832]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1707377";"";"None";"329.38";"0";"1.82";"SID51085738";"O=C(NCCCc1ccccc1)c1c(O)nc2sccn2c1=O";"IC50";"'='";"2420.0";"nM";"5.62";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1738451";"PUBCHEM_BIOASSAY: Dose Response confirmation of inhibitors of NALP3 in yeast using a Caspase-1-ASC counter screen. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2825, AID2832]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1596681";"";"None";"381.40";"0";"4.70";"SID14718880";"Br.CCCCCCCCCn1c2c(c(=N)c3c1CCC3)CCC2";"IC50";"'='";"6260.0";"nM";"5.20";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1738451";"PUBCHEM_BIOASSAY: Dose Response confirmation of inhibitors of NALP3 in yeast using a Caspase-1-ASC counter screen. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2825, AID2832]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1457403";"";"None";"378.91";"0";"4.09";"SID57261334";"CCN(CC)c1ccc2nc3ccc(N)cc3[n+](-c3ccccc3)c2c1.[Cl-]";"IC50";"'='";"1080.0";"nM";"5.97";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1738451";"PUBCHEM_BIOASSAY: Dose Response confirmation of inhibitors of NALP3 in yeast using a Caspase-1-ASC counter screen. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2825, AID2832]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1339245";"";"None";"375.38";"0";"3.30";"SID17514380";"COc1ccc(CNC(=O)c2c(C)oc3c2C(=O)c2ccccc2C3=O)cc1";"IC50";"'='";"3110.0";"nM";"5.51";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1738451";"PUBCHEM_BIOASSAY: Dose Response confirmation of inhibitors of NALP3 in yeast using a Caspase-1-ASC counter screen. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2825, AID2832]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1347185";"";"None";"317.69";"0";"2.86";"SID24824347";"O=c1c2cc(Cl)ccc2nc(-c2ccc([N+](=O)[O-])cc2)n1O";"IC50";"'='";"2700.0";"nM";"5.57";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1738451";"PUBCHEM_BIOASSAY: Dose Response confirmation of inhibitors of NALP3 in yeast using a Caspase-1-ASC counter screen. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2825, AID2832]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL3191011";"";"None";"450.46";"1";"2.38";"SID24801055";"O=[N+]([O-])c1cccc(/C=N/Nc2nc(NCc3ccccc3)nc(N3CCOCC3)n2)c1O";"IC50";"'='";"24300.0";"nM";"4.61";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1737963";"PUBCHEM_BIOASSAY: Dose Response confirmation of uHTS for the identification of inhibitors of NALP3 in yeast using a luminescent assay. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2825, AID2832]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL3780602";"";"None";"246.35";"0";"3.43";"12";"C=C1C(=O)C[C@H]2[C@H]1CC/C(C)=C/CC[C@@]1(C)O[C@@H]21";"IC50";"'='";"2590.0";"nM";"5.59";"";"";"UO_0000065";"22.68";"0.42";"2.16";"18.87";"0";"CHEMBL3784389";"Inhibition of NLRP3 in LPS stimulated human THP1 cells assessed as reduction in IL1beta release after 2 hrs by ELISA analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"THP-1";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3779837";"1";"Scientific Literature";"J Med Chem";"2016";"CHEMBL3307574";"";"";""
"CHEMBL1525362";"";"None";"265.36";"0";"4.32";"SID49641572";"c1ccc(C2Nc3ccccc3C3OCCCC23)cc1";"IC50";"'='";"7360.0";"nM";"5.13";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1737963";"PUBCHEM_BIOASSAY: Dose Response confirmation of uHTS for the identification of inhibitors of NALP3 in yeast using a luminescent assay. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2825, AID2832]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1343658";"";"None";"355.33";"0";"1.46";"SID49730053";"Cn1c(=O)c(C(=O)NNC(=O)c2ccccc2F)c(O)c2ccccc21";"IC50";"'='";"1940.0";"nM";"5.71";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1737963";"PUBCHEM_BIOASSAY: Dose Response confirmation of uHTS for the identification of inhibitors of NALP3 in yeast using a luminescent assay. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2825, AID2832]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1563728";"";"None";"578.00";"0";"3.59";"SID51085168";"CCC1Nc2ncnc(N3CCN(c4ccccn4)CC3)c2N(Cc2ccc(Cl)cc2)C1=O.O=C(O)C(F)(F)F";"IC50";"'='";"3160.0";"nM";"5.50";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1737963";"PUBCHEM_BIOASSAY: Dose Response confirmation of uHTS for the identification of inhibitors of NALP3 in yeast using a luminescent assay. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2825, AID2832]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1398317";"";"None";"227.26";"0";"2.95";"SID56462847";"COc1cccc(NC(=O)c2ccccc2)c1";"IC50";"'='";"13700.0";"nM";"4.86";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1737963";"PUBCHEM_BIOASSAY: Dose Response confirmation of uHTS for the identification of inhibitors of NALP3 in yeast using a luminescent assay. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2825, AID2832]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1703295";"";"None";"308.29";"0";"2.37";"SID56322652";"COc1c(OC(C)=O)c(=O)n2c3ccccc3c3ccnc1c32";"IC50";"'='";"1580.0";"nM";"5.80";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1737963";"PUBCHEM_BIOASSAY: Dose Response confirmation of uHTS for the identification of inhibitors of NALP3 in yeast using a luminescent assay. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2825, AID2832]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL461939";"";"None";"409.41";"0";"4.81";"1; CFTRinh-172";"O=C(O)c1ccc(/C=C2\SC(=S)N(c3cccc(C(F)(F)F)c3)C2=O)cc1";"IC50";"'='";"6390.0";"nM";"5.19";"";"";"UO_0000065";"12.69";"0.26";"0.38";"9.02";"0";"CHEMBL4628081";"Inhibition of NLRP3 inflammasome (unknown origin) activation in LPS-primed bone marrow derived macrophage cells assessed as effect on IL-1beta production in presence of nigericin by ELISA";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4627283";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"";"";""
"CHEMBL4649793";"";"None";"491.56";"0";"4.50";"2";"CN1CCN(C(=O)c2ccc(/C=C3\SC(=S)N(c4cccc(C(F)(F)F)c4)C3=O)cc2)CC1";"IC50";"'='";"2690.0";"nM";"5.57";"";"";"UO_0000065";"11.33";"0.23";"1.07";"12.70";"0";"CHEMBL4628081";"Inhibition of NLRP3 inflammasome (unknown origin) activation in LPS-primed bone marrow derived macrophage cells assessed as effect on IL-1beta production in presence of nigericin by ELISA";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4627283";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"";"";""
"CHEMBL4643934";"";"None";"492.54";"0";"4.71";"4";"O=C(c1ccc(/C=C2\SC(=S)N(c3cccc(C(F)(F)F)c3)C2=O)cc1)N1CCC(O)CC1";"IC50";"'='";"2440.0";"nM";"5.61";"";"";"UO_0000065";"11.40";"0.23";"0.90";"9.22";"0";"CHEMBL4628081";"Inhibition of NLRP3 inflammasome (unknown origin) activation in LPS-primed bone marrow derived macrophage cells assessed as effect on IL-1beta production in presence of nigericin by ELISA";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4627283";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"";"";""
"CHEMBL4634233";"";"None";"507.56";"1";"4.38";"5";"CN1CCN(C(=O)c2ccc(/C=C3\SC(=S)N(c4cccc(OC(F)(F)F)c4)C3=O)cc2)CC1";"IC50";"'='";"2570.0";"nM";"5.59";"";"";"UO_0000065";"11.01";"0.22";"1.21";"10.53";"0";"CHEMBL4628081";"Inhibition of NLRP3 inflammasome (unknown origin) activation in LPS-primed bone marrow derived macrophage cells assessed as effect on IL-1beta production in presence of nigericin by ELISA";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4627283";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"";"";""
"CHEMBL4632676";"";"None";"431.40";"0";"4.12";"17";"O=C1S/C(=C\c2ccc(-c3nnn[nH]3)cc2)C(=O)N1Cc1cccc(C(F)(F)F)c1";"IC50";"'='";"5610.0";"nM";"5.25";"";"";"UO_0000065";"12.17";"0.24";"1.13";"5.72";"0";"CHEMBL4628081";"Inhibition of NLRP3 inflammasome (unknown origin) activation in LPS-primed bone marrow derived macrophage cells assessed as effect on IL-1beta production in presence of nigericin by ELISA";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4627283";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"";"";""
"CHEMBL1505307";"";"None";"343.86";"0";"4.00";"SID24792932";"Cc1cccc(NC(=O)N2CCN(Cc3ccc(Cl)cc3)CC2)c1";"IC50";"'='";"43400.0";"nM";"4.36";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1737963";"PUBCHEM_BIOASSAY: Dose Response confirmation of uHTS for the identification of inhibitors of NALP3 in yeast using a luminescent assay. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2825, AID2832]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1512568";"";"None";"319.39";"0";"2.08";"SID51085724";"O=C(NCCC1=CCCCC1)c1c(O)nc2sccn2c1=O";"IC50";"'='";"2240.0";"nM";"5.65";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1738451";"PUBCHEM_BIOASSAY: Dose Response confirmation of inhibitors of NALP3 in yeast using a Caspase-1-ASC counter screen. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2825, AID2832]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1388722";"";"None";"317.68";"0";"3.73";"SID14728967";"O=c1cc(-c2ccccc2Cl)oc2ccc([N+](=O)[O-])c(O)c12";"IC50";"'='";"1890.0";"nM";"5.72";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1738451";"PUBCHEM_BIOASSAY: Dose Response confirmation of inhibitors of NALP3 in yeast using a Caspase-1-ASC counter screen. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2825, AID2832]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL4752523";"";"None";"389.50";"0";"3.24";"7";"O=C(Nc1c2c(cc3c1CCC3)CCC2)NS(=O)(=O)/C=C/c1nccs1";"IC50";"'='";"24.0";"nM";"7.62";"";"";"UO_0000065";"19.56";"0.40";"4.38";"8.64";"0";"CHEMBL4671764";"Inhibition of NLRP3 inflammasome activation in human THP1 cells assessed as inhibition of IL-1beta release in presence of MSU";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"THP-1";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4665838";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"";"INHIBITOR";""
"CHEMBL4744515";"";"None";"383.47";"0";"3.18";"6";"O=C(Nc1c2c(cc3c1CCC3)CCC2)NS(=O)(=O)/C=C/c1ccccn1";"IC50";"'='";"1000.0";"nM";"6.00";"";"";"UO_0000065";"15.65";"0.30";"2.82";"6.81";"0";"CHEMBL4671767";"Inhibition of NLRP3 in human THP1 cells assessed as inhibition of IL-1beta production";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"THP-1";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4665838";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"";"INHIBITOR";""
"CHEMBL1585618";"";"None";"375.49";"0";"2.77";"SID14745679";"CN(CCOc1ccccc1)c1ccc(S(=O)(=O)N2CCCCC2)cn1";"IC50";"'='";"5100.0";"nM";"5.29";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1738451";"PUBCHEM_BIOASSAY: Dose Response confirmation of inhibitors of NALP3 in yeast using a Caspase-1-ASC counter screen. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2825, AID2832]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1602195";"";"None";"274.32";"0";"1.60";"SID24830824";"CCCCCNC(=O)C(=O)C1C(=O)Nc2ccccc21";"IC50";"'='";"1780.0";"nM";"5.75";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1738451";"PUBCHEM_BIOASSAY: Dose Response confirmation of inhibitors of NALP3 in yeast using a Caspase-1-ASC counter screen. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2825, AID2832]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1711405";"";"None";"340.22";"0";"1.70";"SID49728486";"O=C(CN1CCCCC1)NNC(=O)c1cccc(Br)c1";"IC50";"'='";"4440.0";"nM";"5.35";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1738451";"PUBCHEM_BIOASSAY: Dose Response confirmation of inhibitors of NALP3 in yeast using a Caspase-1-ASC counter screen. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2825, AID2832]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1563728";"";"None";"578.00";"0";"3.59";"SID51085168";"CCC1Nc2ncnc(N3CCN(c4ccccn4)CC3)c2N(Cc2ccc(Cl)cc2)C1=O.O=C(O)C(F)(F)F";"IC50";"'='";"3320.0";"nM";"5.48";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1738451";"PUBCHEM_BIOASSAY: Dose Response confirmation of inhibitors of NALP3 in yeast using a Caspase-1-ASC counter screen. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2825, AID2832]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1525362";"";"None";"265.36";"0";"4.32";"SID49641572";"c1ccc(C2Nc3ccccc3C3OCCCC23)cc1";"IC50";"'='";"881.0";"nM";"6.05";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1738451";"PUBCHEM_BIOASSAY: Dose Response confirmation of inhibitors of NALP3 in yeast using a Caspase-1-ASC counter screen. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2825, AID2832]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1532568";"";"None";"316.15";"0";"4.45";"SID7977519";"O=C(Nc1cccc(Br)c1)c1cc2ccccc2o1";"IC50";"'='";"3370.0";"nM";"5.47";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1738451";"PUBCHEM_BIOASSAY: Dose Response confirmation of inhibitors of NALP3 in yeast using a Caspase-1-ASC counter screen. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2825, AID2832]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1716490";"";"None";"332.24";"0";"4.20";"SID47194217";"O=C(NCCCCc1ccccc1)c1ccccc1Br";"IC50";"'='";"2070.0";"nM";"5.68";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1738451";"PUBCHEM_BIOASSAY: Dose Response confirmation of inhibitors of NALP3 in yeast using a Caspase-1-ASC counter screen. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2825, AID2832]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL4755384";"";"None";"393.45";"0";"2.14";"20";"O=C(Nc1c2c(cc3c1OCC3)OCC2)NS(=O)(=O)/C=C/c1nccs1";"IC50";"'>'";"1000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4671767";"Inhibition of NLRP3 in human THP1 cells assessed as inhibition of IL-1beta production";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"THP-1";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4665838";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"";"";""
"CHEMBL1076347";"TRICLOCARBAN";"4.0";"315.59";"1";"5.29";"SID85148633";"O=C(Nc1ccc(Cl)cc1)Nc1ccc(Cl)c(Cl)c1";"IC50";"'='";"1490.0";"nM";"5.83";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1737963";"PUBCHEM_BIOASSAY: Dose Response confirmation of uHTS for the identification of inhibitors of NALP3 in yeast using a luminescent assay. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2825, AID2832]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL4633769";"";"None";"406.53";"0";"2.61";"11";"Cc1ccc(S(=O)(=O)NS(=O)(=O)Nc2c3c(cc4c2CCC4)CCC3)cc1";"IC50";"'>'";"1000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4605569";"Inhibition of NLRP3 inflammasome activation in LPS-primed human THP1 cells assessed as reduction in IL-1beta level preincubated for 1 hr followed by addition of ATP and nigericin further incubated for 1 hrs and measured post ATP addition 1 hr by ELISA method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"THP-1";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4602705";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"CHEMBL3307574";"";"";""
"CHEMBL4649881";"";"None";"374.41";"1";"5.09";"5";"O=C(Nc1c2c(cc3c1CCC3)CCC2)NC(c1ccccc1)C(F)(F)F";"IC50";"'>'";"1000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4605569";"Inhibition of NLRP3 inflammasome activation in LPS-primed human THP1 cells assessed as reduction in IL-1beta level preincubated for 1 hr followed by addition of ATP and nigericin further incubated for 1 hrs and measured post ATP addition 1 hr by ELISA method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"THP-1";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4602705";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"CHEMBL3307574";"";"";""
"CHEMBL4644835";"";"None";"412.49";"0";"4.16";"29";"Cc1ccc(S(=O)(=NC#N)NC(=O)Nc2c3c(cc4c2CCC4)CCC3)cc1F";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4605574";"Inhibition of NLRP3 inflammasome activation in LPS-primed human THP1 cells assessed as reduction in TNF alpha level preincubated for 1 hr followed by addition of monosodium urate crystals further incubated for 16 hrs and measured post monosodium urate crystals addition 1 hr by ELISA method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"THP-1";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4602705";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"CHEMBL3307574";"";"";""
"CHEMBL1558285";"";"None";"407.30";"0";"3.54";"SID49641834";"CCN(CC)c1ccc2nc3ccccc3[n+](CC)c2c1.[I-]";"IC50";"'='";"14300.0";"nM";"4.84";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1737963";"PUBCHEM_BIOASSAY: Dose Response confirmation of uHTS for the identification of inhibitors of NALP3 in yeast using a luminescent assay. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2825, AID2832]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1716490";"";"None";"332.24";"0";"4.20";"SID47194217";"O=C(NCCCCc1ccccc1)c1ccccc1Br";"IC50";"'='";"18500.0";"nM";"4.73";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1737963";"PUBCHEM_BIOASSAY: Dose Response confirmation of uHTS for the identification of inhibitors of NALP3 in yeast using a luminescent assay. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2825, AID2832]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL5289544";"";"None";"339.44";"0";"2.94";"I-4";"Cc1nc(N[C@@H]2CCCN(C)C2)nnc1-c1ccc(C2CC2)cc1O";"IC50";"'<'";"1.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5260446";"Inhibition of NLRP3 inflammasome activation in PMA-differentiated human THP-1 cells assessed as reduction in IL-1beta secretion preincubated for 20 hrs followed by nigericin addition and measured after 3 hrs by HTRF assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"THP-1";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5257145";"1";"Scientific Literature";"ACS Med Chem Lett";"2023";"None";"TIME = 23.0 hr";"INHIBITOR";""
"CHEMBL5268317";"";"None";"331.40";"0";"2.51";"I-19";"Cc1cc(O)c(-c2nnc(N[C@@H]3CCCN(C)C3)nc2C)c(F)c1";"IC50";"'<'";"1.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5260446";"Inhibition of NLRP3 inflammasome activation in PMA-differentiated human THP-1 cells assessed as reduction in IL-1beta secretion preincubated for 20 hrs followed by nigericin addition and measured after 3 hrs by HTRF assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"THP-1";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5257145";"1";"Scientific Literature";"ACS Med Chem Lett";"2023";"None";"TIME = 23.0 hr";"INHIBITOR";""
"CHEMBL3906283";"";"None";"420.49";"0";"2.49";"2b";"CC(C)(O)c1coc(S(=O)(=O)NC(=O)Nc2c3c(cc4c2CC[C@@H]4O)CCC3)c1";"IC50";"'='";"6352.0";"nM";"5.20";"";"";"UO_0000065";"12.36";"0.24";"2.71";"4.03";"0";"CHEMBL3864034";"Inhibition of NLRP3 inflammasome in LPS-stimulated human monocyte derived macrophages assessed as reduction in NLRP3 inflammasome-induced IL-1beta production preincubated for 30 mins followed by NLRP3 stimulation with ATP for 1 hr by ELISA";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3862040";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"";"";""
"CHEMBL472";"GLYBURIDE";"4.0";"494.01";"0";"3.64";"1; glyburide";"COc1ccc(Cl)cc1C(=O)NCCc1ccc(S(=O)(=O)NC(=O)NC2CCCCC2)cc1";"IC50";"'='";"12000.0";"nM";"4.92";"";"";"UO_0000065";"9.96";"0.20";"1.28";"4.33";"0";"CHEMBL3784286";"Inhibition of NLRP3 in LPS activated human monocytes after 30 mins by ELISA analysis in presence of ATP";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3779837";"1";"Scientific Literature";"J Med Chem";"2016";"None";"";"";""
"CHEMBL4228510";"";"None";"312.32";"0";"3.27";"5d";"COc1ccc(C/C(=N\O)c2nc3ccc(OC)cc3o2)cc1";"IC50";"'='";"1220.0";"nM";"5.91";"";"";"UO_0000065";"18.93";"0.35";"2.64";"7.67";"0";"CHEMBL4221123";"Inhibition of NLRP3 inflammasome in human THP1 cells assessed as reduction in MSU-induced IL-1beta production preincubated for 1 hr followed by MSU stimulation measured after 6 hrs";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4219086";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";"";""
"CHEMBL4227524";"";"None";"286.72";"0";"3.90";"5h";"O/N=C(\Cc1ccccc1)c1nc2ccc(Cl)cc2o1";"IC50";"'='";"21950.0";"nM";"4.66";"";"";"UO_0000065";"16.25";"0.32";"0.76";"7.95";"0";"CHEMBL4221123";"Inhibition of NLRP3 inflammasome in human THP1 cells assessed as reduction in MSU-induced IL-1beta production preincubated for 1 hr followed by MSU stimulation measured after 6 hrs";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4219086";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";"";""
"CHEMBL4227459";"";"None";"266.30";"0";"3.56";"5i";"Cc1ccc2nc(/C(Cc3ccccc3)=N/O)oc2c1";"IC50";"'='";"15880.0";"nM";"4.80";"";"";"UO_0000065";"18.02";"0.33";"1.24";"8.19";"0";"CHEMBL4221123";"Inhibition of NLRP3 inflammasome in human THP1 cells assessed as reduction in MSU-induced IL-1beta production preincubated for 1 hr followed by MSU stimulation measured after 6 hrs";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4219086";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";"";""
"CHEMBL3192672";"";"None";"282.35";"0";"2.97";"SID14741635";"C=CCc1c(C)nc(C)nc1N/N=C/c1ccccc1O";"IC50";"'='";"9370.0";"nM";"5.03";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1738451";"PUBCHEM_BIOASSAY: Dose Response confirmation of inhibitors of NALP3 in yeast using a Caspase-1-ASC counter screen. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2825, AID2832]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1398317";"";"None";"227.26";"0";"2.95";"SID56462847";"COc1cccc(NC(=O)c2ccccc2)c1";"IC50";"'='";"4540.0";"nM";"5.34";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1738451";"PUBCHEM_BIOASSAY: Dose Response confirmation of inhibitors of NALP3 in yeast using a Caspase-1-ASC counter screen. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2825, AID2832]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL4640644";"";"None";"394.50";"0";"3.20";"14";"Cc1ccc(S(=O)(=O)N/C(=N\C#N)Nc2c3c(cc4c2CCC4)CCC3)cc1";"IC50";"'>'";"1000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4605569";"Inhibition of NLRP3 inflammasome activation in LPS-primed human THP1 cells assessed as reduction in IL-1beta level preincubated for 1 hr followed by addition of ATP and nigericin further incubated for 1 hrs and measured post ATP addition 1 hr by ELISA method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"THP-1";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4602705";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"CHEMBL3307574";"";"";""
"CHEMBL4642066";"";"None";"370.47";"0";"3.48";"3";"Cc1ccc(S(=O)(=O)NC(=O)Nc2c3c(cc4c2CCC4)CCC3)cc1";"IC50";"'='";"15.0";"nM";"7.82";"";"";"UO_0000065";"21.12";"0.41";"4.34";"10.39";"0";"CHEMBL4605569";"Inhibition of NLRP3 inflammasome activation in LPS-primed human THP1 cells assessed as reduction in IL-1beta level preincubated for 1 hr followed by addition of ATP and nigericin further incubated for 1 hrs and measured post ATP addition 1 hr by ELISA method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"THP-1";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4602705";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"CHEMBL3307574";"";"";""
"CHEMBL3183703";"";"None";"404.49";"0";"2.99";"1; MCC950, CRID3, CP-456,773";"CC(C)(O)c1coc(S(=O)(=O)NC(=O)Nc2c3c(cc4c2CCC4)CCC3)c1";"IC50";"'='";"8.0";"nM";"8.10";"";"";"UO_0000065";"20.02";"0.39";"5.11";"7.45";"1";"CHEMBL4605569";"Inhibition of NLRP3 inflammasome activation in LPS-primed human THP1 cells assessed as reduction in IL-1beta level preincubated for 1 hr followed by addition of ATP and nigericin further incubated for 1 hrs and measured post ATP addition 1 hr by ELISA method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"THP-1";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4602705";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"CHEMBL3307574";"";"";""
"CHEMBL4643205";"";"None";"405.48";"0";"3.58";"30";"N#CN=S(=O)(NC(=O)Nc1c2c(cc3c1CCC3)CCC2)c1ccc(C#N)cc1";"IC50";"'='";"34.0";"nM";"7.47";"";"";"UO_0000065";"18.42";"0.35";"3.89";"6.32";"0";"CHEMBL4605569";"Inhibition of NLRP3 inflammasome activation in LPS-primed human THP1 cells assessed as reduction in IL-1beta level preincubated for 1 hr followed by addition of ATP and nigericin further incubated for 1 hrs and measured post ATP addition 1 hr by ELISA method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"THP-1";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4602705";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"CHEMBL3307574";"";"";""
"CHEMBL4649141";"";"None";"381.46";"0";"3.10";"34";"N#CN=S(=O)(NC(=O)Nc1c2c(cc3c1CCC3)CCC2)c1ccccn1";"IC50";"'='";"23.0";"nM";"7.64";"";"";"UO_0000065";"20.02";"0.39";"4.54";"7.12";"0";"CHEMBL4605569";"Inhibition of NLRP3 inflammasome activation in LPS-primed human THP1 cells assessed as reduction in IL-1beta level preincubated for 1 hr followed by addition of ATP and nigericin further incubated for 1 hrs and measured post ATP addition 1 hr by ELISA method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"THP-1";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4602705";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"CHEMBL3307574";"";"";""
"CHEMBL4647621";"";"None";"380.47";"0";"3.71";"16";"N#CN=S(=O)(NC(=O)Nc1c2c(cc3c1CCC3)CCC2)c1ccccc1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4605574";"Inhibition of NLRP3 inflammasome activation in LPS-primed human THP1 cells assessed as reduction in TNF alpha level preincubated for 1 hr followed by addition of monosodium urate crystals further incubated for 16 hrs and measured post monosodium urate crystals addition 1 hr by ELISA method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"THP-1";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4602705";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"CHEMBL3307574";"";"";""
"CHEMBL4204644";"";"None";"410.52";"0";"2.99";"4";"[2H]C([2H])([2H])C(O)(c1coc(S(=O)(=O)NC(=O)Nc2c3c(cc4c2CCC4)CCC3)c1)C([2H])([2H])[2H]";"IC50";"'='";"5.0";"nM";"8.30";"";"";"UO_0000065";"20.52";"0.40";"5.31";"7.64";"0";"CHEMBL4187544";"Inhibition of NLRP3 in human monocyte derived macrophages assessed as reduction in LPS-induced IL-1beta production incubated for 30 mins followed by nigericin sodium salt stimulation for 2 hrs post LPS challenge for 3 hrs by ELISA";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4184214";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";""
"CHEMBL4209503";"";"None";"408.51";"0";"2.99";"3";"[2H]C1([2H])CCc2cc3c(c(NC(=O)NS(=O)(=O)c4cc(C(C)(C)O)co4)c21)C([2H])([2H])CC3";"IC50";"'='";"6.0";"nM";"8.22";"";"";"UO_0000065";"20.33";"0.40";"5.23";"7.57";"0";"CHEMBL4187544";"Inhibition of NLRP3 in human monocyte derived macrophages assessed as reduction in LPS-induced IL-1beta production incubated for 30 mins followed by nigericin sodium salt stimulation for 2 hrs post LPS challenge for 3 hrs by ELISA";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4184214";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";""
"CHEMBL1339092";"";"None";"461.37";"0";"4.04";"SID22411930";"I.c1ccc(Sc2cccc3ccccc23)c(CNC2=NCCN2)c1";"IC50";"'='";"11700.0";"nM";"4.93";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1737963";"PUBCHEM_BIOASSAY: Dose Response confirmation of uHTS for the identification of inhibitors of NALP3 in yeast using a luminescent assay. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2825, AID2832]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1339245";"";"None";"375.38";"0";"3.30";"SID17514380";"COc1ccc(CNC(=O)c2c(C)oc3c2C(=O)c2ccccc2C3=O)cc1";"IC50";"'='";"9700.0";"nM";"5.01";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1737963";"PUBCHEM_BIOASSAY: Dose Response confirmation of uHTS for the identification of inhibitors of NALP3 in yeast using a luminescent assay. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2825, AID2832]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1447078";"";"None";"258.36";"0";"4.25";"SID47198483";"CCCC1CCC(c2ccc(OCC)cc2)=CC1=O";"IC50";"'='";"4850.0";"nM";"5.31";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1738451";"PUBCHEM_BIOASSAY: Dose Response confirmation of inhibitors of NALP3 in yeast using a Caspase-1-ASC counter screen. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2825, AID2832]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1539913";"";"None";"299.17";"0";"4.30";"SID49674185";"Brc1ccc(-n2cnc(-c3ccccc3)c2)cc1";"IC50";"'='";"10100.0";"nM";"5.00";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1738451";"PUBCHEM_BIOASSAY: Dose Response confirmation of inhibitors of NALP3 in yeast using a Caspase-1-ASC counter screen. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2825, AID2832]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL3193158";"";"None";"415.53";"0";"3.33";"SID4248264";"CCCCCC(=O)N1CCN(CC/N=C/C2=C(O)CC(c3ccco3)CC2=O)CC1";"IC50";"'='";"8620.0";"nM";"5.06";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1738451";"PUBCHEM_BIOASSAY: Dose Response confirmation of inhibitors of NALP3 in yeast using a Caspase-1-ASC counter screen. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2825, AID2832]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1343658";"";"None";"355.33";"0";"1.46";"SID49730053";"Cn1c(=O)c(C(=O)NNC(=O)c2ccccc2F)c(O)c2ccccc21";"IC50";"'='";"1560.0";"nM";"5.81";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1738451";"PUBCHEM_BIOASSAY: Dose Response confirmation of inhibitors of NALP3 in yeast using a Caspase-1-ASC counter screen. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2825, AID2832]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1994635";"";"None";"254.31";"0";"3.75";"SID26671049";"Oc1c(/C=N/c2ccccn2)sc2ccccc12";"IC50";"'='";"3800.0";"nM";"5.42";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1738451";"PUBCHEM_BIOASSAY: Dose Response confirmation of inhibitors of NALP3 in yeast using a Caspase-1-ASC counter screen. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2825, AID2832]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1529733";"";"None";"296.29";"0";"1.29";"SID7972888";"Cn1c(=O)c(C(=O)Nc2ncccn2)c(O)c2ccccc21";"IC50";"'='";"3180.0";"nM";"5.50";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1738451";"PUBCHEM_BIOASSAY: Dose Response confirmation of inhibitors of NALP3 in yeast using a Caspase-1-ASC counter screen. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2825, AID2832]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1559889";"";"None";"246.27";"0";"1.78";"SID857404";"CC(C)NC(=O)c1c(O)nc2ccccc2c1O";"IC50";"'='";"1190.0";"nM";"5.92";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1738451";"PUBCHEM_BIOASSAY: Dose Response confirmation of inhibitors of NALP3 in yeast using a Caspase-1-ASC counter screen. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2825, AID2832]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1386774";"";"None";"362.14";"0";"2.97";"SID24824363";"O=c1c2cc(Br)ccc2nc(-c2ccc([N+](=O)[O-])cc2)n1O";"IC50";"'='";"4910.0";"nM";"5.31";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1737963";"PUBCHEM_BIOASSAY: Dose Response confirmation of uHTS for the identification of inhibitors of NALP3 in yeast using a luminescent assay. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2825, AID2832]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1602195";"";"None";"274.32";"0";"1.60";"SID24830824";"CCCCCNC(=O)C(=O)C1C(=O)Nc2ccccc21";"IC50";"'='";"2900.0";"nM";"5.54";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1737963";"PUBCHEM_BIOASSAY: Dose Response confirmation of uHTS for the identification of inhibitors of NALP3 in yeast using a luminescent assay. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2825, AID2832]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1447669";"";"None";"272.70";"0";"2.64";"SID4261206";"O=C(Nc1cccc(Cl)c1)c1cnn2cccnc12";"IC50";"'='";"8190.0";"nM";"5.09";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1737963";"PUBCHEM_BIOASSAY: Dose Response confirmation of uHTS for the identification of inhibitors of NALP3 in yeast using a luminescent assay. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2825, AID2832]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1530042";"";"None";"321.30";"0";"4.00";"SID864095";"CC1CC(=O)c2cnc(Nc3cccc(C(F)(F)F)c3)nc2C1";"IC50";"'='";"46000.0";"nM";"4.34";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1737963";"PUBCHEM_BIOASSAY: Dose Response confirmation of uHTS for the identification of inhibitors of NALP3 in yeast using a luminescent assay. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2825, AID2832]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL488823";"";"None";"423.44";"0";"4.81";"9";"O=C(O)c1ccc(/C=C2\SC(=S)N(Cc3cccc(C(F)(F)F)c3)C2=O)cc1";"IC50";"'='";"2400.0";"nM";"5.62";"";"";"UO_0000065";"13.27";"0.27";"0.81";"9.75";"0";"CHEMBL4628081";"Inhibition of NLRP3 inflammasome (unknown origin) activation in LPS-primed bone marrow derived macrophage cells assessed as effect on IL-1beta production in presence of nigericin by ELISA";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4627283";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"";"";""
"CHEMBL1339092";"";"None";"461.37";"0";"4.04";"SID22411930";"I.c1ccc(Sc2cccc3ccccc23)c(CNC2=NCCN2)c1";"IC50";"'='";"7620.0";"nM";"5.12";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1738451";"PUBCHEM_BIOASSAY: Dose Response confirmation of inhibitors of NALP3 in yeast using a Caspase-1-ASC counter screen. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2825, AID2832]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1334557";"";"None";"366.87";"0";"4.13";"SID22413246";"CCOC(=O)N1C(=O)C2(CCCCC2)N(c2ccccc2Cl)C1=S";"IC50";"'='";"10600.0";"nM";"4.97";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1738451";"PUBCHEM_BIOASSAY: Dose Response confirmation of inhibitors of NALP3 in yeast using a Caspase-1-ASC counter screen. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2825, AID2832]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1505335";"";"None";"346.48";"0";"3.29";"SID24790921";"Cc1ccc(S(=O)(=O)N2CCN=C2SCc2ccccc2)cc1";"IC50";"'='";"3170.0";"nM";"5.50";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1738451";"PUBCHEM_BIOASSAY: Dose Response confirmation of inhibitors of NALP3 in yeast using a Caspase-1-ASC counter screen. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2825, AID2832]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1447669";"";"None";"272.70";"0";"2.64";"SID4261206";"O=C(Nc1cccc(Cl)c1)c1cnn2cccnc12";"IC50";"'='";"4350.0";"nM";"5.36";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1738451";"PUBCHEM_BIOASSAY: Dose Response confirmation of inhibitors of NALP3 in yeast using a Caspase-1-ASC counter screen. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2825, AID2832]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1427059";"";"None";"298.37";"0";"3.43";"SID49641964";"CCSc1nsc(NC(=O)Nc2cccc(F)c2)n1";"IC50";"'='";"1220.0";"nM";"5.91";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1738451";"PUBCHEM_BIOASSAY: Dose Response confirmation of inhibitors of NALP3 in yeast using a Caspase-1-ASC counter screen. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2825, AID2832]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1703295";"";"None";"308.29";"0";"2.37";"SID56322652";"COc1c(OC(C)=O)c(=O)n2c3ccccc3c3ccnc1c32";"IC50";"'='";"665.0";"nM";"6.18";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1738451";"PUBCHEM_BIOASSAY: Dose Response confirmation of inhibitors of NALP3 in yeast using a Caspase-1-ASC counter screen. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2825, AID2832]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1549127";"";"None";"354.41";"0";"3.82";"SID14743634";"CCOC(=O)c1ccc2c(c1)nc(COc1ccc(OC)cc1)n2CC";"IC50";"'='";"9830.0";"nM";"5.01";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1738451";"PUBCHEM_BIOASSAY: Dose Response confirmation of inhibitors of NALP3 in yeast using a Caspase-1-ASC counter screen. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2825, AID2832]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1411435";"";"None";"333.34";"0";"1.48";"SID49645184";"O=C(NC(=S)NNC(=O)c1ccccc1O)c1ccc(F)cc1";"IC50";"'='";"1820.0";"nM";"5.74";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1738451";"PUBCHEM_BIOASSAY: Dose Response confirmation of inhibitors of NALP3 in yeast using a Caspase-1-ASC counter screen. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2825, AID2832]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1256359";"ALAPROCLATE HYDROCHLORIDE";"None";"292.21";"0";"2.55";"SID56463328";"CC(N)C(=O)OC(C)(C)Cc1ccc(Cl)cc1.Cl";"IC50";"'='";"4300.0";"nM";"5.37";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1738451";"PUBCHEM_BIOASSAY: Dose Response confirmation of inhibitors of NALP3 in yeast using a Caspase-1-ASC counter screen. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2825, AID2832]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1530042";"";"None";"321.30";"0";"4.00";"SID864095";"CC1CC(=O)c2cnc(Nc3cccc(C(F)(F)F)c3)nc2C1";"IC50";"'='";"2730.0";"nM";"5.56";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1738451";"PUBCHEM_BIOASSAY: Dose Response confirmation of inhibitors of NALP3 in yeast using a Caspase-1-ASC counter screen. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2825, AID2832]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1727095";"";"None";"333.41";"0";"2.39";"SID51090750";"Cc1csc2nc(O)c(C(=O)NCCC3=CCCCC3)c(=O)n12";"IC50";"'='";"2330.0";"nM";"5.63";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1738451";"PUBCHEM_BIOASSAY: Dose Response confirmation of inhibitors of NALP3 in yeast using a Caspase-1-ASC counter screen. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2825, AID2832]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL4648131";"";"None";"345.38";"0";"2.54";"9b";"COc1ccc(S(=O)(=O)N/N=C(\C)c2nc3ccccc3o2)cc1";"IC50";"'='";"7500.0";"nM";"5.12";"";"";"UO_0000065";"14.84";"0.29";"2.58";"5.46";"0";"CHEMBL4611534";"Inhibition of NLRP3 in human THP1 cells assessed as inhibition of MSU-induced IL-1beta production";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"THP-1";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4610050";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"CHEMBL3307574";"";"";""
"CHEMBL4646705";"";"None";"356.43";"0";"3.18";"20";"O=C(O)c1ccc(/C=C2\SC(=S)N(Cc3cccnc3)C2=O)cc1";"IC50";"'='";"6270.0";"nM";"5.20";"";"";"UO_0000065";"14.60";"0.30";"2.02";"7.38";"0";"CHEMBL4628081";"Inhibition of NLRP3 inflammasome (unknown origin) activation in LPS-primed bone marrow derived macrophage cells assessed as effect on IL-1beta production in presence of nigericin by ELISA";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4627283";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"";"";""
"CHEMBL4126909";"";"None";"188.15";"0";"0.37";"17";"CC(=O)OC[C@@H]1C=C(F)C(=O)CO1";"IC50";"'='";"3700.0";"nM";"5.43";"";"";"UO_0000065";"28.87";"0.57";"5.06";"10.33";"0";"CHEMBL4125669";"Inhibition of nigericin-induced NLRP3 inflammasome activation in PMA-differentiated human THP1 cells assessed as reduction in LPS-stimulated IL-1beta secretion incubated for 1 hr prior to stimulation with nigericin for 1 hr by quanti-blue based SEAP reporter gene assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4118290";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";"";""
"CHEMBL1532568";"";"None";"316.15";"0";"4.45";"SID7977519";"O=C(Nc1cccc(Br)c1)c1cc2ccccc2o1";"IC50";"'='";"9810.0";"nM";"5.01";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1737963";"PUBCHEM_BIOASSAY: Dose Response confirmation of uHTS for the identification of inhibitors of NALP3 in yeast using a luminescent assay. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2825, AID2832]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1580883";"";"None";"278.31";"0";"3.36";"SID49645260";"COc1ccc(-c2nn(-c3ccccc3)cc2C=O)cc1";"IC50";"'='";"81000.0";"nM";"4.09";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1737963";"PUBCHEM_BIOASSAY: Dose Response confirmation of uHTS for the identification of inhibitors of NALP3 in yeast using a luminescent assay. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2825, AID2832]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1313152";"";"None";"252.28";"0";"2.24";"SID17433209";"c1ccc(OCc2nnnn2-c2ccccc2)cc1";"IC50";"'='";"6000.0";"nM";"5.22";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1737963";"PUBCHEM_BIOASSAY: Dose Response confirmation of uHTS for the identification of inhibitors of NALP3 in yeast using a luminescent assay. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2825, AID2832]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL4443648";"";"None";"236.32";"0";"4.03";"Fc11a-2";"CCn1c(-c2ccccc2)nc2cc(C)ccc21";"IC50";"'='";"10000.0";"nM";"5.00";"";"";"UO_0000065";"21.16";"0.38";"0.97";"28.06";"0";"CHEMBL4324165";"Inhibition of NLRP3 inflammasome activation in LPS-primed human THP1 cells assessed as reduction in IL-1beta level preincubated for 1 hr followed by addition of ATP and measured after 1 hr by ELISA method";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4321841";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"";"";""
"CHEMBL1711405";"";"None";"340.22";"0";"1.70";"SID49728486";"O=C(CN1CCCCC1)NNC(=O)c1cccc(Br)c1";"IC50";"'='";"23300.0";"nM";"4.63";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1737963";"PUBCHEM_BIOASSAY: Dose Response confirmation of uHTS for the identification of inhibitors of NALP3 in yeast using a luminescent assay. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2825, AID2832]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL602526";"";"None";"318.38";"0";"4.03";"SID49819226";"Cc1cccc(C(=O)ONC(=N)Cc2cccc3ccccc23)c1";"IC50";"'='";"1620.0";"nM";"5.79";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1737963";"PUBCHEM_BIOASSAY: Dose Response confirmation of uHTS for the identification of inhibitors of NALP3 in yeast using a luminescent assay. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2825, AID2832]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1549127";"";"None";"354.41";"0";"3.82";"SID14743634";"CCOC(=O)c1ccc2c(c1)nc(COc1ccc(OC)cc1)n2CC";"IC50";"'>'";"100000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1737963";"PUBCHEM_BIOASSAY: Dose Response confirmation of uHTS for the identification of inhibitors of NALP3 in yeast using a luminescent assay. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2825, AID2832]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL4212407";"";"None";"406.50";"0";"2.99";"1";"[2H]C1([2H])CCc2c1cc1c(c2NC(=O)NS(=O)(=O)c2cc(C(C)(C)O)co2)CCC1";"IC50";"'='";"6.0";"nM";"8.22";"";"";"UO_0000065";"20.33";"0.40";"5.23";"7.57";"0";"CHEMBL4187544";"Inhibition of NLRP3 in human monocyte derived macrophages assessed as reduction in LPS-induced IL-1beta production incubated for 30 mins followed by nigericin sodium salt stimulation for 2 hrs post LPS challenge for 3 hrs by ELISA";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4184214";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";""
"CHEMBL4874656";"";"None";"484.58";"0";"3.25";"29";"COc1cn2nc1S(=O)(=O)NC(=O)Cc1c(cccc1C(C)C)-c1ccnc(c1)OCC2(C)C";"IC50";"'<='";"500.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4827631";"Inhibition of NLRP3 inflammasome activation in LPS/nigericin-treated human THP-1 cells assessed as reduction in pyroptosis pretreated for 3 hrs in presence of LPS followed by nigericin addition and measured after 1 hr by resazurin assay";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"None";"THP-1";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4825720";"1";"Scientific Literature";"ACS Med Chem Lett";"2021";"None";"TIME = 4.0 hr";"INHIBITOR";""
"CHEMBL4752523";"";"None";"389.50";"0";"3.24";"7";"O=C(Nc1c2c(cc3c1CCC3)CCC2)NS(=O)(=O)/C=C/c1nccs1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4671762";"Inhibition of NLRP3 (unknown origin) assessed as inhibition of TNFalpha production by cell based assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4665838";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"";"";""
"CHEMBL4751187";"";"None";"403.53";"0";"3.55";"19";"Cc1c2c(c(NC(=O)NS(=O)(=O)/C=C/c3nccs3)c3c1CCC3)CCC2";"IC50";"'='";"294.0";"nM";"6.53";"";"";"UO_0000065";"16.19";"0.33";"2.98";"7.41";"0";"CHEMBL4671767";"Inhibition of NLRP3 in human THP1 cells assessed as inhibition of IL-1beta production";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"THP-1";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4665838";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"";"INHIBITOR";""
"CHEMBL4216836";"";"None";"408.51";"0";"2.99";"2";"[2H]C1([2H])CCc2c1cc1c(c2NC(=O)NS(=O)(=O)c2cc(C(C)(C)O)co2)CCC1([2H])[2H]";"IC50";"'='";"7.0";"nM";"8.15";"";"";"UO_0000065";"20.16";"0.40";"5.16";"7.51";"0";"CHEMBL4187544";"Inhibition of NLRP3 in human monocyte derived macrophages assessed as reduction in LPS-induced IL-1beta production incubated for 30 mins followed by nigericin sodium salt stimulation for 2 hrs post LPS challenge for 3 hrs by ELISA";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4184214";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";""
"CHEMBL140";"";"None";"368.39";"0";"3.37";"CUR";"COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O";"IC50";"'='";"24200.0";"nM";"4.62";"";"";"UO_0000065";"12.53";"0.23";"1.25";"4.96";"0";"CHEMBL4702878";"Inhibition of NLRP3 inflammasome activation in LPS-primed human PMA-differentiated THP-1 cells assessed as reduction in nigericin-induced IL-1beta level preincubated for 30 mins followed by nigericin addition and measured after 1 hrs by Western blot analysis";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"None";"THP-1";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699526";"1";"Scientific Literature";"J Nat Prod";"2020";"None";"TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5186834";"";"None";"397.48";"0";"3.73";"14";"O=c1cc(Cc2ccccc2)[nH]c2nc(Nc3c4c(cc5c3CCC5)CCC4)nn12";"IC50";"'='";"1800.0";"nM";"5.75";"";"";"UO_0000065";"14.45";"0.26";"2.01";"7.65";"0";"CHEMBL5149834";"Inhibition of NLRP3 inflammasome in LPS-pretreated PBMC (unknown origin) assessed as reduction in IL-1beta release pretreated for 30 mins followed by ATP stimulated and measured after 1 hr by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5143747";"1";"Scientific Literature";"ACS Med Chem Lett";"2022";"None";"TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5174336";"";"None";"431.93";"0";"4.38";"23";"O=c1cc(Cc2ccccc2Cl)[nH]c2nc(Nc3c4c(cc5c3CCC5)CCC4)nn12";"IC50";"";"";"";"";"";"Nd(Insoluble)";"";"";"";"";"";"0";"CHEMBL5149834";"Inhibition of NLRP3 inflammasome in LPS-pretreated PBMC (unknown origin) assessed as reduction in IL-1beta release pretreated for 30 mins followed by ATP stimulated and measured after 1 hr by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5143747";"1";"Scientific Literature";"ACS Med Chem Lett";"2022";"None";"TIME = 1.5 hr";"";""
"CHEMBL5204527";"";"None";"401.47";"0";"2.46";"45";"Cn1ccc(Cc2cc(=O)n3nc(Nc4c5c(cc6c4CCC6)CCC5)nc3[nH]2)n1";"IC50";"'='";"1800.0";"nM";"5.75";"";"";"UO_0000065";"14.31";"0.26";"3.28";"6.18";"0";"CHEMBL5149834";"Inhibition of NLRP3 inflammasome in LPS-pretreated PBMC (unknown origin) assessed as reduction in IL-1beta release pretreated for 30 mins followed by ATP stimulated and measured after 1 hr by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5143747";"1";"Scientific Literature";"ACS Med Chem Lett";"2022";"None";"TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL4859990";"";"None";"490.53";"0";"3.52";"42";"CC(C)c1c(F)c(F)cc2c1CC(=O)NS(=O)(=O)c1cnn(c1)C(C)(C)COc1cc-2ccn1";"IC50";"'<='";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4827631";"Inhibition of NLRP3 inflammasome activation in LPS/nigericin-treated human THP-1 cells assessed as reduction in pyroptosis pretreated for 3 hrs in presence of LPS followed by nigericin addition and measured after 1 hr by resazurin assay";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"None";"THP-1";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4825720";"1";"Scientific Literature";"ACS Med Chem Lett";"2021";"None";"TIME = 4.0 hr";"INHIBITOR";""
"CHEMBL4866852";"";"None";"472.54";"0";"3.38";"25";"CC(C)c1cc(F)cc2c1CC(=O)NS(=O)(=O)c1cnn(c1)C(C)(C)COc1cc-2ccn1";"IC50";"'<='";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4827632";"Inhibition of NLRP3 inflammasome activation in LPS-primed human whole blood assessed as reduction in nigericin-induced IL-1beta level preincubated for 3 hrs followed by nigericin addition and measured after 1 hrs by AlphaLISA assay";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"Blood";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4825720";"1";"Scientific Literature";"ACS Med Chem Lett";"2021";"None";"TIME = 4.0 hr";"INHIBITOR";""
"CHEMBL4756014";"";"None";"370.47";"0";"3.04";"8";"O=C(CS(=O)(=O)Nc1ccccc1)Nc1c2c(cc3c1CCC3)CCC2";"IC50";"'>'";"20000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4702271";"Inhibition of NLRP3 in human PBMC cells assessed as inhibition of LPS and ATP-induced IL-1beta production";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699510";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"";"";""
"CHEMBL5205427";"";"None";"405.50";"0";"3.25";"36;NDT-30408";"O=c1cc(CC2CCCCO2)[nH]c2nc(Nc3c4c(cc5c3CCC5)CCC4)nn12";"IC50";"'='";"1300.0";"nM";"5.89";"";"";"UO_0000065";"14.52";"0.27";"2.64";"6.98";"0";"CHEMBL5149841";"Inhibition of NLRP3 inflammasome in LPS-pretreated human THP1-ASC-GFP cells assessed as reduction in speck positive cells measured after 30 mins in presence of caspase inhibitor zVAD-FMK by Hoechst 33342 staining based confocal microscopy";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"THP1-ASC-GFP";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5143747";"1";"Scientific Literature";"ACS Med Chem Lett";"2022";"None";"TIME = 0.5 hr";"INHIBITOR";""
"CHEMBL5185975";"";"None";"277.32";"0";"3.73";"54";"O=C(Cc1cccc2ccccc12)Nc1cccc(O)c1";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5138374";"Inhibition of NLRP3 inflammasome activation in LPS/nigericin-stimulated PMA-differentiated human THP-1 macrophages assessed as reduction in pyroptosis pretreated with LPS followed by compound treatment for 30 mins then stimulation with nigericin and measured after 3 hrs by MTT assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"THP-1";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5137000";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"TIME = 3.5 hr";"";""
"CHEMBL5172367";"";"None";"320.37";"0";"1.94";"52";"CS(=O)(=O)Nc1ccc(CC(=O)Nc2cccc(O)c2)cc1";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5138374";"Inhibition of NLRP3 inflammasome activation in LPS/nigericin-stimulated PMA-differentiated human THP-1 macrophages assessed as reduction in pyroptosis pretreated with LPS followed by compound treatment for 30 mins then stimulation with nigericin and measured after 3 hrs by MTT assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"THP-1";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5137000";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"TIME = 3.5 hr";"";""
"CHEMBL5169914";"";"None";"280.33";"0";"3.08";"67";"CN(C(=O)Cc1ccc2cc[nH]c2c1)c1cccc(O)c1";"IC50";"'='";"7096.0";"nM";"5.15";"";"";"UO_0000065";"18.37";"0.33";"2.07";"9.14";"0";"CHEMBL5138374";"Inhibition of NLRP3 inflammasome activation in LPS/nigericin-stimulated PMA-differentiated human THP-1 macrophages assessed as reduction in pyroptosis pretreated with LPS followed by compound treatment for 30 mins then stimulation with nigericin and measured after 3 hrs by MTT assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"THP-1";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5137000";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"TIME = 3.5 hr";"INHIBITOR";""
"CHEMBL5207526";"";"None";"391.48";"0";"2.72";"35";"O=c1cc(CC2CCOC2)[nH]c2nc(Nc3c4c(cc5c3CCC5)CCC4)nn12";"IC50";"'='";"5000.0";"nM";"5.30";"";"";"UO_0000065";"13.54";"0.25";"2.58";"6.29";"0";"CHEMBL5149834";"Inhibition of NLRP3 inflammasome in LPS-pretreated PBMC (unknown origin) assessed as reduction in IL-1beta release pretreated for 30 mins followed by ATP stimulated and measured after 1 hr by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5143747";"1";"Scientific Literature";"ACS Med Chem Lett";"2022";"None";"TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5176716";"";"None";"406.49";"0";"1.97";"38";"O=c1cc(CN2CCOCC2)[nH]c2nc(Nc3c4c(cc5c3CCC5)CCC4)nn12";"IC50";"'='";"7800.0";"nM";"5.11";"";"";"UO_0000065";"12.57";"0.23";"3.14";"5.83";"0";"CHEMBL5149834";"Inhibition of NLRP3 inflammasome in LPS-pretreated PBMC (unknown origin) assessed as reduction in IL-1beta release pretreated for 30 mins followed by ATP stimulated and measured after 1 hr by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5143747";"1";"Scientific Literature";"ACS Med Chem Lett";"2022";"None";"TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5203357";"";"None";"406.49";"0";"1.67";"41";"O=c1cc(CC2COCCN2)[nH]c2nc(Nc3c4c(cc5c3CCC5)CCC4)nn12";"IC50";"'='";"5400.0";"nM";"5.27";"";"";"UO_0000065";"12.96";"0.24";"3.60";"5.47";"0";"CHEMBL5149834";"Inhibition of NLRP3 inflammasome in LPS-pretreated PBMC (unknown origin) assessed as reduction in IL-1beta release pretreated for 30 mins followed by ATP stimulated and measured after 1 hr by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5143747";"1";"Scientific Literature";"ACS Med Chem Lett";"2022";"None";"TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5174663";"";"None";"420.52";"0";"2.01";"42";"CN1CCOCC1Cc1cc(=O)n2nc(Nc3c4c(cc5c3CCC5)CCC4)nc2[nH]1";"IC50";"'='";"6000.0";"nM";"5.22";"";"";"UO_0000065";"12.42";"0.23";"3.21";"5.96";"0";"CHEMBL5149834";"Inhibition of NLRP3 inflammasome in LPS-pretreated PBMC (unknown origin) assessed as reduction in IL-1beta release pretreated for 30 mins followed by ATP stimulated and measured after 1 hr by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5143747";"1";"Scientific Literature";"ACS Med Chem Lett";"2022";"None";"TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL4744726";"";"None";"378.47";"0";"3.57";"28";"COC(=O)C(Cc1ccccc1)NC(=O)Nc1c2c(cc3c1CCC3)CCC2";"IC50";"'='";"14000.0";"nM";"4.85";"";"";"UO_0000065";"12.82";"0.24";"1.28";"7.20";"0";"CHEMBL4702271";"Inhibition of NLRP3 in human PBMC cells assessed as inhibition of LPS and ATP-induced IL-1beta production";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699510";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"";"INHIBITOR";""
"CHEMBL4757956";"";"None";"378.47";"0";"3.57";"30";"COC(=O)[C@@H](Cc1ccccc1)NC(=O)Nc1c2c(cc3c1CCC3)CCC2";"IC50";"'='";"6100.0";"nM";"5.21";"";"";"UO_0000065";"13.78";"0.25";"1.64";"7.73";"0";"CHEMBL4702271";"Inhibition of NLRP3 in human PBMC cells assessed as inhibition of LPS and ATP-induced IL-1beta production";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699510";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"";"INHIBITOR";""
"CHEMBL4760013";"";"None";"380.45";"0";"2.36";"42";"COC(=O)[C@@H](Cc1cccnn1)NC(=O)Nc1c2c(cc3c1CCC3)CCC2";"IC50";"'='";"3300.0";"nM";"5.48";"";"";"UO_0000065";"14.41";"0.27";"3.12";"5.88";"0";"CHEMBL4702271";"Inhibition of NLRP3 in human PBMC cells assessed as inhibition of LPS and ATP-induced IL-1beta production";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699510";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"";"INHIBITOR";""
"CHEMBL4780624";"";"None";"394.48";"0";"2.75";"44";"CCOC(=O)[C@@H](Cc1ncccn1)NC(=O)Nc1c2c(cc3c1CCC3)CCC2";"IC50";"'='";"36.0";"nM";"7.44";"";"";"UO_0000065";"18.87";"0.35";"4.69";"7.99";"0";"CHEMBL4702271";"Inhibition of NLRP3 in human PBMC cells assessed as inhibition of LPS and ATP-induced IL-1beta production";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699510";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"";"INHIBITOR";""
"CHEMBL4790034";"";"None";"394.48";"0";"2.75";"45";"CCOC(=O)[C@@H](Cc1cnccn1)NC(=O)Nc1c2c(cc3c1CCC3)CCC2";"IC50";"'='";"200.0";"nM";"6.70";"";"";"UO_0000065";"16.98";"0.32";"3.95";"7.19";"0";"CHEMBL4702274";"Inhibition of NLRP3 in human THP-1 cells assessed as reduction in nigercin-induced ASC speck formation measuring green fluorescent protein aggregation by confocal microscopy";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"THP-1";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699510";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"";"INHIBITOR";""
"CHEMBL5196139";"";"None";"414.54";"0";"4.49";"50;NDT-30805";"S=c1cc(Cc2ccccn2)[nH]c2nc(Nc3c4c(cc5c3CCC5)CCC4)nn12";"IC50";"'='";"1500.0";"nM";"5.82";"";"";"UO_0000065";"14.05";"0.27";"1.33";"8.21";"0";"CHEMBL5149840";"Inhibition of NLRP3 inflammasome in LPS-pretreated human whole blood assessed as reduction in IL-1beta release pretreated for 30 mins followed by ATP stimulated and measured after 1 hr by HTRF assay";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"Blood";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5143747";"1";"Scientific Literature";"ACS Med Chem Lett";"2022";"None";"TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL3183703";"";"None";"404.49";"0";"2.99";"MCC950";"CC(C)(O)c1coc(S(=O)(=O)NC(=O)Nc2c3c(cc4c2CCC4)CCC3)c1";"IC50";"'='";"5.0";"nM";"8.30";"";"";"UO_0000065";"20.52";"0.40";"5.31";"7.64";"0";"CHEMBL4187544";"Inhibition of NLRP3 in human monocyte derived macrophages assessed as reduction in LPS-induced IL-1beta production incubated for 30 mins followed by nigericin sodium salt stimulation for 2 hrs post LPS challenge for 3 hrs by ELISA";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4184214";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";""
"CHEMBL1802309";"";"None";"257.29";"0";"2.58";"10";"COc1ccc(CC(=O)Nc2ccc(O)cc2)cc1";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5138374";"Inhibition of NLRP3 inflammasome activation in LPS/nigericin-stimulated PMA-differentiated human THP-1 macrophages assessed as reduction in pyroptosis pretreated with LPS followed by compound treatment for 30 mins then stimulation with nigericin and measured after 3 hrs by MTT assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"THP-1";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5137000";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"TIME = 3.5 hr";"";""
"CHEMBL5182012";"";"None";"321.38";"0";"2.45";"6";"Cc1c[nH]c2nc(Nc3c4c(cc5c3CCC5)CCC4)nn2c1=O";"IC50";"'>'";"40000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5149834";"Inhibition of NLRP3 inflammasome in LPS-pretreated PBMC (unknown origin) assessed as reduction in IL-1beta release pretreated for 30 mins followed by ATP stimulated and measured after 1 hr by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5143747";"1";"Scientific Literature";"ACS Med Chem Lett";"2022";"None";"TIME = 1.5 hr";"";""
"CHEMBL3781001";"";"None";"438.98";"1";"5.15";"4; CP-412,245";"CC(C)c1cc(Cl)cc(C(C)C)c1NC(=O)NS(=O)(=O)c1cccc(C(C)O)c1";"IC50";"'='";"210.0";"nM";"6.68";"";"";"UO_0000065";"15.21";"0.31";"1.53";"6.99";"0";"CHEMBL3784288";"Reversible inhibition of NLRP3 in LPS activated human monocytes after 30 mins by ELISA analysis in presence of ATP";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3779837";"1";"Scientific Literature";"J Med Chem";"2016";"None";"";"";""
"CHEMBL4792984";"";"None";"658.82";"2";"6.32";"9";"CS(=O)(=O)N1CCCc2ccc(N(S(=O)(=O)c3ccc(-c4ccccc4)cc3)S(=O)(=O)c3ccc(-c4ccccc4)cc3)cc21";"IC50";"'='";"14950.0";"nM";"4.83";"";"";"UO_0000065";"7.32";"0.15";"-1.49";"4.43";"0";"CHEMBL4775286";"Inhibition of NLRP3 in PMA-stimulated human THP-1 cells assessed as reduction in IL-1beta release pre-treated for 24 hrs followed by stimulation with LPS for 3 hrs and ATP for 1 hr by ELISA analysis";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"None";"THP-1";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765468";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 28.0 hr";"INHIBITOR";""
"CHEMBL4636825";"";"None";"381.46";"0";"3.10";"33";"N#CN=S(=O)(NC(=O)Nc1c2c(cc3c1CCC3)CCC2)c1cccnc1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4605574";"Inhibition of NLRP3 inflammasome activation in LPS-primed human THP1 cells assessed as reduction in TNF alpha level preincubated for 1 hr followed by addition of monosodium urate crystals further incubated for 16 hrs and measured post monosodium urate crystals addition 1 hr by ELISA method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"THP-1";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4602705";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"CHEMBL3307574";"";"";""
"CHEMBL4791679";"";"None";"495.65";"0";"3.18";"16";"CCS(=O)(=O)Cc1csc(/C=C/S(=O)(=O)NC(=O)Nc2c3c(cc4c2CCC4)CCC3)n1";"IC50";"'='";"79.0";"nM";"7.10";"";"";"UO_0000065";"14.33";"0.30";"3.92";"5.81";"0";"CHEMBL4671767";"Inhibition of NLRP3 in human THP1 cells assessed as inhibition of IL-1beta production";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"THP-1";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4665838";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"";"INHIBITOR";""
"CHEMBL4797652";"";"None";"395.36";"0";"3.42";"23";"O=C(Nc1c(F)cccc1C(F)(F)F)NS(=O)(=O)/C=C/c1nccs1";"IC50";"'>'";"1000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4671767";"Inhibition of NLRP3 in human THP1 cells assessed as inhibition of IL-1beta production";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"THP-1";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4665838";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"";"";""
"CHEMBL4649372";"";"None";"451.49";"1";"5.24";"11";"O=C(O)c1ccc(/C=C2\SC(=S)N(CCCc3cccc(C(F)(F)F)c3)C2=O)cc1";"IC50";"'='";"4320.0";"nM";"5.37";"";"";"UO_0000065";"11.88";"0.24";"0.12";"9.31";"0";"CHEMBL4628081";"Inhibition of NLRP3 inflammasome (unknown origin) activation in LPS-primed bone marrow derived macrophage cells assessed as effect on IL-1beta production in presence of nigericin by ELISA";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4627283";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"";"";""
"CHEMBL5203371";"";"None";"335.41";"0";"2.76";"7";"Cc1[nH]c2nc(Nc3c4c(cc5c3CCC5)CCC4)nn2c(=O)c1C";"IC50";"'>'";"40000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5149834";"Inhibition of NLRP3 inflammasome in LPS-pretreated PBMC (unknown origin) assessed as reduction in IL-1beta release pretreated for 30 mins followed by ATP stimulated and measured after 1 hr by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5143747";"1";"Scientific Literature";"ACS Med Chem Lett";"2022";"None";"TIME = 1.5 hr";"";""
"CHEMBL5193439";"";"None";"422.49";"0";"3.60";"26";"N#Cc1ccccc1Cc1cc(=O)n2nc(Nc3c4c(cc5c3CCC5)CCC4)nc2[nH]1";"IC50";"";"";"";"";"";"Nd(Insoluble)";"";"";"";"";"";"0";"CHEMBL5149834";"Inhibition of NLRP3 inflammasome in LPS-pretreated PBMC (unknown origin) assessed as reduction in IL-1beta release pretreated for 30 mins followed by ATP stimulated and measured after 1 hr by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5143747";"1";"Scientific Literature";"ACS Med Chem Lett";"2022";"None";"TIME = 1.5 hr";"";""
"CHEMBL5200838";"";"None";"398.47";"0";"3.12";"31;NDT-30347";"O=c1cc(Cc2ccccn2)[nH]c2nc(Nc3c4c(cc5c3CCC5)CCC4)nn12";"IC50";"'='";"260.0";"nM";"6.58";"";"";"UO_0000065";"16.53";"0.30";"3.47";"7.49";"0";"CHEMBL5149834";"Inhibition of NLRP3 inflammasome in LPS-pretreated PBMC (unknown origin) assessed as reduction in IL-1beta release pretreated for 30 mins followed by ATP stimulated and measured after 1 hr by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5143747";"1";"Scientific Literature";"ACS Med Chem Lett";"2022";"None";"TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5219182";"";"None";"400.50";"0";"2.71";"16";"O=C(Nc1c2c(cc3c1CCC3)CCC2)NS(=O)(=O)c1cnn2c1CCCC2";"IC50";"'='";"410.0";"nM";"6.39";"";"";"UO_0000065";"15.95";"0.31";"3.68";"6.86";"0";"CHEMBL5217806";"Inhibition of NLRP3 inflammasome activation in LPS and nigericin-stimulated human PBMC cells assessed as reduction in IL-1beta release preincubated with LPS for 3 hrs followed by compound addition for 30 mins and further stimulated with nigericin for 1.5 hrs by ELISA analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5214989";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 2.0 hr";"INHIBITOR";""
"CHEMBL1331770";"";"None";"351.36";"0";"1.63";"SID49730057";"Cc1cccc(C(=O)NNC(=O)c2c(O)c3ccccc3n(C)c2=O)c1";"IC50";"'='";"1030.0";"nM";"5.99";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1737963";"PUBCHEM_BIOASSAY: Dose Response confirmation of uHTS for the identification of inhibitors of NALP3 in yeast using a luminescent assay. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2825, AID2832]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1994635";"";"None";"254.31";"0";"3.75";"SID26671049";"Oc1c(/C=N/c2ccccn2)sc2ccccc12";"IC50";"'='";"10200.0";"nM";"4.99";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1737963";"PUBCHEM_BIOASSAY: Dose Response confirmation of uHTS for the identification of inhibitors of NALP3 in yeast using a luminescent assay. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2825, AID2832]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL601543";"";"None";"610.73";"1";"7.85";"SID24827750";"CCN1/C(=C/C=C/c2oc3ccc(-c4ccccc4)cc3[n+]2CC)Oc2ccc(-c3ccccc3)cc21.CCOS(=O)(=O)[O-]";"IC50";"'='";"9070.0";"nM";"5.04";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1737963";"PUBCHEM_BIOASSAY: Dose Response confirmation of uHTS for the identification of inhibitors of NALP3 in yeast using a luminescent assay. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2825, AID2832]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1727095";"";"None";"333.41";"0";"2.39";"SID51090750";"Cc1csc2nc(O)c(C(=O)NCCC3=CCCCC3)c(=O)n12";"IC50";"'='";"4070.0";"nM";"5.39";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1737963";"PUBCHEM_BIOASSAY: Dose Response confirmation of uHTS for the identification of inhibitors of NALP3 in yeast using a luminescent assay. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2825, AID2832]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1518625";"";"None";"377.37";"0";"4.97";"SID24797245";"Br.CCCCCCCCn1c2c(c(=N)c3ccccc31)CCC2";"IC50";"'='";"11900.0";"nM";"4.92";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1737963";"PUBCHEM_BIOASSAY: Dose Response confirmation of uHTS for the identification of inhibitors of NALP3 in yeast using a luminescent assay. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2825, AID2832]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL4741204";"";"None";"384.50";"0";"2.77";"3";"O=C([N-]S(=O)(=O)c1ccco1)Nc1c2c(cc3c1CCC3)CCC2.[K+]";"IC50";"'='";"450.0";"nM";"6.35";"";"";"UO_0000065";"18.32";"0.36";"3.58";"7.18";"0";"CHEMBL4702271";"Inhibition of NLRP3 in human PBMC cells assessed as inhibition of LPS and ATP-induced IL-1beta production";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699510";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"";"INHIBITOR";""
"CHEMBL4762837";"";"None";"392.50";"0";"3.96";"31";"COC(=O)C(CCc1ccccc1)NC(=O)Nc1c2c(cc3c1CCC3)CCC2";"IC50";"'>'";"20000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4702271";"Inhibition of NLRP3 in human PBMC cells assessed as inhibition of LPS and ATP-induced IL-1beta production";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699510";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"";"";""
"CHEMBL4644503";"";"None";"441.55";"0";"4.69";"23";"CCOC(=O)N=S(=O)(NC(=O)Nc1c2c(cc3c1CCC3)CCC2)c1ccc(C)cc1";"IC50";"'>'";"1000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4605569";"Inhibition of NLRP3 inflammasome activation in LPS-primed human THP1 cells assessed as reduction in IL-1beta level preincubated for 1 hr followed by addition of ATP and nigericin further incubated for 1 hrs and measured post ATP addition 1 hr by ELISA method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"THP-1";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4602705";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"CHEMBL3307574";"";"";""
"CHEMBL4765040";"";"None";"316.40";"0";"2.74";"19";"CCOC(=O)CNC(=O)Nc1c2c(cc3c1CCC3)CCCC2";"IC50";"'>'";"20000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4702271";"Inhibition of NLRP3 in human PBMC cells assessed as inhibition of LPS and ATP-induced IL-1beta production";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699510";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"";"";""
"CHEMBL4783425";"";"None";"303.36";"0";"1.74";"22";"CCOC(=O)CNC(=O)Nc1c2c(nc3c1CCC3)CCC2";"IC50";"'>'";"20000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4702271";"Inhibition of NLRP3 in human PBMC cells assessed as inhibition of LPS and ATP-induced IL-1beta production";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699510";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"";"";""
"CHEMBL4749410";"";"None";"292.38";"0";"3.23";"23";"COC(=O)CNC(=O)Nc1c(C(C)C)cccc1C(C)C";"IC50";"'>'";"20000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4702271";"Inhibition of NLRP3 in human PBMC cells assessed as inhibition of LPS and ATP-induced IL-1beta production";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699510";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"";"";""
"CHEMBL4764722";"";"None";"403.48";"0";"3.44";"36";"COC(=O)[C@@H](Cc1ccc(C#N)cc1)NC(=O)Nc1c2c(cc3c1CCC3)CCC2";"IC50";"'='";"1500.0";"nM";"5.82";"";"";"UO_0000065";"14.43";"0.27";"2.38";"6.38";"0";"CHEMBL4702271";"Inhibition of NLRP3 in human PBMC cells assessed as inhibition of LPS and ATP-induced IL-1beta production";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699510";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"";"INHIBITOR";""
"CHEMBL4646271";"";"None";"381.46";"0";"3.10";"32";"N#CN=S(=O)(NC(=O)Nc1c2c(cc3c1CCC3)CCC2)c1ccncc1";"IC50";"'='";"110.0";"nM";"6.96";"";"";"UO_0000065";"18.24";"0.35";"3.86";"6.49";"0";"CHEMBL4605569";"Inhibition of NLRP3 inflammasome activation in LPS-primed human THP1 cells assessed as reduction in IL-1beta level preincubated for 1 hr followed by addition of ATP and nigericin further incubated for 1 hrs and measured post ATP addition 1 hr by ELISA method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"THP-1";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4602705";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"CHEMBL3307574";"";"";""
"CHEMBL3920126";"";"None";"420.49";"0";"1.97";"3";"CC(C)(O)c1coc(S(=O)(=O)NC(=O)Nc2c3c(cc4c2CC(O)C4)CCC3)c1";"IC50";"'='";"1828.0";"nM";"5.74";"";"";"UO_0000065";"13.65";"0.27";"3.77";"4.45";"0";"CHEMBL3864034";"Inhibition of NLRP3 inflammasome in LPS-stimulated human monocyte derived macrophages assessed as reduction in NLRP3 inflammasome-induced IL-1beta production preincubated for 30 mins followed by NLRP3 stimulation with ATP for 1 hr by ELISA";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3862040";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"";"";""
"CHEMBL129795";"ISOLIQUIRITIGENIN";"None";"256.26";"0";"2.70";"Isoliquiritigenin";"O=C(/C=C/c1ccc(O)cc1)c1ccc(O)cc1O";"IC50";"'='";"10100.0";"nM";"5.00";"";"";"UO_0000065";"19.49";"0.36";"2.30";"6.42";"0";"CHEMBL4611534";"Inhibition of NLRP3 in human THP1 cells assessed as inhibition of MSU-induced IL-1beta production";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"THP-1";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4610050";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"CHEMBL3307574";"";"";""
"CHEMBL4640151";"";"None";"356.45";"0";"3.17";"2";"O=C(Nc1c2c(cc3c1CCC3)CCC2)NS(=O)(=O)c1ccccc1";"IC50";"'='";"35.0";"nM";"7.46";"";"";"UO_0000065";"20.92";"0.41";"4.29";"9.91";"0";"CHEMBL4605569";"Inhibition of NLRP3 inflammasome activation in LPS-primed human THP1 cells assessed as reduction in IL-1beta level preincubated for 1 hr followed by addition of ATP and nigericin further incubated for 1 hrs and measured post ATP addition 1 hr by ELISA method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"THP-1";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4602705";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"CHEMBL3307574";"";"";""
"CHEMBL4647621";"";"None";"380.47";"0";"3.71";"16";"N#CN=S(=O)(NC(=O)Nc1c2c(cc3c1CCC3)CCC2)c1ccccc1";"IC50";"'='";"21.0";"nM";"7.68";"";"";"UO_0000065";"20.18";"0.39";"3.97";"8.14";"0";"CHEMBL4605569";"Inhibition of NLRP3 inflammasome activation in LPS-primed human THP1 cells assessed as reduction in IL-1beta level preincubated for 1 hr followed by addition of ATP and nigericin further incubated for 1 hrs and measured post ATP addition 1 hr by ELISA method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"THP-1";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4602705";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"CHEMBL3307574";"";"";""
"CHEMBL4647321";"";"None";"394.50";"0";"4.02";"15";"Cc1ccc(S(=O)(=NC#N)NC(=O)Nc2c3c(cc4c2CCC4)CCC3)cc1";"IC50";"'='";"6.8";"nM";"8.17";"";"";"UO_0000065";"20.70";"0.40";"4.15";"8.66";"0";"CHEMBL4605569";"Inhibition of NLRP3 inflammasome activation in LPS-primed human THP1 cells assessed as reduction in IL-1beta level preincubated for 1 hr followed by addition of ATP and nigericin further incubated for 1 hrs and measured post ATP addition 1 hr by ELISA method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"THP-1";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4602705";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"CHEMBL3307574";"";"";""
"CHEMBL5198156";"";"None";"241.29";"0";"2.88";"2";"COc1ccc(CC(=O)Nc2ccccc2)cc1";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5138374";"Inhibition of NLRP3 inflammasome activation in LPS/nigericin-stimulated PMA-differentiated human THP-1 macrophages assessed as reduction in pyroptosis pretreated with LPS followed by compound treatment for 30 mins then stimulation with nigericin and measured after 3 hrs by MTT assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"THP-1";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5137000";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"TIME = 3.5 hr";"";""
"CHEMBL4798966";"";"None";"561.66";"1";"2.27";"9c";"CC1=C2CC[C@@](C)(O)[C@@H]2[C@H]2OC(=O)[C@@H](CN(C)CCCOc3no[n+]([O-])c3S(=O)(=O)c3ccccc3)[C@@H]2CC1";"IC50";"'='";"2300.0";"nM";"5.64";"";"";"UO_0000065";"10.04";"0.20";"3.37";"3.86";"0";"CHEMBL4727731";"Inhibition of NLRP3 inflammasome in human primary glial cells assessed as reduction in LPS-induced IL-1beta release";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Primary neuron";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4725325";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"";"INHIBITOR";""
"CHEMBL5208173";"";"None";"283.37";"0";"3.87";"40";"CC(C)(C)c1ccc(CC(=O)Nc2cccc(O)c2)cc1";"IC50";"'='";"12420.0";"nM";"4.91";"";"";"UO_0000065";"17.31";"0.32";"1.04";"9.95";"0";"CHEMBL5138374";"Inhibition of NLRP3 inflammasome activation in LPS/nigericin-stimulated PMA-differentiated human THP-1 macrophages assessed as reduction in pyroptosis pretreated with LPS followed by compound treatment for 30 mins then stimulation with nigericin and measured after 3 hrs by MTT assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"THP-1";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5137000";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"TIME = 3.5 hr";"INHIBITOR";""
"CHEMBL4441031";"";"None";"309.29";"0";"3.90";"20";"COc1ccc(CC(=O)Nc2cccc(C(F)(F)F)c2)cc1";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5138374";"Inhibition of NLRP3 inflammasome activation in LPS/nigericin-stimulated PMA-differentiated human THP-1 macrophages assessed as reduction in pyroptosis pretreated with LPS followed by compound treatment for 30 mins then stimulation with nigericin and measured after 3 hrs by MTT assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"THP-1";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5137000";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"TIME = 3.5 hr";"";""
"CHEMBL4538032";"";"None";"378.88";"0";"2.45";"122";"C=C(Cc1ccccc1Cl)C(=O)NCCc1ccc(S(N)(=O)=O)cc1";"IC50";"'='";"74000.0";"nM";"4.13";"";"";"UO_0000065";"10.90";"0.23";"1.68";"4.63";"1";"CHEMBL5109120";"Inhibition of recombinant human NLRP3 ATPase activity preincubated for 15 mins followed by ATP addition measured after 40 mins by ADP-Glo Kinase assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5107969";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"TIME = 0.9167 hr";"INHIBITOR";""
"CHEMBL4750067";"";"None";"316.40";"0";"2.74";"27";"COC(=O)C(C)(C)NC(=O)Nc1c2c(cc3c1CCC3)CCC2";"IC50";"'>'";"20000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4702271";"Inhibition of NLRP3 in human PBMC cells assessed as inhibition of LPS and ATP-induced IL-1beta production";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699510";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"";"";""
"CHEMBL4742164";"";"None";"378.47";"0";"3.57";"29";"COC(=O)[C@H](Cc1ccccc1)NC(=O)Nc1c2c(cc3c1CCC3)CCC2";"IC50";"'>'";"20000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4702271";"Inhibition of NLRP3 in human PBMC cells assessed as inhibition of LPS and ATP-induced IL-1beta production";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699510";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"";"";""
"CHEMBL4781662";"";"None";"547.63";"1";"1.88";"9b";"CC1=C2CC[C@@](C)(O)[C@@H]2[C@H]2OC(=O)[C@@H](CN(C)CCOc3no[n+]([O-])c3S(=O)(=O)c3ccccc3)[C@@H]2CC1";"IC50";"'='";"1700.0";"nM";"5.77";"";"";"UO_0000065";"10.54";"0.21";"3.89";"3.95";"0";"CHEMBL4727731";"Inhibition of NLRP3 inflammasome in human primary glial cells assessed as reduction in LPS-induced IL-1beta release";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Primary neuron";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4725325";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"";"INHIBITOR";""
"CHEMBL453974";"";"None";"364.78";"0";"2.69";"SID24841464";"C[C@@H]1C[C@@H]2O[C@H]2/C=C\C=C\C(=O)Cc2c(Cl)c(O)cc(O)c2C(=O)O1";"IC50";"'='";"8410.0";"nM";"5.08";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1737963";"PUBCHEM_BIOASSAY: Dose Response confirmation of uHTS for the identification of inhibitors of NALP3 in yeast using a luminescent assay. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2825, AID2832]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1381195";"";"None";"328.80";"0";"4.44";"SID49670289";"Cl.Nc1ccc(Oc2cc(N)cc(Oc3ccccc3)c2)cc1";"IC50";"'='";"4740.0";"nM";"5.32";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1737963";"PUBCHEM_BIOASSAY: Dose Response confirmation of uHTS for the identification of inhibitors of NALP3 in yeast using a luminescent assay. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2825, AID2832]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1529733";"";"None";"296.29";"0";"1.29";"SID7972888";"Cn1c(=O)c(C(=O)Nc2ncccn2)c(O)c2ccccc21";"IC50";"'='";"13600.0";"nM";"4.87";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1737963";"PUBCHEM_BIOASSAY: Dose Response confirmation of uHTS for the identification of inhibitors of NALP3 in yeast using a luminescent assay. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2825, AID2832]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1451060";"";"None";"423.25";"0";"2.31";"SID49645365";"O=C(NNC(=S)NC(=O)c1ccc(Br)cc1)c1ccc([N+](=O)[O-])cc1";"IC50";"'='";"5630.0";"nM";"5.25";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1737963";"PUBCHEM_BIOASSAY: Dose Response confirmation of uHTS for the identification of inhibitors of NALP3 in yeast using a luminescent assay. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2825, AID2832]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1707377";"";"None";"329.38";"0";"1.82";"SID51085738";"O=C(NCCCc1ccccc1)c1c(O)nc2sccn2c1=O";"IC50";"'='";"9610.0";"nM";"5.02";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1737963";"PUBCHEM_BIOASSAY: Dose Response confirmation of uHTS for the identification of inhibitors of NALP3 in yeast using a luminescent assay. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2825, AID2832]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL4862114";"";"None";"508.52";"1";"3.66";"34";"CC(C)c1cc(F)c(F)c2c1CC(=O)NS(=O)(=O)c1nn(cc1F)C(C)(C)COc1cc-2ccn1";"IC50";"'<='";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4827632";"Inhibition of NLRP3 inflammasome activation in LPS-primed human whole blood assessed as reduction in nigericin-induced IL-1beta level preincubated for 3 hrs followed by nigericin addition and measured after 1 hrs by AlphaLISA assay";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"Blood";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4825720";"1";"Scientific Literature";"ACS Med Chem Lett";"2021";"None";"TIME = 4.0 hr";"INHIBITOR";""
"CHEMBL3929254";"";"None";"420.49";"0";"2.49";"2";"CC(C)(O)c1coc(S(=O)(=O)NC(=O)Nc2c3c(cc4c2CCC4O)CCC3)c1";"IC50";"'='";"1971.0";"nM";"5.71";"";"";"UO_0000065";"13.57";"0.27";"3.22";"4.43";"0";"CHEMBL3864034";"Inhibition of NLRP3 inflammasome in LPS-stimulated human monocyte derived macrophages assessed as reduction in NLRP3 inflammasome-induced IL-1beta production preincubated for 30 mins followed by NLRP3 stimulation with ATP for 1 hr by ELISA";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3862040";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"";"";""
"CHEMBL299112";"";"None";"366.38";"0";"0.97";"7";"O=S(=O)(c1ccccc1)c1no[n+]([O-])c1S(=O)(=O)c1ccccc1";"IC50";"'='";"1900.0";"nM";"5.72";"";"";"UO_0000065";"15.62";"0.33";"4.75";"4.72";"0";"CHEMBL4727731";"Inhibition of NLRP3 inflammasome in human primary glial cells assessed as reduction in LPS-induced IL-1beta release";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Primary neuron";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4725325";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"";"INHIBITOR";""
"CHEMBL3781583";"";"None";"453.00";"1";"5.32";"5; CP-424,174";"CC(C)c1cc(Cl)cc(C(C)C)c1NC(=O)NS(=O)(=O)c1cccc(C(C)(C)O)c1";"IC50";"'='";"260.0";"nM";"6.58";"";"";"UO_0000065";"14.54";"0.30";"1.27";"6.90";"0";"CHEMBL3784288";"Reversible inhibition of NLRP3 in LPS activated human monocytes after 30 mins by ELISA analysis in presence of ATP";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3779837";"1";"Scientific Literature";"J Med Chem";"2016";"None";"";"";""
"CHEMBL4639190";"";"None";"468.56";"0";"3.39";"7";"CN1CCN(C(=O)c2ccc(/C=C3\SC(=S)N(c4cccc([N+](=O)[O-])c4)C3=O)cc2)CC1";"IC50";"'='";"2980.0";"nM";"5.53";"";"";"UO_0000065";"11.79";"0.24";"2.14";"6.35";"0";"CHEMBL4628081";"Inhibition of NLRP3 inflammasome (unknown origin) activation in LPS-primed bone marrow derived macrophage cells assessed as effect on IL-1beta production in presence of nigericin by ELISA";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4627283";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"";"";""
"CHEMBL4643205";"";"None";"405.48";"0";"3.58";"30";"N#CN=S(=O)(NC(=O)Nc1c2c(cc3c1CCC3)CCC2)c1ccc(C#N)cc1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4605574";"Inhibition of NLRP3 inflammasome activation in LPS-primed human THP1 cells assessed as reduction in TNF alpha level preincubated for 1 hr followed by addition of monosodium urate crystals further incubated for 16 hrs and measured post monosodium urate crystals addition 1 hr by ELISA method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"THP-1";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4602705";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"CHEMBL3307574";"";"";""
"CHEMBL3183703";"";"None";"404.49";"0";"2.99";"MCC950";"CC(C)(O)c1coc(S(=O)(=O)NC(=O)Nc2c3c(cc4c2CCC4)CCC3)c1";"IC50";"'='";"8.0";"nM";"8.10";"";"";"UO_0000065";"20.02";"0.39";"5.11";"7.45";"0";"CHEMBL4187545";"Inhibition of NLRP3 in human monocyte derived macrophages assessed as reduction in LPS-induced IL-1beta production by ELISA";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4184214";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";""
"CHEMBL4753623";"";"None";"419.53";"0";"2.74";"13";"O=C(Nc1c2c(cc3c1CCC3)CCC2)NS(=O)(=O)/C=C/c1nc(CO)cs1";"IC50";"'='";"306.0";"nM";"6.51";"";"";"UO_0000065";"15.53";"0.32";"3.77";"6.01";"0";"CHEMBL4671767";"Inhibition of NLRP3 in human THP1 cells assessed as inhibition of IL-1beta production";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"THP-1";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4665838";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"";"INHIBITOR";""
"CHEMBL4745706";"";"None";"369.42";"0";"2.28";"22";"COc1cccc(OC)c1NC(=O)NS(=O)(=O)/C=C/c1nccs1";"IC50";"'>'";"1000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4671767";"Inhibition of NLRP3 in human THP1 cells assessed as inhibition of IL-1beta production";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"THP-1";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4665838";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"";"";""
"CHEMBL4649621";"";"None";"422.51";"0";"3.11";"7";"Cc1ccc(S(=O)(=O)Nc2c(Nc3c4c(cc5c3CCC5)CCC4)c(=O)c2=O)cc1";"IC50";"'>'";"1000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4605569";"Inhibition of NLRP3 inflammasome activation in LPS-primed human THP1 cells assessed as reduction in IL-1beta level preincubated for 1 hr followed by addition of ATP and nigericin further incubated for 1 hrs and measured post ATP addition 1 hr by ELISA method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"THP-1";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4602705";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"CHEMBL3307574";"";"";""
"CHEMBL4644865";"";"None";"451.51";"1";"5.10";"18";"Cc1ccc(S(=O)(=NCC(F)(F)F)NC(=O)Nc2c3c(cc4c2CCC4)CCC3)cc1";"IC50";"'>'";"1000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4605569";"Inhibition of NLRP3 inflammasome activation in LPS-primed human THP1 cells assessed as reduction in IL-1beta level preincubated for 1 hr followed by addition of ATP and nigericin further incubated for 1 hrs and measured post ATP addition 1 hr by ELISA method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"THP-1";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4602705";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"CHEMBL3307574";"";"";""
"CHEMBL4635816";"";"None";"411.53";"0";"4.08";"24";"CC(=O)N=S(=O)(NC(=O)Nc1c2c(cc3c1CCC3)CCC2)c1ccc(C)cc1";"IC50";"'>'";"1000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4605569";"Inhibition of NLRP3 inflammasome activation in LPS-primed human THP1 cells assessed as reduction in IL-1beta level preincubated for 1 hr followed by addition of ATP and nigericin further incubated for 1 hrs and measured post ATP addition 1 hr by ELISA method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"THP-1";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4602705";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"CHEMBL3307574";"";"";""
"CHEMBL4644835";"";"None";"412.49";"0";"4.16";"29";"Cc1ccc(S(=O)(=NC#N)NC(=O)Nc2c3c(cc4c2CCC4)CCC3)cc1F";"IC50";"'='";"5.3";"nM";"8.28";"";"";"UO_0000065";"20.06";"0.39";"4.12";"8.77";"0";"CHEMBL4605569";"Inhibition of NLRP3 inflammasome activation in LPS-primed human THP1 cells assessed as reduction in IL-1beta level preincubated for 1 hr followed by addition of ATP and nigericin further incubated for 1 hrs and measured post ATP addition 1 hr by ELISA method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"THP-1";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4602705";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"CHEMBL3307574";"";"";""
"CHEMBL4859990";"";"None";"490.53";"0";"3.52";"42";"CC(C)c1c(F)c(F)cc2c1CC(=O)NS(=O)(=O)c1cnn(c1)C(C)(C)COc1cc-2ccn1";"IC50";"'<='";"500.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4827632";"Inhibition of NLRP3 inflammasome activation in LPS-primed human whole blood assessed as reduction in nigericin-induced IL-1beta level preincubated for 3 hrs followed by nigericin addition and measured after 1 hrs by AlphaLISA assay";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"Blood";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4825720";"1";"Scientific Literature";"ACS Med Chem Lett";"2021";"None";"TIME = 4.0 hr";"INHIBITOR";""
"CHEMBL4752523";"";"None";"389.50";"0";"3.24";"7";"O=C(Nc1c2c(cc3c1CCC3)CCC2)NS(=O)(=O)/C=C/c1nccs1";"IC50";"'='";"35.0";"nM";"7.46";"";"";"UO_0000065";"19.14";"0.39";"4.22";"8.46";"0";"CHEMBL4671767";"Inhibition of NLRP3 in human THP1 cells assessed as inhibition of IL-1beta production";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"THP-1";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4665838";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"";"INHIBITOR";""
"CHEMBL4849674";"";"None";"454.55";"0";"3.24";"16";"CC(C)c1cccc2c1CC(=O)NS(=O)(=O)c1cnn(c1)C(C)(C)COc1cc-2ccn1";"IC50";"'<='";"500.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4827631";"Inhibition of NLRP3 inflammasome activation in LPS/nigericin-treated human THP-1 cells assessed as reduction in pyroptosis pretreated for 3 hrs in presence of LPS followed by nigericin addition and measured after 1 hr by resazurin assay";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"None";"THP-1";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4825720";"1";"Scientific Literature";"ACS Med Chem Lett";"2021";"None";"TIME = 4.0 hr";"INHIBITOR";""
"CHEMBL4798266";"";"None";"466.65";"0";"2.46";"26";"CCCCS(=O)(=O)N(c1ccc2c(c1)N(S(C)(=O)=O)CCC2)S(=O)(=O)CCCC";"IC50";"'='";"14780.0";"nM";"4.83";"";"";"UO_0000065";"10.35";"0.23";"2.37";"4.44";"0";"CHEMBL4775286";"Inhibition of NLRP3 in PMA-stimulated human THP-1 cells assessed as reduction in IL-1beta release pre-treated for 24 hrs followed by stimulation with LPS for 3 hrs and ATP for 1 hr by ELISA analysis";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"None";"THP-1";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765468";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 28.0 hr";"INHIBITOR";""
"CHEMBL4781934";"";"None";"700.77";"1";"1.46";"28";"CS(=O)(=O)N1CCCc2ccc(N(S(=O)(=O)CCN3C(=O)c4ccccc4C3=O)S(=O)(=O)CCN3C(=O)c4ccccc4C3=O)cc21";"IC50";"'='";"11720.0";"nM";"4.93";"";"";"UO_0000065";"7.04";"0.14";"3.47";"2.68";"0";"CHEMBL4775286";"Inhibition of NLRP3 in PMA-stimulated human THP-1 cells assessed as reduction in IL-1beta release pre-treated for 24 hrs followed by stimulation with LPS for 3 hrs and ATP for 1 hr by ELISA analysis";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"None";"THP-1";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765468";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 28.0 hr";"INHIBITOR";""
"CHEMBL4797667";"";"None";"362.45";"0";"2.02";"2";"CC(C)(O)c1coc(S(=O)(=O)[N-]C(=O)Nc2ccccc2)c1.[K+]";"IC50";"'>'";"20000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4702271";"Inhibition of NLRP3 in human PBMC cells assessed as inhibition of LPS and ATP-induced IL-1beta production";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699510";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"";"";""
"CHEMBL4786282";"";"None";"364.42";"0";"2.51";"1";"CC(C)(O)c1coc(S(=O)(=O)NC(=O)Nc2cccc3c2CCC3)c1";"IC50";"'>'";"20000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4702271";"Inhibition of NLRP3 in human PBMC cells assessed as inhibition of LPS and ATP-induced IL-1beta production";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699510";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"";"";""
"CHEMBL4790034";"";"None";"394.48";"0";"2.75";"45";"CCOC(=O)[C@@H](Cc1cnccn1)NC(=O)Nc1c2c(cc3c1CCC3)CCC2";"IC50";"'='";"30.0";"nM";"7.52";"";"";"UO_0000065";"19.07";"0.35";"4.77";"8.07";"0";"CHEMBL4702271";"Inhibition of NLRP3 in human PBMC cells assessed as inhibition of LPS and ATP-induced IL-1beta production";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699510";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"";"INHIBITOR";""
"CHEMBL4862114";"";"None";"508.52";"1";"3.66";"34";"CC(C)c1cc(F)c(F)c2c1CC(=O)NS(=O)(=O)c1nn(cc1F)C(C)(C)COc1cc-2ccn1";"IC50";"'<='";"500.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4827631";"Inhibition of NLRP3 inflammasome activation in LPS/nigericin-treated human THP-1 cells assessed as reduction in pyroptosis pretreated for 3 hrs in presence of LPS followed by nigericin addition and measured after 1 hr by resazurin assay";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"None";"THP-1";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4825720";"1";"Scientific Literature";"ACS Med Chem Lett";"2021";"None";"TIME = 4.0 hr";"INHIBITOR";""
"CHEMBL4850095";"";"None";"452.54";"0";"3.00";"32";"CC(C)c1cccc2c1CC(=O)NS(=O)(=O)c1cnn(c1)C1(CC1)COc1cc-2ccn1";"IC50";"'<='";"500.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4827632";"Inhibition of NLRP3 inflammasome activation in LPS-primed human whole blood assessed as reduction in nigericin-induced IL-1beta level preincubated for 3 hrs followed by nigericin addition and measured after 1 hrs by AlphaLISA assay";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"Blood";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4825720";"1";"Scientific Literature";"ACS Med Chem Lett";"2021";"None";"TIME = 4.0 hr";"INHIBITOR";""
"CHEMBL4866852";"";"None";"472.54";"0";"3.38";"25";"CC(C)c1cc(F)cc2c1CC(=O)NS(=O)(=O)c1cnn(c1)C(C)(C)COc1cc-2ccn1";"IC50";"'<='";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4827631";"Inhibition of NLRP3 inflammasome activation in LPS/nigericin-treated human THP-1 cells assessed as reduction in pyroptosis pretreated for 3 hrs in presence of LPS followed by nigericin addition and measured after 1 hr by resazurin assay";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"None";"THP-1";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4825720";"1";"Scientific Literature";"ACS Med Chem Lett";"2021";"None";"TIME = 4.0 hr";"INHIBITOR";""
"CHEMBL28";"APIGENIN";"None";"270.24";"0";"2.58";"Apigenin";"O=c1cc(-c2ccc(O)cc2)oc2cc(O)cc(O)c12";"IC50";"'='";"10000.0";"nM";"5.00";"";"";"UO_0000065";"18.50";"0.34";"2.42";"5.50";"0";"CHEMBL4324164";"Inhibition of NLRP3 inflammasome activation in PMA differentiated human THP1 cells assessed as reduction in IL-1beta level preincubated for 30 mins followed by addition of MSU and meaured after 6 hrs by ELISA method relative to control";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4321841";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"";"";""
"CHEMBL4756693";"";"None";"389.50";"0";"3.24";"10";"O=C(Nc1c2c(cc3c1CCC3)CCC2)NS(=O)(=O)/C=C/c1cncs1";"IC50";"'='";"126.0";"nM";"6.90";"";"";"UO_0000065";"17.71";"0.36";"3.66";"7.83";"0";"CHEMBL4671767";"Inhibition of NLRP3 in human THP1 cells assessed as inhibition of IL-1beta production";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"THP-1";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4665838";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"";"INHIBITOR";""
"CHEMBL4641660";"";"None";"348.45";"0";"3.71";"6";"O=C(Nc1c2c(cc3c1CCC3)CCC2)NC1(c2ccccc2)COC1";"IC50";"'>'";"1000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4605569";"Inhibition of NLRP3 inflammasome activation in LPS-primed human THP1 cells assessed as reduction in IL-1beta level preincubated for 1 hr followed by addition of ATP and nigericin further incubated for 1 hrs and measured post ATP addition 1 hr by ELISA method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"THP-1";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4602705";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"CHEMBL3307574";"";"";""
"CHEMBL4126941";"";"None";"126.11";"0";"-0.13";"Levoglucosenone";"O=C1C=C[C@H]2CO[C@@H]1O2";"IC50";"'='";"6600.0";"nM";"5.18";"";"";"UO_0000065";"41.08";"0.79";"5.31";"14.58";"0";"CHEMBL4125669";"Inhibition of nigericin-induced NLRP3 inflammasome activation in PMA-differentiated human THP1 cells assessed as reduction in LPS-stimulated IL-1beta secretion incubated for 1 hr prior to stimulation with nigericin for 1 hr by quanti-blue based SEAP reporter gene assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4118290";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";"";""
"CHEMBL4759516";"";"None";"403.53";"0";"3.55";"8";"Cc1csc(/C=C/S(=O)(=O)NC(=O)Nc2c3c(cc4c2CCC4)CCC3)n1";"IC50";"'='";"76.0";"nM";"7.12";"";"";"UO_0000065";"17.64";"0.36";"3.57";"8.08";"0";"CHEMBL4671767";"Inhibition of NLRP3 in human THP1 cells assessed as inhibition of IL-1beta production";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"THP-1";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4665838";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"";"INHIBITOR";""
"CHEMBL5190936";"";"None";"335.41";"0";"2.46";"2";"Cc1cc(=O)n2nc(Nc3c4c(cc5c3CCC5)CCC4)nc2n1C";"IC50";"'>'";"40000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5149834";"Inhibition of NLRP3 inflammasome in LPS-pretreated PBMC (unknown origin) assessed as reduction in IL-1beta release pretreated for 30 mins followed by ATP stimulated and measured after 1 hr by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5143747";"1";"Scientific Literature";"ACS Med Chem Lett";"2022";"None";"TIME = 1.5 hr";"";""
"CHEMBL5192039";"";"None";"406.49";"0";"1.67";"39";"O=c1cc(CC2CNCCO2)[nH]c2nc(Nc3c4c(cc5c3CCC5)CCC4)nn12";"IC50";"'='";"20000.0";"nM";"4.70";"";"";"UO_0000065";"11.56";"0.21";"3.03";"4.88";"0";"CHEMBL5149834";"Inhibition of NLRP3 inflammasome in LPS-pretreated PBMC (unknown origin) assessed as reduction in IL-1beta release pretreated for 30 mins followed by ATP stimulated and measured after 1 hr by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5143747";"1";"Scientific Literature";"ACS Med Chem Lett";"2022";"None";"TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL4778322";"";"None";"383.47";"0";"3.18";"5";"O=C(Nc1c2c(cc3c1CCC3)CCC2)NS(=O)(=O)/C=C/c1ccncc1";"IC50";"'='";"164.0";"nM";"6.79";"";"";"UO_0000065";"17.69";"0.34";"3.61";"7.70";"0";"CHEMBL4671767";"Inhibition of NLRP3 in human THP1 cells assessed as inhibition of IL-1beta production";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"THP-1";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4665838";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"";"INHIBITOR";""
"CHEMBL4763529";"";"None";"439.56";"0";"4.40";"18";"O=C(Nc1c2c(cc3c1CCC3)CCC2)NS(=O)(=O)/C=C/c1nc2ccccc2s1";"IC50";"'>'";"1000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4671767";"Inhibition of NLRP3 in human THP1 cells assessed as inhibition of IL-1beta production";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"THP-1";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4665838";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"";"";""
"CHEMBL4229108";"";"None";"310.31";"0";"3.42";"7f";"COc1ccccc1C(=O)O/N=C(\C)c1nc2ccccc2o1";"IC50";"'='";"39470.0";"nM";"4.40";"";"";"UO_0000065";"14.19";"0.26";"0.98";"5.96";"0";"CHEMBL4221123";"Inhibition of NLRP3 inflammasome in human THP1 cells assessed as reduction in MSU-induced IL-1beta production preincubated for 1 hr followed by MSU stimulation measured after 6 hrs";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4219086";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";"";""
"CHEMBL4854135";"";"None";"472.54";"0";"3.38";"5";"CC(C)c1cccc2c1CC(=O)NS(=O)(=O)c1nn(cc1F)C(C)(C)COc1cc-2ccn1";"IC50";"'<='";"500.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4827631";"Inhibition of NLRP3 inflammasome activation in LPS/nigericin-treated human THP-1 cells assessed as reduction in pyroptosis pretreated for 3 hrs in presence of LPS followed by nigericin addition and measured after 1 hr by resazurin assay";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"None";"THP-1";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4825720";"1";"Scientific Literature";"ACS Med Chem Lett";"2021";"None";"TIME = 4.0 hr";"INHIBITOR";""
"CHEMBL4854135";"";"None";"472.54";"0";"3.38";"5";"CC(C)c1cccc2c1CC(=O)NS(=O)(=O)c1nn(cc1F)C(C)(C)COc1cc-2ccn1";"IC50";"'<='";"500.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4827632";"Inhibition of NLRP3 inflammasome activation in LPS-primed human whole blood assessed as reduction in nigericin-induced IL-1beta level preincubated for 3 hrs followed by nigericin addition and measured after 1 hrs by AlphaLISA assay";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"Blood";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4825720";"1";"Scientific Literature";"ACS Med Chem Lett";"2021";"None";"TIME = 4.0 hr";"INHIBITOR";""
"CHEMBL4861331";"";"None";"490.53";"0";"3.52";"35";"CC(C)c1cc(F)c(F)c2c1CC(=O)NS(=O)(=O)c1cnn(c1)C(C)(C)COc1cc-2ccn1";"IC50";"'<='";"1000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4827632";"Inhibition of NLRP3 inflammasome activation in LPS-primed human whole blood assessed as reduction in nigericin-induced IL-1beta level preincubated for 3 hrs followed by nigericin addition and measured after 1 hrs by AlphaLISA assay";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"Blood";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4825720";"1";"Scientific Literature";"ACS Med Chem Lett";"2021";"None";"TIME = 4.0 hr";"INHIBITOR";""
"CHEMBL3183703";"";"None";"404.49";"0";"2.99";"MCC950";"CC(C)(O)c1coc(S(=O)(=O)NC(=O)Nc2c3c(cc4c2CCC4)CCC3)c1";"IC50";"'='";"8.1";"nM";"8.09";"";"";"UO_0000065";"20.00";"0.39";"5.10";"7.45";"0";"CHEMBL4324147";"Inhibition of NLRP3 in LPS/ATP-treated human monocyte derived macrophages assessed as reduction in NLRP3 inflammasome activation by measuring reduction in IL-1beta level by ELISA method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4321841";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"";"";""
"CHEMBL4641564";"";"None";"494.52";"0";"4.46";"6";"O=C(c1ccc(/C=C2\SC(=S)N(c3cccc(OC(F)(F)F)c3)C2=O)cc1)N1CCOCC1";"IC50";"'='";"3180.0";"nM";"5.50";"";"";"UO_0000065";"11.12";"0.23";"1.04";"9.31";"0";"CHEMBL4628081";"Inhibition of NLRP3 inflammasome (unknown origin) activation in LPS-primed bone marrow derived macrophage cells assessed as effect on IL-1beta production in presence of nigericin by ELISA";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4627283";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"";"";""
"CHEMBL4647496";"";"None";"431.54";"1";"5.45";"21";"O=C(O)c1ccc(/C=C2\SC(=S)N(Cc3ccc(-c4ccccc4)cc3)C2=O)cc1";"IC50";"'='";"7630.0";"nM";"5.12";"";"";"UO_0000065";"11.86";"0.23";"-0.33";"8.88";"0";"CHEMBL4628081";"Inhibition of NLRP3 inflammasome (unknown origin) activation in LPS-primed bone marrow derived macrophage cells assessed as effect on IL-1beta production in presence of nigericin by ELISA";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4627283";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"";"";""
"CHEMBL4756798";"";"None";"388.51";"0";"3.85";"4";"O=C(Nc1c2c(cc3c1CCC3)CCC2)NS(=O)(=O)/C=C/c1ccsc1";"IC50";"'='";"96.0";"nM";"7.02";"";"";"UO_0000065";"18.06";"0.37";"3.17";"9.32";"0";"CHEMBL4671767";"Inhibition of NLRP3 in human THP1 cells assessed as inhibition of IL-1beta production";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"THP-1";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4665838";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"";"INHIBITOR";""
"CHEMBL4760079";"";"None";"403.53";"0";"3.55";"9";"Cc1cnc(/C=C/S(=O)(=O)NC(=O)Nc2c3c(cc4c2CCC4)CCC3)s1";"IC50";"'='";"1061.0";"nM";"5.97";"";"";"UO_0000065";"14.81";"0.30";"2.42";"6.78";"0";"CHEMBL4671767";"Inhibition of NLRP3 in human THP1 cells assessed as inhibition of IL-1beta production";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"THP-1";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4665838";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"";"INHIBITOR";""
"CHEMBL4777050";"";"None";"445.37";"0";"4.30";"24";"O=C(Nc1cc(C(F)(F)F)ccc1C(F)(F)F)NS(=O)(=O)/C=C/c1nccs1";"IC50";"'>'";"1000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4671767";"Inhibition of NLRP3 in human THP1 cells assessed as inhibition of IL-1beta production";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"THP-1";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4665838";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"";"";""
"CHEMBL4796009";"";"None";"596.62";"1";"2.80";"5";"CS(=O)(=O)N1CCCc2ccc(N(S(=O)(=O)c3ccccc3[N+](=O)[O-])S(=O)(=O)c3ccccc3[N+](=O)[O-])cc21";"IC50";"'='";"13720.0";"nM";"4.86";"";"";"UO_0000065";"8.15";"0.17";"2.06";"2.49";"0";"CHEMBL4775286";"Inhibition of NLRP3 in PMA-stimulated human THP-1 cells assessed as reduction in IL-1beta release pre-treated for 24 hrs followed by stimulation with LPS for 3 hrs and ATP for 1 hr by ELISA analysis";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"None";"THP-1";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765468";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 28.0 hr";"INHIBITOR";""
"CHEMBL4646037";"";"None";"463.58";"1";"6.01";"20";"Cc1ccc(S(=O)(=Nc2ccc(F)cc2)NC(=O)Nc2c3c(cc4c2CCC4)CCC3)cc1";"IC50";"'>'";"1000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4605569";"Inhibition of NLRP3 inflammasome activation in LPS-primed human THP1 cells assessed as reduction in IL-1beta level preincubated for 1 hr followed by addition of ATP and nigericin further incubated for 1 hrs and measured post ATP addition 1 hr by ELISA method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"THP-1";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4602705";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"CHEMBL3307574";"";"";""
"CHEMBL4641361";"";"None";"475.52";"0";"4.72";"14";"O=C1/C(=C/c2ccc(-c3nnn[nH]3)cc2)SC(=S)N1CCCc1cccc(C(F)(F)F)c1";"IC50";"'='";"4850.0";"nM";"5.31";"";"";"UO_0000065";"11.18";"0.23";"0.59";"7.11";"0";"CHEMBL4628081";"Inhibition of NLRP3 inflammasome (unknown origin) activation in LPS-primed bone marrow derived macrophage cells assessed as effect on IL-1beta production in presence of nigericin by ELISA";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4627283";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"";"";""
"CHEMBL4643011";"";"None";"385.49";"0";"2.51";"9";"Cc1ccc(S(=O)(=O)NC(=O)C(O)c2c3c(cc4c2CCC4)CCC3)cc1";"IC50";"'>'";"1000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4605569";"Inhibition of NLRP3 inflammasome activation in LPS-primed human THP1 cells assessed as reduction in IL-1beta level preincubated for 1 hr followed by addition of ATP and nigericin further incubated for 1 hrs and measured post ATP addition 1 hr by ELISA method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"THP-1";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4602705";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"CHEMBL3307574";"";"";""
"CHEMBL4634682";"";"None";"383.52";"0";"4.17";"17";"CN=S(=O)(NC(=O)Nc1c2c(cc3c1CCC3)CCC2)c1ccc(C)cc1";"IC50";"'>'";"1000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4605569";"Inhibition of NLRP3 inflammasome activation in LPS-primed human THP1 cells assessed as reduction in IL-1beta level preincubated for 1 hr followed by addition of ATP and nigericin further incubated for 1 hrs and measured post ATP addition 1 hr by ELISA method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"THP-1";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4602705";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"CHEMBL3307574";"";"";""
"CHEMBL4637610";"";"None";"412.52";"0";"3.61";"22";"Cc1ccc(S(=O)(=NC(N)=O)NC(=O)Nc2c3c(cc4c2CCC4)CCC3)cc1";"IC50";"'>'";"1000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4605569";"Inhibition of NLRP3 inflammasome activation in LPS-primed human THP1 cells assessed as reduction in IL-1beta level preincubated for 1 hr followed by addition of ATP and nigericin further incubated for 1 hrs and measured post ATP addition 1 hr by ELISA method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"THP-1";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4602705";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"CHEMBL3307574";"";"";""
"CHEMBL4641961";"";"None";"405.48";"0";"3.58";"31";"N#CN=S(=O)(NC(=O)Nc1c2c(cc3c1CCC3)CCC2)c1cccc(C#N)c1";"IC50";"'='";"11.7";"nM";"7.93";"";"";"UO_0000065";"19.56";"0.37";"4.35";"6.71";"0";"CHEMBL4605569";"Inhibition of NLRP3 inflammasome activation in LPS-primed human THP1 cells assessed as reduction in IL-1beta level preincubated for 1 hr followed by addition of ATP and nigericin further incubated for 1 hrs and measured post ATP addition 1 hr by ELISA method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"THP-1";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4602705";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"CHEMBL3307574";"";"";""
"CHEMBL3956814";"";"None";"420.49";"0";"2.49";"2a";"CC(C)(O)c1coc(S(=O)(=O)NC(=O)Nc2c3c(cc4c2CC[C@H]4O)CCC3)c1";"IC50";"'='";"1238.0";"nM";"5.91";"";"";"UO_0000065";"14.05";"0.28";"3.42";"4.58";"0";"CHEMBL3864034";"Inhibition of NLRP3 inflammasome in LPS-stimulated human monocyte derived macrophages assessed as reduction in NLRP3 inflammasome-induced IL-1beta production preincubated for 30 mins followed by NLRP3 stimulation with ATP for 1 hr by ELISA";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3862040";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"";"";""
"CHEMBL4782189";"";"None";"308.33";"0";"4.35";"6";"COc1c(/C=C/C(=O)c2ccccc2)cc(OC)c2occc12";"IC50";"'='";"1300.0";"nM";"5.89";"";"";"UO_0000065";"19.09";"0.35";"1.54";"12.09";"0";"CHEMBL4702878";"Inhibition of NLRP3 inflammasome activation in LPS-primed human PMA-differentiated THP-1 cells assessed as reduction in nigericin-induced IL-1beta level preincubated for 30 mins followed by nigericin addition and measured after 1 hrs by Western blot analysis";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"None";"THP-1";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699526";"1";"Scientific Literature";"J Nat Prod";"2020";"None";"TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL4744580";"";"None";"312.37";"0";"2.68";"18";"Cc1nnc(CNC(=O)Nc2c3c(cc4c2CCC4)CCC3)o1";"IC50";"'>'";"20000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4702271";"Inhibition of NLRP3 in human PBMC cells assessed as inhibition of LPS and ATP-induced IL-1beta production";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699510";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"";"";""
"CHEMBL4746193";"";"None";"379.46";"0";"2.96";"37";"COC(=O)[C@@H](Cc1ccccn1)NC(=O)Nc1c2c(cc3c1CCC3)CCC2";"IC50";"'='";"4200.0";"nM";"5.38";"";"";"UO_0000065";"14.17";"0.26";"2.42";"6.69";"0";"CHEMBL4702271";"Inhibition of NLRP3 in human PBMC cells assessed as inhibition of LPS and ATP-induced IL-1beta production";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699510";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"";"INHIBITOR";""
"CHEMBL4647321";"";"None";"394.50";"0";"4.02";"15";"Cc1ccc(S(=O)(=NC#N)NC(=O)Nc2c3c(cc4c2CCC4)CCC3)cc1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4605574";"Inhibition of NLRP3 inflammasome activation in LPS-primed human THP1 cells assessed as reduction in TNF alpha level preincubated for 1 hr followed by addition of monosodium urate crystals further incubated for 16 hrs and measured post monosodium urate crystals addition 1 hr by ELISA method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"THP-1";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4602705";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"CHEMBL3307574";"";"";""
"CHEMBL4641961";"";"None";"405.48";"0";"3.58";"31";"N#CN=S(=O)(NC(=O)Nc1c2c(cc3c1CCC3)CCC2)c1cccc(C#N)c1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4605574";"Inhibition of NLRP3 inflammasome activation in LPS-primed human THP1 cells assessed as reduction in TNF alpha level preincubated for 1 hr followed by addition of monosodium urate crystals further incubated for 16 hrs and measured post monosodium urate crystals addition 1 hr by ELISA method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"THP-1";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4602705";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"CHEMBL3307574";"";"";""
"CHEMBL5220890";"";"None";"374.47";"0";"2.22";"10";"Cc1nc(S(=O)(=O)NC(=O)Nc2c3c(cc4c2CCC4)CCC3)cn1C";"IC50";"'='";"2310.0";"nM";"5.64";"";"";"UO_0000065";"15.05";"0.30";"3.42";"6.05";"0";"CHEMBL5217806";"Inhibition of NLRP3 inflammasome activation in LPS and nigericin-stimulated human PBMC cells assessed as reduction in IL-1beta release preincubated with LPS for 3 hrs followed by compound addition for 30 mins and further stimulated with nigericin for 1.5 hrs by ELISA analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5214989";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 2.0 hr";"INHIBITOR";""
"CHEMBL5219249";"";"None";"429.50";"0";"1.46";"19";"CN1CCn2ncc(S(=O)(=O)NC(=O)Nc3c4c(cc5c3CCC5)CCC4)c2C1=O";"IC50";"'='";"6200.0";"nM";"5.21";"";"";"UO_0000065";"12.12";"0.24";"3.75";"4.59";"0";"CHEMBL5217806";"Inhibition of NLRP3 inflammasome activation in LPS and nigericin-stimulated human PBMC cells assessed as reduction in IL-1beta release preincubated with LPS for 3 hrs followed by compound addition for 30 mins and further stimulated with nigericin for 1.5 hrs by ELISA analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5214989";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 2.0 hr";"INHIBITOR";""
"CHEMBL5220779";"";"None";"445.55";"0";"1.69";"21";"CN(C)[C@@H]1COc2c(S(=O)(=O)NC(=O)Nc3c4c(cc5c3CCC5)CCC4)cnn2C1";"IC50";"'='";"13.0";"nM";"7.89";"";"";"UO_0000065";"17.70";"0.35";"6.20";"7.47";"0";"CHEMBL5217806";"Inhibition of NLRP3 inflammasome activation in LPS and nigericin-stimulated human PBMC cells assessed as reduction in IL-1beta release preincubated with LPS for 3 hrs followed by compound addition for 30 mins and further stimulated with nigericin for 1.5 hrs by ELISA analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5214989";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 2.0 hr";"INHIBITOR";""
"CHEMBL4647571";"";"None";"461.49";"0";"4.33";"13";"O=C1/C(=C/c2ccc(-c3nnn[nH]3)cc2)SC(=S)N1CCc1cccc(C(F)(F)F)c1";"IC50";"'='";"6500.0";"nM";"5.19";"";"";"UO_0000065";"11.24";"0.23";"0.86";"6.94";"0";"CHEMBL4628081";"Inhibition of NLRP3 inflammasome (unknown origin) activation in LPS-primed bone marrow derived macrophage cells assessed as effect on IL-1beta production in presence of nigericin by ELISA";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4627283";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"";"";""
"CHEMBL4639758";"";"None";"373.43";"0";"3.93";"19";"O=C(O)c1ccc(/C=C2\SC(=S)N(Cc3cccc(F)c3)C2=O)cc1";"IC50";"'='";"3520.0";"nM";"5.45";"";"";"UO_0000065";"14.60";"0.30";"1.52";"9.47";"0";"CHEMBL4628081";"Inhibition of NLRP3 inflammasome (unknown origin) activation in LPS-primed bone marrow derived macrophage cells assessed as effect on IL-1beta production in presence of nigericin by ELISA";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4627283";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"";"";""
"CHEMBL5220239";"";"None";"397.46";"0";"2.22";"18";"O=C(Nc1c2c(cc3c1CCC3)CCC2)NS(=O)(=O)c1cnn2cccnc12";"IC50";"'='";"430.0";"nM";"6.37";"";"";"UO_0000065";"16.02";"0.31";"4.15";"6.04";"0";"CHEMBL5217806";"Inhibition of NLRP3 inflammasome activation in LPS and nigericin-stimulated human PBMC cells assessed as reduction in IL-1beta release preincubated with LPS for 3 hrs followed by compound addition for 30 mins and further stimulated with nigericin for 1.5 hrs by ELISA analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5214989";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 2.0 hr";"INHIBITOR";""
"CHEMBL4539790";"";"None";"409.51";"None";"None";"NBC6";"CC(=O)C1=C(C(Cl)(Cl)Cl)N[B-](c2ccccc2)(c2ccccc2)[O+]=C1N";"IC50";"'='";"74.0";"nM";"7.13";"";"";"UO_0000065";"17.41";"None";"None";"None";"0";"CHEMBL4324155";"Inhibition of NLRP3 inflammasome activation in LPS-primed human THP1 cells assessed as reduction in IL-1beta level preincubated for 10 mins followed by addition of nigericin";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4321841";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"";"";""
"CHEMBL5197960";"";"None";"306.16";"0";"3.34";"45";"O=C(Cc1ccc(Br)cc1)Nc1cccc(O)c1";"IC50";"'='";"645.3";"nM";"6.19";"";"";"UO_0000065";"20.22";"0.47";"2.85";"12.55";"0";"CHEMBL5138374";"Inhibition of NLRP3 inflammasome activation in LPS/nigericin-stimulated PMA-differentiated human THP-1 macrophages assessed as reduction in pyroptosis pretreated with LPS followed by compound treatment for 30 mins then stimulation with nigericin and measured after 3 hrs by MTT assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"THP-1";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5137000";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"TIME = 3.5 hr";"INHIBITOR";""
"CHEMBL5172364";"";"None";"285.11";"None";"None";"1";"COc1ccc(CC(=O)Nc2cccc(B(O)O)c2)cc1";"IC50";"'='";"3136.0";"nM";"5.50";"";"";"UO_0000065";"19.30";"None";"None";"None";"0";"CHEMBL5138374";"Inhibition of NLRP3 inflammasome activation in LPS/nigericin-stimulated PMA-differentiated human THP-1 macrophages assessed as reduction in pyroptosis pretreated with LPS followed by compound treatment for 30 mins then stimulation with nigericin and measured after 3 hrs by MTT assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"THP-1";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5137000";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"TIME = 3.5 hr";"INHIBITOR";""
"CHEMBL5182226";"";"None";"257.29";"0";"2.58";"33";"COc1cccc(CC(=O)Nc2cccc(O)c2)c1";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5138374";"Inhibition of NLRP3 inflammasome activation in LPS/nigericin-stimulated PMA-differentiated human THP-1 macrophages assessed as reduction in pyroptosis pretreated with LPS followed by compound treatment for 30 mins then stimulation with nigericin and measured after 3 hrs by MTT assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"THP-1";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5137000";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"TIME = 3.5 hr";"";""
"CHEMBL5171597";"";"None";"266.30";"0";"3.05";"62";"O=C(Cc1c[nH]c2ccccc12)Nc1cccc(O)c1";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5138374";"Inhibition of NLRP3 inflammasome activation in LPS/nigericin-stimulated PMA-differentiated human THP-1 macrophages assessed as reduction in pyroptosis pretreated with LPS followed by compound treatment for 30 mins then stimulation with nigericin and measured after 3 hrs by MTT assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"THP-1";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5137000";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"TIME = 3.5 hr";"";""
"CHEMBL5184033";"";"None";"441.51";"0";"2.78";"7a";"CN(C)c1ccc(S(=O)(=O)NC(=O)Nc2c3c(cc4c2CCC4)CCC3)c2nonc12";"IC50";"'='";"60.0";"nM";"7.22";"";"";"UO_0000065";"16.36";"0.32";"4.44";"6.15";"0";"CHEMBL5122649";"Inhibition of NLRP3 inflammasome activation in PMA differentiated LPS-primed human THP-1 cells assessed as reduction in nigericin-induced IL-1beta level pretreated for 2 hrs followed by nigericin addition and measured after 30 mins by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"THP-1";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5120824";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"TIME = 2.5 hr";"INHIBITOR";""
"CHEMBL4780624";"";"None";"394.48";"0";"2.75";"44";"CCOC(=O)[C@@H](Cc1ncccn1)NC(=O)Nc1c2c(cc3c1CCC3)CCC2";"IC50";"'='";"160.0";"nM";"6.80";"";"";"UO_0000065";"17.23";"0.32";"4.05";"7.29";"0";"CHEMBL4702272";"Inhibition of NLRP3 in human whole blood assessed as inhibition of LPS and ATP-induced IL-1beta production";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"Blood";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699510";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"";"INHIBITOR";""
"CHEMBL4795430";"";"None";"316.36";"0";"1.75";"5";"CS(=O)(=O)[N-]C(=O)Nc1c2c(cc3c1CCC3)CCC2.[Na+]";"IC50";"'='";"2800.0";"nM";"5.55";"";"";"UO_0000065";"18.86";"0.38";"3.80";"7.38";"0";"CHEMBL4702271";"Inhibition of NLRP3 in human PBMC cells assessed as inhibition of LPS and ATP-induced IL-1beta production";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699510";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"";"INHIBITOR";""
"CHEMBL4762524";"";"None";"379.46";"0";"2.96";"38";"COC(=O)[C@@H](Cc1cccnc1)NC(=O)Nc1c2c(cc3c1CCC3)CCC2";"IC50";"'='";"1500.0";"nM";"5.82";"";"";"UO_0000065";"15.35";"0.28";"2.86";"7.25";"0";"CHEMBL4702271";"Inhibition of NLRP3 in human PBMC cells assessed as inhibition of LPS and ATP-induced IL-1beta production";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699510";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"";"INHIBITOR";""
"CHEMBL4758640";"";"None";"388.51";"0";"3.85";"3";"O=C(Nc1c2c(cc3c1CCC3)CCC2)NS(=O)(=O)/C=C/c1cccs1";"IC50";"'='";"70.0";"nM";"7.16";"";"";"UO_0000065";"18.42";"0.38";"3.30";"9.51";"0";"CHEMBL4671767";"Inhibition of NLRP3 in human THP1 cells assessed as inhibition of IL-1beta production";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"THP-1";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4665838";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"";"INHIBITOR";""
"CHEMBL5180041";"";"None";"266.30";"0";"3.05";"59; J114";"O=C(Cc1ccc2cc[nH]c2c1)Nc1cccc(O)c1";"IC50";"'='";"77.0";"nM";"7.11";"";"";"UO_0000065";"26.71";"0.49";"4.06";"10.92";"0";"CHEMBL5138374";"Inhibition of NLRP3 inflammasome activation in LPS/nigericin-stimulated PMA-differentiated human THP-1 macrophages assessed as reduction in pyroptosis pretreated with LPS followed by compound treatment for 30 mins then stimulation with nigericin and measured after 3 hrs by MTT assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"THP-1";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5137000";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"TIME = 3.5 hr";"INHIBITOR";""
"CHEMBL5172825";"";"None";"241.29";"0";"2.88";"37";"Cc1ccc(CC(=O)Nc2cccc(O)c2)cc1";"IC50";"'='";"2821.0";"nM";"5.55";"";"";"UO_0000065";"23.00";"0.42";"2.67";"11.25";"0";"CHEMBL5138374";"Inhibition of NLRP3 inflammasome activation in LPS/nigericin-stimulated PMA-differentiated human THP-1 macrophages assessed as reduction in pyroptosis pretreated with LPS followed by compound treatment for 30 mins then stimulation with nigericin and measured after 3 hrs by MTT assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"THP-1";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5137000";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"TIME = 3.5 hr";"INHIBITOR";""
"CHEMBL5186642";"";"None";"280.33";"0";"2.73";"65";"O=C(Cc1ccc2cc[nH]c2c1)NCc1cccc(O)c1";"IC50";"'='";"4146.0";"nM";"5.38";"";"";"UO_0000065";"19.20";"0.35";"2.65";"8.27";"0";"CHEMBL5138374";"Inhibition of NLRP3 inflammasome activation in LPS/nigericin-stimulated PMA-differentiated human THP-1 macrophages assessed as reduction in pyroptosis pretreated with LPS followed by compound treatment for 30 mins then stimulation with nigericin and measured after 3 hrs by MTT assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"THP-1";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5137000";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"TIME = 3.5 hr";"INHIBITOR";""
"CHEMBL5183946";"";"None";"283.33";"0";"2.91";"24";"COc1ccc(CC(=O)Nc2ccc3c(c2)COC3)cc1";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5138374";"Inhibition of NLRP3 inflammasome activation in LPS/nigericin-stimulated PMA-differentiated human THP-1 macrophages assessed as reduction in pyroptosis pretreated with LPS followed by compound treatment for 30 mins then stimulation with nigericin and measured after 3 hrs by MTT assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"THP-1";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5137000";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"TIME = 3.5 hr";"";""
"CHEMBL5202864";"";"None";"275.74";"0";"3.53";"18";"COc1ccc(CC(=O)Nc2cccc(Cl)c2)cc1";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5138374";"Inhibition of NLRP3 inflammasome activation in LPS/nigericin-stimulated PMA-differentiated human THP-1 macrophages assessed as reduction in pyroptosis pretreated with LPS followed by compound treatment for 30 mins then stimulation with nigericin and measured after 3 hrs by MTT assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"THP-1";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5137000";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"TIME = 3.5 hr";"";""
"CHEMBL5180041";"";"None";"266.30";"0";"3.05";"59; J114";"O=C(Cc1ccc2cc[nH]c2c1)Nc1cccc(O)c1";"IC50";"'='";"98.0";"nM";"7.01";"";"";"UO_0000065";"26.32";"0.48";"3.96";"10.76";"0";"CHEMBL5138377";"Inhibition of NLRP3 inflammasome activation in LPS-primed human THP-1 cells assessed as reduction in IL-1beta release in supernatant pretreated for 30 mins followed by nigericin stimulation and measured after 30 mins by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"THP-1";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5137000";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"TIME = 1.0 hr";"INHIBITOR";""
"CHEMBL129795";"ISOLIQUIRITIGENIN";"None";"256.26";"0";"2.70";"Isoliquiritigenin";"O=C(/C=C/c1ccc(O)cc1)c1ccc(O)cc1O";"IC50";"'='";"1540.0";"nM";"5.81";"";"";"UO_0000065";"22.68";"0.42";"3.11";"7.47";"0";"CHEMBL4221123";"Inhibition of NLRP3 inflammasome in human THP1 cells assessed as reduction in MSU-induced IL-1beta production preincubated for 1 hr followed by MSU stimulation measured after 6 hrs";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4219086";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";"";""
"CHEMBL5169601";"";"None";"401.47";"0";"2.46";"47";"Cn1cnc(Cc2cc(=O)n3nc(Nc4c5c(cc6c4CCC6)CCC5)nc3[nH]2)c1";"IC50";"'='";"5500.0";"nM";"5.26";"";"";"UO_0000065";"13.10";"0.24";"2.80";"5.66";"0";"CHEMBL5149834";"Inhibition of NLRP3 inflammasome in LPS-pretreated PBMC (unknown origin) assessed as reduction in IL-1beta release pretreated for 30 mins followed by ATP stimulated and measured after 1 hr by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5143747";"1";"Scientific Literature";"ACS Med Chem Lett";"2022";"None";"TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL4744586";"";"None";"394.48";"0";"2.75";"43";"CCOC(=O)C(Cc1ccnnc1)NC(=O)Nc1c2c(cc3c1CCC3)CCC2";"IC50";"'='";"6000.0";"nM";"5.22";"";"";"UO_0000065";"13.24";"0.25";"2.47";"5.60";"0";"CHEMBL4702271";"Inhibition of NLRP3 in human PBMC cells assessed as inhibition of LPS and ATP-induced IL-1beta production";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699510";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"";"INHIBITOR";""
"CHEMBL4861331";"";"None";"490.53";"0";"3.52";"35";"CC(C)c1cc(F)c(F)c2c1CC(=O)NS(=O)(=O)c1cnn(c1)C(C)(C)COc1cc-2ccn1";"IC50";"'<='";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4827631";"Inhibition of NLRP3 inflammasome activation in LPS/nigericin-treated human THP-1 cells assessed as reduction in pyroptosis pretreated for 3 hrs in presence of LPS followed by nigericin addition and measured after 1 hr by resazurin assay";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"None";"THP-1";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4825720";"1";"Scientific Literature";"ACS Med Chem Lett";"2021";"None";"TIME = 4.0 hr";"INHIBITOR";""
"CHEMBL4635308";"";"None";"329.38";"0";"2.84";"9a";"C/C(=N\NS(=O)(=O)c1ccc(C)cc1)c1nc2ccccc2o1";"IC50";"'='";"13800.0";"nM";"4.86";"";"";"UO_0000065";"14.76";"0.29";"2.02";"5.75";"0";"CHEMBL4611534";"Inhibition of NLRP3 in human THP1 cells assessed as inhibition of MSU-induced IL-1beta production";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"THP-1";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4610050";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"CHEMBL3307574";"";"";""
"CHEMBL4850095";"";"None";"452.54";"0";"3.00";"32";"CC(C)c1cccc2c1CC(=O)NS(=O)(=O)c1cnn(c1)C1(CC1)COc1cc-2ccn1";"IC50";"'<='";"1000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4827631";"Inhibition of NLRP3 inflammasome activation in LPS/nigericin-treated human THP-1 cells assessed as reduction in pyroptosis pretreated for 3 hrs in presence of LPS followed by nigericin addition and measured after 1 hr by resazurin assay";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"None";"THP-1";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4825720";"1";"Scientific Literature";"ACS Med Chem Lett";"2021";"None";"TIME = 4.0 hr";"INHIBITOR";""
"CHEMBL4874656";"";"None";"484.58";"0";"3.25";"29";"COc1cn2nc1S(=O)(=O)NC(=O)Cc1c(cccc1C(C)C)-c1ccnc(c1)OCC2(C)C";"IC50";"'<='";"500.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4827632";"Inhibition of NLRP3 inflammasome activation in LPS-primed human whole blood assessed as reduction in nigericin-induced IL-1beta level preincubated for 3 hrs followed by nigericin addition and measured after 1 hrs by AlphaLISA assay";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"Blood";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4825720";"1";"Scientific Literature";"ACS Med Chem Lett";"2021";"None";"TIME = 4.0 hr";"INHIBITOR";""
"CHEMBL5208282";"";"None";"296.33";"0";"2.12";"29";"COc1ccc(CC(=O)Nc2ccc3c(c2)CNC3=O)cc1";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5138374";"Inhibition of NLRP3 inflammasome activation in LPS/nigericin-stimulated PMA-differentiated human THP-1 macrophages assessed as reduction in pyroptosis pretreated with LPS followed by compound treatment for 30 mins then stimulation with nigericin and measured after 3 hrs by MTT assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"THP-1";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5137000";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"TIME = 3.5 hr";"";""
"CHEMBL5196699";"";"None";"271.32";"0";"2.89";"11";"COc1ccc(CC(=O)Nc2cccc(OC)c2)cc1";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5138374";"Inhibition of NLRP3 inflammasome activation in LPS/nigericin-stimulated PMA-differentiated human THP-1 macrophages assessed as reduction in pyroptosis pretreated with LPS followed by compound treatment for 30 mins then stimulation with nigericin and measured after 3 hrs by MTT assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"THP-1";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5137000";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"TIME = 3.5 hr";"";""
"CHEMBL3183703";"";"None";"404.49";"0";"2.99";"1; MCC950";"CC(C)(O)c1coc(S(=O)(=O)NC(=O)Nc2c3c(cc4c2CCC4)CCC3)c1";"IC50";"'='";"13.0";"nM";"7.89";"";"";"UO_0000065";"19.50";"0.38";"4.90";"7.26";"0";"CHEMBL5122649";"Inhibition of NLRP3 inflammasome activation in PMA differentiated LPS-primed human THP-1 cells assessed as reduction in nigericin-induced IL-1beta level pretreated for 2 hrs followed by nigericin addition and measured after 30 mins by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"THP-1";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5120824";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"TIME = 2.5 hr";"INHIBITOR";""
"CHEMBL5188246";"";"None";"509.59";"1";"3.08";"7e";"O=C(Nc1c2c(cc3c1CCC3)CCC2)NS(=O)(=O)c1ccc(N2CC3CCC(C2)O3)c2nonc12";"IC50";"'='";"243.0";"nM";"6.61";"";"";"UO_0000065";"12.98";"0.25";"3.53";"5.22";"0";"CHEMBL5122649";"Inhibition of NLRP3 inflammasome activation in PMA differentiated LPS-primed human THP-1 cells assessed as reduction in nigericin-induced IL-1beta level pretreated for 2 hrs followed by nigericin addition and measured after 30 mins by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"THP-1";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5120824";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"TIME = 2.5 hr";"INHIBITOR";""
"CHEMBL4795321";"";"None";"389.50";"0";"3.24";"11";"O=C(Nc1c2c(cc3c1CCC3)CCC2)NS(=O)(=O)/C=C/c1cscn1";"IC50";"'='";"369.0";"nM";"6.43";"";"";"UO_0000065";"16.52";"0.34";"3.19";"7.30";"0";"CHEMBL4671767";"Inhibition of NLRP3 in human THP1 cells assessed as inhibition of IL-1beta production";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"THP-1";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4665838";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"";"INHIBITOR";""
"CHEMBL4745667";"";"None";"463.65";"0";"4.50";"14";"CCSCc1csc(/C=C/S(=O)(=O)NC(=O)Nc2c3c(cc4c2CCC4)CCC3)n1";"IC50";"'='";"93.0";"nM";"7.03";"";"";"UO_0000065";"15.17";"0.32";"2.53";"7.98";"0";"CHEMBL4671767";"Inhibition of NLRP3 in human THP1 cells assessed as inhibition of IL-1beta production";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"THP-1";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4665838";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"";"INHIBITOR";""
"CHEMBL4758006";"";"None";"460.58";"0";"2.94";"17";"CN(C)C(=O)c1csc(/C=C/S(=O)(=O)NC(=O)Nc2c3c(cc4c2CCC4)CCC3)n1";"IC50";"'='";"344.0";"nM";"6.46";"";"";"UO_0000065";"14.03";"0.28";"3.52";"5.96";"0";"CHEMBL4671767";"Inhibition of NLRP3 in human THP1 cells assessed as inhibition of IL-1beta production";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"THP-1";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4665838";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"";"INHIBITOR";""
"CHEMBL5220708";"";"None";"360.44";"0";"1.91";"12";"Cn1ccc(S(=O)(=O)NC(=O)Nc2c3c(cc4c2CCC4)CCC3)n1";"IC50";"'='";"340.0";"nM";"6.47";"";"";"UO_0000065";"17.95";"0.35";"4.56";"6.95";"0";"CHEMBL5217806";"Inhibition of NLRP3 inflammasome activation in LPS and nigericin-stimulated human PBMC cells assessed as reduction in IL-1beta release preincubated with LPS for 3 hrs followed by compound addition for 30 mins and further stimulated with nigericin for 1.5 hrs by ELISA analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5214989";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 2.0 hr";"INHIBITOR";""
"CHEMBL5220378";"";"None";"388.49";"0";"2.95";"14";"CC(C)n1cc(S(=O)(=O)NC(=O)Nc2c3c(cc4c2CCC4)CCC3)cn1";"IC50";"'='";"86.0";"nM";"7.07";"";"";"UO_0000065";"18.19";"0.36";"4.12";"7.59";"0";"CHEMBL5217806";"Inhibition of NLRP3 inflammasome activation in LPS and nigericin-stimulated human PBMC cells assessed as reduction in IL-1beta release preincubated with LPS for 3 hrs followed by compound addition for 30 mins and further stimulated with nigericin for 1.5 hrs by ELISA analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5214989";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 2.0 hr";"INHIBITOR";""
"CHEMBL5219385";"";"None";"459.57";"0";"1.94";"23";"CN(C)CC1COc2c(S(=O)(=O)NC(=O)Nc3c4c(cc5c3CCC5)CCC4)cnn2C1";"IC50";"'='";"2400.0";"nM";"5.62";"";"";"UO_0000065";"12.23";"0.24";"3.68";"5.32";"0";"CHEMBL5217806";"Inhibition of NLRP3 inflammasome activation in LPS and nigericin-stimulated human PBMC cells assessed as reduction in IL-1beta release preincubated with LPS for 3 hrs followed by compound addition for 30 mins and further stimulated with nigericin for 1.5 hrs by ELISA analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5214989";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 2.0 hr";"INHIBITOR";""
"CHEMBL4781244";"";"None";"248.32";"0";"2.76";"2; PTL";"C=C1C(=O)O[C@@H]2[C@H]3O[C@@]3(C)CC/C=C(\C)CC[C@@H]12";"IC50";"'='";"1800.0";"nM";"5.75";"";"";"UO_0000065";"23.13";"0.44";"2.98";"14.79";"0";"CHEMBL4727731";"Inhibition of NLRP3 inflammasome in human primary glial cells assessed as reduction in LPS-induced IL-1beta release";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Primary neuron";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4725325";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"";"INHIBITOR";""
"CHEMBL4740148";"";"None";"547.63";"1";"2.29";"8b";"C/C1=C\CC[C@]2(C)O[C@@H]2[C@H]2OC(=O)[C@@H](CN(C)CCOc3no[n+]([O-])c3S(=O)(=O)c3ccccc3)[C@@H]2CC1";"IC50";"'='";"1000.0";"nM";"6.00";"";"";"UO_0000065";"10.96";"0.22";"3.71";"4.33";"0";"CHEMBL4727731";"Inhibition of NLRP3 inflammasome in human primary glial cells assessed as reduction in LPS-induced IL-1beta release";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Primary neuron";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4725325";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"";"INHIBITOR";""
"CHEMBL211693";"";"None";"227.26";"0";"2.57";"31";"O=C(Cc1ccccc1)Nc1cccc(O)c1";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5138374";"Inhibition of NLRP3 inflammasome activation in LPS/nigericin-stimulated PMA-differentiated human THP-1 macrophages assessed as reduction in pyroptosis pretreated with LPS followed by compound treatment for 30 mins then stimulation with nigericin and measured after 3 hrs by MTT assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"THP-1";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5137000";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"TIME = 3.5 hr";"";""
"CHEMBL5183967";"";"None";"296.33";"0";"2.12";"28";"COc1ccc(CC(=O)Nc2ccc3c(c2)C(=O)NC3)cc1";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5138374";"Inhibition of NLRP3 inflammasome activation in LPS/nigericin-stimulated PMA-differentiated human THP-1 macrophages assessed as reduction in pyroptosis pretreated with LPS followed by compound treatment for 30 mins then stimulation with nigericin and measured after 3 hrs by MTT assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"THP-1";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5137000";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"TIME = 3.5 hr";"";""
"CHEMBL5205278";"";"None";"295.34";"0";"3.01";"25";"COc1ccc(CC(=O)Nc2ccc3c(c2)C(=O)CC3)cc1";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5138374";"Inhibition of NLRP3 inflammasome activation in LPS/nigericin-stimulated PMA-differentiated human THP-1 macrophages assessed as reduction in pyroptosis pretreated with LPS followed by compound treatment for 30 mins then stimulation with nigericin and measured after 3 hrs by MTT assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"THP-1";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5137000";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"TIME = 3.5 hr";"";""
"CHEMBL5192177";"";"None";"320.19";"0";"3.64";"19";"COc1ccc(CC(=O)Nc2cccc(Br)c2)cc1";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5138374";"Inhibition of NLRP3 inflammasome activation in LPS/nigericin-stimulated PMA-differentiated human THP-1 macrophages assessed as reduction in pyroptosis pretreated with LPS followed by compound treatment for 30 mins then stimulation with nigericin and measured after 3 hrs by MTT assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"THP-1";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5137000";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"TIME = 3.5 hr";"";""
"CHEMBL4752523";"";"None";"389.50";"0";"3.24";"7";"O=C(Nc1c2c(cc3c1CCC3)CCC2)NS(=O)(=O)/C=C/c1nccs1";"IC50";"'='";"26.0";"nM";"7.58";"";"";"UO_0000065";"19.47";"0.40";"4.35";"8.60";"0";"CHEMBL4671765";"Inhibition of NLRP3 inflammasome activation in human THP1 cells assessed as inhibition of IL-1beta release in presence of nigericin";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"THP-1";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4665838";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"";"INHIBITOR";""
"CHEMBL4780080";"";"None";"330.43";"0";"3.13";"14";"CC(C)(C)OC(=O)CNC(=O)Nc1c2c(cc3c1CCC3)CCC2";"IC50";"'>'";"20000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4702271";"Inhibition of NLRP3 in human PBMC cells assessed as inhibition of LPS and ATP-induced IL-1beta production";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699510";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"";"";""
"CHEMBL4799541";"";"None";"394.47";"0";"3.28";"34";"COC(=O)[C@@H](Cc1ccc(O)cc1)NC(=O)Nc1c2c(cc3c1CCC3)CCC2";"IC50";"'='";"2700.0";"nM";"5.57";"";"";"UO_0000065";"14.12";"0.26";"2.29";"6.35";"0";"CHEMBL4702271";"Inhibition of NLRP3 in human PBMC cells assessed as inhibition of LPS and ATP-induced IL-1beta production";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699510";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"";"INHIBITOR";""
"CHEMBL4764240";"";"None";"250.30";"0";"1.99";"24";"CCOC(=O)CNC(=O)Nc1c(C)cccc1C";"IC50";"'>'";"20000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4702271";"Inhibition of NLRP3 in human PBMC cells assessed as inhibition of LPS and ATP-induced IL-1beta production";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699510";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"";"";""
"CHEMBL4752523";"";"None";"389.50";"0";"3.24";"7";"O=C(Nc1c2c(cc3c1CCC3)CCC2)NS(=O)(=O)/C=C/c1nccs1";"IC50";"'='";"33.0";"nM";"7.48";"";"";"UO_0000065";"19.21";"0.39";"4.24";"8.49";"0";"CHEMBL4671763";"Inhibition of NLRP3 (unknown origin) assessed as inhibition of IL-18 production by cell based assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4665838";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"";"INHIBITOR";""
"CHEMBL4753197";"";"None";"393.53";"0";"4.51";"21";"CC(C)c1cccc(C(C)C)c1NC(=O)NS(=O)(=O)/C=C/c1nccs1";"IC50";"'>'";"1000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4671767";"Inhibition of NLRP3 in human THP1 cells assessed as inhibition of IL-1beta production";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"THP-1";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4665838";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"";"";""
"CHEMBL4756259";"";"None";"561.66";"1";"2.68";"8c";"C/C1=C\CC[C@]2(C)O[C@@H]2[C@H]2OC(=O)[C@@H](CN(C)CCCOc3no[n+]([O-])c3S(=O)(=O)c3ccccc3)[C@@H]2CC1";"IC50";"'='";"2200.0";"nM";"5.66";"";"";"UO_0000065";"10.07";"0.20";"2.98";"4.09";"0";"CHEMBL4727731";"Inhibition of NLRP3 inflammasome in human primary glial cells assessed as reduction in LPS-induced IL-1beta release";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Primary neuron";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4725325";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"";"INHIBITOR";""
"CHEMBL4760323";"";"None";"378.43";"0";"3.17";"4";"O=C([N-]S(=O)(=O)c1ccccc1)Nc1c2c(cc3c1CCC3)CCC2.[Na+]";"IC50";"'='";"1800.0";"nM";"5.75";"";"";"UO_0000065";"16.12";"0.31";"2.57";"7.63";"0";"CHEMBL4702271";"Inhibition of NLRP3 in human PBMC cells assessed as inhibition of LPS and ATP-induced IL-1beta production";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699510";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"";"INHIBITOR";""
"CHEMBL4785852";"";"None";"274.32";"0";"1.87";"10";"O=C(O)CNC(=O)Nc1c2c(cc3c1CCC3)CCC2";"IC50";"'>'";"20000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4702271";"Inhibition of NLRP3 in human PBMC cells assessed as inhibition of LPS and ATP-induced IL-1beta production";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699510";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"";"";""
"CHEMBL4755720";"";"None";"312.37";"0";"2.68";"17";"Cc1nc(CNC(=O)Nc2c3c(cc4c2CCC4)CCC3)no1";"IC50";"'>'";"20000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4702271";"Inhibition of NLRP3 in human PBMC cells assessed as inhibition of LPS and ATP-induced IL-1beta production";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699510";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"";"";""
"CHEMBL5219824";"";"None";"374.47";"0";"2.22";"15";"Cc1c(S(=O)(=O)NC(=O)Nc2c3c(cc4c2CCC4)CCC3)cnn1C";"IC50";"'='";"2570.0";"nM";"5.59";"";"";"UO_0000065";"14.93";"0.29";"3.37";"6.01";"0";"CHEMBL5217806";"Inhibition of NLRP3 inflammasome activation in LPS and nigericin-stimulated human PBMC cells assessed as reduction in IL-1beta release preincubated with LPS for 3 hrs followed by compound addition for 30 mins and further stimulated with nigericin for 1.5 hrs by ELISA analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5214989";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 2.0 hr";"INHIBITOR";""
"CHEMBL5279284";"";"None";"329.40";"0";"2.07";"I-5";"COc1ccc(-c2nnc(N[C@@H]3CCCN(C)C3)nc2C)c(O)c1";"IC50";"'<'";"1.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5260446";"Inhibition of NLRP3 inflammasome activation in PMA-differentiated human THP-1 cells assessed as reduction in IL-1beta secretion preincubated for 20 hrs followed by nigericin addition and measured after 3 hrs by HTRF assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"THP-1";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5257145";"1";"Scientific Literature";"ACS Med Chem Lett";"2023";"None";"TIME = 23.0 hr";"INHIBITOR";""
"CHEMBL5219226";"";"None";"358.42";"0";"1.96";"7";"O=C(Nc1c2c(cc3c1CCC3)CCC2)NS(=O)(=O)c1cnccn1";"IC50";"'='";"960.0";"nM";"6.02";"";"";"UO_0000065";"16.79";"0.33";"4.06";"5.96";"0";"CHEMBL5217806";"Inhibition of NLRP3 inflammasome activation in LPS and nigericin-stimulated human PBMC cells assessed as reduction in IL-1beta release preincubated with LPS for 3 hrs followed by compound addition for 30 mins and further stimulated with nigericin for 1.5 hrs by ELISA analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5214989";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 2.0 hr";"INHIBITOR";""
"CHEMBL5219660";"";"None";"402.48";"0";"2.15";"17";"O=C(Nc1c2c(cc3c1CCC3)CCC2)NS(=O)(=O)c1cnn2c1OCCC2";"IC50";"'='";"1210.0";"nM";"5.92";"";"";"UO_0000065";"14.70";"0.29";"3.77";"5.78";"0";"CHEMBL5217807";"Inhibition of NLRP3 inflammasome activation in LPS and ATP-stimulated human whole blood assessed as reduction in IL-1beta release in plasma preincubated for 3 hrs followed by ATP stimulation and measured after 1 hr";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"Blood";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5214989";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 4.0 hr";"INHIBITOR";""
"CHEMBL5219789";"";"None";"431.52";"0";"1.35";"20; GDC-2394";"CN[C@@H]1COc2c(S(=O)(=O)NC(=O)Nc3c4c(cc5c3CCC5)CCC4)cnn2C1";"IC50";"'='";"400.0";"nM";"6.40";"";"";"UO_0000065";"14.83";"0.29";"5.05";"5.60";"0";"CHEMBL5217807";"Inhibition of NLRP3 inflammasome activation in LPS and ATP-stimulated human whole blood assessed as reduction in IL-1beta release in plasma preincubated for 3 hrs followed by ATP stimulation and measured after 1 hr";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"Blood";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5214989";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 4.0 hr";"INHIBITOR";""
"CHEMBL5176135";"";"None";"257.29";"0";"2.58";"9";"COc1ccc(CC(=O)Nc2ccccc2O)cc1";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5138374";"Inhibition of NLRP3 inflammasome activation in LPS/nigericin-stimulated PMA-differentiated human THP-1 macrophages assessed as reduction in pyroptosis pretreated with LPS followed by compound treatment for 30 mins then stimulation with nigericin and measured after 3 hrs by MTT assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"THP-1";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5137000";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"TIME = 3.5 hr";"";""
"CHEMBL5173382";"";"None";"305.39";"0";"3.15";"3";"Cc1ccn2nc(Nc3c4c(cc5c3CCC5)CCC4)nc2n1";"IC50";"'>'";"40000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5149834";"Inhibition of NLRP3 inflammasome in LPS-pretreated PBMC (unknown origin) assessed as reduction in IL-1beta release pretreated for 30 mins followed by ATP stimulated and measured after 1 hr by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5143747";"1";"Scientific Literature";"ACS Med Chem Lett";"2022";"None";"TIME = 1.5 hr";"";""
"CHEMBL5174347";"";"None";"411.51";"0";"4.04";"8";"Cc1[nH]c2nc(Nc3c4c(cc5c3CCC5)CCC4)nn2c(=O)c1Cc1ccccc1";"IC50";"'>'";"40000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5149834";"Inhibition of NLRP3 inflammasome in LPS-pretreated PBMC (unknown origin) assessed as reduction in IL-1beta release pretreated for 30 mins followed by ATP stimulated and measured after 1 hr by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5143747";"1";"Scientific Literature";"ACS Med Chem Lett";"2022";"None";"TIME = 1.5 hr";"";""
"CHEMBL5186145";"";"None";"351.41";"0";"2.46";"9";"COc1c(C)[nH]c2nc(Nc3c4c(cc5c3CCC5)CCC4)nn2c1=O";"IC50";"'>'";"40000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5149834";"Inhibition of NLRP3 inflammasome in LPS-pretreated PBMC (unknown origin) assessed as reduction in IL-1beta release pretreated for 30 mins followed by ATP stimulated and measured after 1 hr by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5143747";"1";"Scientific Literature";"ACS Med Chem Lett";"2022";"None";"TIME = 1.5 hr";"";""
"CHEMBL5172161";"";"None";"365.44";"0";"2.33";"13";"COCCc1cc(=O)n2nc(Nc3c4c(cc5c3CCC5)CCC4)nc2[nH]1";"IC50";"'='";"2800.0";"nM";"5.55";"";"";"UO_0000065";"15.19";"0.28";"3.22";"6.59";"0";"CHEMBL5149834";"Inhibition of NLRP3 inflammasome in LPS-pretreated PBMC (unknown origin) assessed as reduction in IL-1beta release pretreated for 30 mins followed by ATP stimulated and measured after 1 hr by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5143747";"1";"Scientific Literature";"ACS Med Chem Lett";"2022";"None";"TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5208497";"";"None";"419.53";"0";"1.89";"43";"CN1CCN(Cc2cc(=O)n3nc(Nc4c5c(cc6c4CCC6)CCC5)nc3[nH]2)CC1";"IC50";"'>'";"40000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5149834";"Inhibition of NLRP3 inflammasome in LPS-pretreated PBMC (unknown origin) assessed as reduction in IL-1beta release pretreated for 30 mins followed by ATP stimulated and measured after 1 hr by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5143747";"1";"Scientific Literature";"ACS Med Chem Lett";"2022";"None";"TIME = 1.5 hr";"";""
"CHEMBL5195278";"";"None";"337.45";"0";"3.82";"49";"Cc1cc(=S)n2nc(Nc3c4c(cc5c3CCC5)CCC4)nc2[nH]1";"IC50";"'='";"600.0";"nM";"6.22";"";"";"UO_0000065";"18.44";"0.35";"2.40";"10.73";"0";"CHEMBL5149834";"Inhibition of NLRP3 inflammasome in LPS-pretreated PBMC (unknown origin) assessed as reduction in IL-1beta release pretreated for 30 mins followed by ATP stimulated and measured after 1 hr by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5143747";"1";"Scientific Literature";"ACS Med Chem Lett";"2022";"None";"TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5185500";"";"None";"421.57";"0";"4.62";"51;NDT-30744";"S=c1cc(CC2CCCCO2)[nH]c2nc(Nc3c4c(cc5c3CCC5)CCC4)nn12";"IC50";"'='";"190.0";"nM";"6.72";"";"";"UO_0000065";"15.94";"0.31";"2.10";"10.00";"0";"CHEMBL5149841";"Inhibition of NLRP3 inflammasome in LPS-pretreated human THP1-ASC-GFP cells assessed as reduction in speck positive cells measured after 30 mins in presence of caspase inhibitor zVAD-FMK by Hoechst 33342 staining based confocal microscopy";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"THP1-ASC-GFP";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5143747";"1";"Scientific Literature";"ACS Med Chem Lett";"2022";"None";"TIME = 0.5 hr";"INHIBITOR";""
"CHEMBL5189690";"";"None";"509.59";"1";"2.39";"7d";"O=C(Nc1c2c(cc3c1CCC3)CCC2)NS(=O)(=O)c1ccc(N2C[C@@H]3[C@@H](CO)[C@@H]3C2)c2nonc12";"IC50";"'='";"641.0";"nM";"6.19";"";"";"UO_0000065";"12.15";"0.23";"3.80";"4.50";"0";"CHEMBL5122649";"Inhibition of NLRP3 inflammasome activation in PMA differentiated LPS-primed human THP-1 cells assessed as reduction in nigericin-induced IL-1beta level pretreated for 2 hrs followed by nigericin addition and measured after 30 mins by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"THP-1";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5120824";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"TIME = 2.5 hr";"INHIBITOR";""
"CHEMBL4750616";"";"None";"426.47";"0";"2.99";"CP-456,773";"CC(C)(O)c1coc(S(=O)(=O)[N-]C(=O)Nc2c3c(cc4c2CCC4)CCC3)c1.[Na+]";"IC50";"'='";"28.0";"nM";"7.55";"";"";"UO_0000065";"18.67";"0.37";"4.56";"6.95";"0";"CHEMBL4702274";"Inhibition of NLRP3 in human THP-1 cells assessed as reduction in nigercin-induced ASC speck formation measuring green fluorescent protein aggregation by confocal microscopy";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"THP-1";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699510";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"";"INHIBITOR";""
"CHEMBL5171938";"";"None";"404.52";"0";"2.95";"18";"CN1CCC(c2cc(=O)n3nc(Nc4c5c(cc6c4CCC6)CCC5)nc3[nH]2)CC1";"IC50";"'>'";"40000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5149834";"Inhibition of NLRP3 inflammasome in LPS-pretreated PBMC (unknown origin) assessed as reduction in IL-1beta release pretreated for 30 mins followed by ATP stimulated and measured after 1 hr by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5143747";"1";"Scientific Literature";"ACS Med Chem Lett";"2022";"None";"TIME = 1.5 hr";"";""
"CHEMBL5174838";"";"None";"405.50";"0";"3.11";"37";"O=c1cc(CC2CCOCC2)[nH]c2nc(Nc3c4c(cc5c3CCC5)CCC4)nn12";"IC50";"'='";"3400.0";"nM";"5.47";"";"";"UO_0000065";"13.49";"0.25";"2.36";"6.49";"0";"CHEMBL5149834";"Inhibition of NLRP3 inflammasome in LPS-pretreated PBMC (unknown origin) assessed as reduction in IL-1beta release pretreated for 30 mins followed by ATP stimulated and measured after 1 hr by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5143747";"1";"Scientific Literature";"ACS Med Chem Lett";"2022";"None";"TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5196139";"";"None";"414.54";"0";"4.49";"50;NDT-30805";"S=c1cc(Cc2ccccn2)[nH]c2nc(Nc3c4c(cc5c3CCC5)CCC4)nn12";"IC50";"'='";"34.0";"nM";"7.47";"";"";"UO_0000065";"18.02";"0.34";"2.98";"10.53";"0";"CHEMBL5149841";"Inhibition of NLRP3 inflammasome in LPS-pretreated human THP1-ASC-GFP cells assessed as reduction in speck positive cells measured after 30 mins in presence of caspase inhibitor zVAD-FMK by Hoechst 33342 staining based confocal microscopy";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"THP1-ASC-GFP";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5143747";"1";"Scientific Literature";"ACS Med Chem Lett";"2022";"None";"TIME = 0.5 hr";"INHIBITOR";""
"CHEMBL4126946";"";"None";"146.14";"0";"-1.30";"6";"O=C1CO[C@H](CO)[C@@H](O)C1";"IC50";"'='";"2300000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4125669";"Inhibition of nigericin-induced NLRP3 inflammasome activation in PMA-differentiated human THP1 cells assessed as reduction in LPS-stimulated IL-1beta secretion incubated for 1 hr prior to stimulation with nigericin for 1 hr by quanti-blue based SEAP reporter gene assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4118290";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";"";""
"CHEMBL3183703";"";"None";"404.49";"0";"2.99";"1; MCC950, CP-456773";"CC(C)(O)c1coc(S(=O)(=O)NC(=O)Nc2c3c(cc4c2CCC4)CCC3)c1";"IC50";"'='";"8.0";"nM";"8.10";"";"";"UO_0000065";"20.02";"0.39";"5.11";"7.45";"1";"CHEMBL4671767";"Inhibition of NLRP3 in human THP1 cells assessed as inhibition of IL-1beta production";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"THP-1";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4665838";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"";"INHIBITOR";""
"CHEMBL5170114";"";"None";"526.62";"1";"1.82";"7g";"O=C(Nc1c2c(cc3c1CCC3)CCC2)NS(=O)(=O)c1ccc(N2CCN(CCO)CC2)c2nonc12";"IC50";"'='";"2380.0";"nM";"5.62";"";"";"UO_0000065";"10.68";"0.21";"3.80";"3.99";"0";"CHEMBL5122649";"Inhibition of NLRP3 inflammasome activation in PMA differentiated LPS-primed human THP-1 cells assessed as reduction in nigericin-induced IL-1beta level pretreated for 2 hrs followed by nigericin addition and measured after 30 mins by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"THP-1";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5120824";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"TIME = 2.5 hr";"INHIBITOR";""
"CHEMBL4128029";"";"None";"198.22";"0";"0.85";"9";"CCCC(=O)OC[C@@H]1C=CC(=O)CO1";"IC50";"'='";"3600.0";"nM";"5.44";"";"";"UO_0000065";"27.46";"0.53";"4.59";"10.35";"0";"CHEMBL4125669";"Inhibition of nigericin-induced NLRP3 inflammasome activation in PMA-differentiated human THP1 cells assessed as reduction in LPS-stimulated IL-1beta secretion incubated for 1 hr prior to stimulation with nigericin for 1 hr by quanti-blue based SEAP reporter gene assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4118290";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";"";""
"CHEMBL5288479";"";"None";"347.39";"0";"2.21";"I-21";"COc1cc(O)c(-c2nnc(N[C@@H]3CCCN(C)C3)nc2C)c(F)c1";"IC50";"'<'";"1.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5260446";"Inhibition of NLRP3 inflammasome activation in PMA-differentiated human THP-1 cells assessed as reduction in IL-1beta secretion preincubated for 20 hrs followed by nigericin addition and measured after 3 hrs by HTRF assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"THP-1";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5257145";"1";"Scientific Literature";"ACS Med Chem Lett";"2023";"None";"TIME = 23.0 hr";"INHIBITOR";""
"CHEMBL5188716";"";"None";"346.39";"0";"2.32";"10";"Cc1[nH]c2nc(Nc3c4c(cc5c3CCC5)CCC4)nn2c(=O)c1C#N";"IC50";"'>'";"40000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5149834";"Inhibition of NLRP3 inflammasome in LPS-pretreated PBMC (unknown origin) assessed as reduction in IL-1beta release pretreated for 30 mins followed by ATP stimulated and measured after 1 hr by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5143747";"1";"Scientific Literature";"ACS Med Chem Lett";"2022";"None";"TIME = 1.5 hr";"";""
"CHEMBL5203803";"";"None";"391.48";"0";"3.03";"16";"O=c1cc(C2CCOCC2)[nH]c2nc(Nc3c4c(cc5c3CCC5)CCC4)nn12";"IC50";"'='";"6300.0";"nM";"5.20";"";"";"UO_0000065";"13.28";"0.24";"2.17";"6.17";"0";"CHEMBL5149834";"Inhibition of NLRP3 inflammasome in LPS-pretreated PBMC (unknown origin) assessed as reduction in IL-1beta release pretreated for 30 mins followed by ATP stimulated and measured after 1 hr by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5143747";"1";"Scientific Literature";"ACS Med Chem Lett";"2022";"None";"TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5202277";"";"None";"404.52";"0";"2.95";"20";"CN1CCCC(c2cc(=O)n3nc(Nc4c5c(cc6c4CCC6)CCC5)nc3[nH]2)C1";"IC50";"'='";"4900.0";"nM";"5.31";"";"";"UO_0000065";"13.13";"0.24";"2.36";"6.78";"0";"CHEMBL5149834";"Inhibition of NLRP3 inflammasome in LPS-pretreated PBMC (unknown origin) assessed as reduction in IL-1beta release pretreated for 30 mins followed by ATP stimulated and measured after 1 hr by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5143747";"1";"Scientific Literature";"ACS Med Chem Lett";"2022";"None";"TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5199318";"";"None";"399.46";"0";"2.52";"34";"O=c1cc(Cc2ncccn2)[nH]c2nc(Nc3c4c(cc5c3CCC5)CCC4)nn12";"IC50";"'='";"1700.0";"nM";"5.77";"";"";"UO_0000065";"14.44";"0.26";"3.25";"5.72";"0";"CHEMBL5149834";"Inhibition of NLRP3 inflammasome in LPS-pretreated PBMC (unknown origin) assessed as reduction in IL-1beta release pretreated for 30 mins followed by ATP stimulated and measured after 1 hr by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5143747";"1";"Scientific Literature";"ACS Med Chem Lett";"2022";"None";"TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5219789";"";"None";"431.52";"0";"1.35";"20; GDC-2394";"CN[C@@H]1COc2c(S(=O)(=O)NC(=O)Nc3c4c(cc5c3CCC5)CCC4)cnn2C1";"IC50";"'='";"17.0";"nM";"7.77";"";"";"UO_0000065";"18.01";"0.35";"6.42";"6.79";"0";"CHEMBL5217846";"Inhibition of NLRP3 inflammasome activation in LPS-stimulated human monocyte-derived macrophage assessed as reduction in IL-18 secretion in presence of CHC";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"MDM";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5214989";"1";"Scientific Literature";"J Med Chem";"2022";"None";"";"INHIBITOR";""
"CHEMBL5219789";"";"None";"431.52";"0";"1.35";"20; GDC-2394";"CN[C@@H]1COc2c(S(=O)(=O)NC(=O)Nc3c4c(cc5c3CCC5)CCC4)cnn2C1";"IC50";"'='";"51.0";"nM";"7.29";"";"";"UO_0000065";"16.90";"0.33";"5.94";"6.38";"0";"CHEMBL5217835";"Inhibition of NLRP3 induced caspase 1 activity in LPS/nigericin-treated human THP-1 cells preincubated with LPS for 3 hrs followed by compound addition for 30 mins and further stimulated with nigericin for 90 min";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"THP-1";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5214989";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 2.0 hr";"INHIBITOR";""
"CHEMBL5219789";"";"None";"431.52";"0";"1.35";"20; GDC-2394";"CN[C@@H]1COc2c(S(=O)(=O)NC(=O)Nc3c4c(cc5c3CCC5)CCC4)cnn2C1";"IC50";"'='";"290.0";"nM";"6.54";"";"";"UO_0000065";"15.15";"0.30";"5.19";"5.72";"0";"CHEMBL5217843";"Inhibition of NLRP3 inflammasome activation in LPS-stimulated human whole blood assessed as reduction in ILbeta secretion in presence of calcium pyrophosphate dihydrate";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"Blood";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5214989";"1";"Scientific Literature";"J Med Chem";"2022";"None";"";"INHIBITOR";""
"CHEMBL5196080";"";"None";"305.36";"0";"1.98";"49";"CS(=O)(=O)c1ccc(CC(=O)Nc2cccc(O)c2)cc1";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5138374";"Inhibition of NLRP3 inflammasome activation in LPS/nigericin-stimulated PMA-differentiated human THP-1 macrophages assessed as reduction in pyroptosis pretreated with LPS followed by compound treatment for 30 mins then stimulation with nigericin and measured after 3 hrs by MTT assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"THP-1";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5137000";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"TIME = 3.5 hr";"";""
"CHEMBL5203191";"";"None";"311.26";"0";"3.47";"47";"O=C(Cc1ccc(OC(F)(F)F)cc1)Nc1cccc(O)c1";"IC50";"'='";"2318.0";"nM";"5.63";"";"";"UO_0000065";"18.10";"0.35";"2.16";"9.62";"0";"CHEMBL5138374";"Inhibition of NLRP3 inflammasome activation in LPS/nigericin-stimulated PMA-differentiated human THP-1 macrophages assessed as reduction in pyroptosis pretreated with LPS followed by compound treatment for 30 mins then stimulation with nigericin and measured after 3 hrs by MTT assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"THP-1";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5137000";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"TIME = 3.5 hr";"INHIBITOR";""
"CHEMBL5196575";"";"None";"269.34";"0";"3.70";"39";"CC(C)c1ccc(CC(=O)Nc2cccc(O)c2)cc1";"IC50";"'='";"176.8";"nM";"6.75";"";"";"UO_0000065";"25.07";"0.46";"3.05";"13.69";"0";"CHEMBL5138374";"Inhibition of NLRP3 inflammasome activation in LPS/nigericin-stimulated PMA-differentiated human THP-1 macrophages assessed as reduction in pyroptosis pretreated with LPS followed by compound treatment for 30 mins then stimulation with nigericin and measured after 3 hrs by MTT assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"THP-1";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5137000";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"TIME = 3.5 hr";"INHIBITOR";""
"CHEMBL5197232";"";"None";"269.30";"0";"2.51";"56";"O=C(Cc1ccc2c(c1)CCO2)Nc1cccc(O)c1";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5138374";"Inhibition of NLRP3 inflammasome activation in LPS/nigericin-stimulated PMA-differentiated human THP-1 macrophages assessed as reduction in pyroptosis pretreated with LPS followed by compound treatment for 30 mins then stimulation with nigericin and measured after 3 hrs by MTT assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"THP-1";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5137000";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"TIME = 3.5 hr";"";""
"CHEMBL5176529";"";"None";"277.32";"0";"3.73";"53";"O=C(Cc1ccc2ccccc2c1)Nc1cccc(O)c1";"IC50";"'='";"1621.0";"nM";"5.79";"";"";"UO_0000065";"20.88";"0.38";"2.06";"11.74";"0";"CHEMBL5138374";"Inhibition of NLRP3 inflammasome activation in LPS/nigericin-stimulated PMA-differentiated human THP-1 macrophages assessed as reduction in pyroptosis pretreated with LPS followed by compound treatment for 30 mins then stimulation with nigericin and measured after 3 hrs by MTT assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"THP-1";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5137000";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"TIME = 3.5 hr";"INHIBITOR";""
"CHEMBL5192979";"";"None";"272.26";"0";"2.48";"50";"O=C(Cc1ccc([N+](=O)[O-])cc1)Nc1cccc(O)c1";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5138374";"Inhibition of NLRP3 inflammasome activation in LPS/nigericin-stimulated PMA-differentiated human THP-1 macrophages assessed as reduction in pyroptosis pretreated with LPS followed by compound treatment for 30 mins then stimulation with nigericin and measured after 3 hrs by MTT assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"THP-1";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5137000";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"TIME = 3.5 hr";"";""
"CHEMBL5181840";"";"None";"307.30";"0";"3.48";"22";"COc1ccc(CC(=O)Nc2cccc(OC(F)F)c2)cc1";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5138374";"Inhibition of NLRP3 inflammasome activation in LPS/nigericin-stimulated PMA-differentiated human THP-1 macrophages assessed as reduction in pyroptosis pretreated with LPS followed by compound treatment for 30 mins then stimulation with nigericin and measured after 3 hrs by MTT assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"THP-1";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5137000";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"TIME = 3.5 hr";"";""
"CHEMBL5196600";"";"None";"266.30";"0";"3.05";"61";"O=C(Cc1cccc2[nH]ccc12)Nc1cccc(O)c1";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5138374";"Inhibition of NLRP3 inflammasome activation in LPS/nigericin-stimulated PMA-differentiated human THP-1 macrophages assessed as reduction in pyroptosis pretreated with LPS followed by compound treatment for 30 mins then stimulation with nigericin and measured after 3 hrs by MTT assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"THP-1";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5137000";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"TIME = 3.5 hr";"";""
"CHEMBL5205674";"";"None";"252.27";"0";"3.13";"64";"O=C(Nc1cccc(O)c1)c1ccc2cc[nH]c2c1";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5138374";"Inhibition of NLRP3 inflammasome activation in LPS/nigericin-stimulated PMA-differentiated human THP-1 macrophages assessed as reduction in pyroptosis pretreated with LPS followed by compound treatment for 30 mins then stimulation with nigericin and measured after 3 hrs by MTT assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"THP-1";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5137000";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"TIME = 3.5 hr";"";""
"CHEMBL4802424";"";"None";"346.41";"0";"2.77";"2";"O=C(Nc1c2c(cc3c1CCC3)CCC2)NS(=O)(=O)c1ccco1";"IC50";"'='";"440.0";"nM";"6.36";"";"";"UO_0000065";"18.35";"0.36";"3.59";"7.19";"0";"CHEMBL5217806";"Inhibition of NLRP3 inflammasome activation in LPS and nigericin-stimulated human PBMC cells assessed as reduction in IL-1beta release preincubated with LPS for 3 hrs followed by compound addition for 30 mins and further stimulated with nigericin for 1.5 hrs by ELISA analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5214989";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 2.0 hr";"INHIBITOR";""
"CHEMBL5219789";"";"None";"431.52";"0";"1.35";"20; GDC-2394";"CN[C@@H]1COc2c(S(=O)(=O)NC(=O)Nc3c4c(cc5c3CCC5)CCC4)cnn2C1";"IC50";"'='";"48.0";"nM";"7.32";"";"";"UO_0000065";"16.96";"0.33";"5.97";"6.40";"0";"CHEMBL5217838";"Inhibition of NLRP3 inflammasome activation in LPS/nigericin stimulated human THP1-ASC-GFP cells assessed as decrease in ASC speck formation preincubated with LPS for 3 hrs followed by compound addition for 30 mins and further stimulated with nigericin by microscopic analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"THP1-ASC-GFP";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5214989";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 0.5 hr";"INHIBITOR";""
"CHEMBL5219789";"";"None";"431.52";"0";"1.35";"20; GDC-2394";"CN[C@@H]1COc2c(S(=O)(=O)NC(=O)Nc3c4c(cc5c3CCC5)CCC4)cnn2C1";"IC50";"'='";"16.0";"nM";"7.80";"";"";"UO_0000065";"18.07";"0.35";"6.45";"6.82";"0";"CHEMBL5217839";"Inhibition of NLRP3 inflammasome activation in LPS-stimulated human monocyte-derived macrophage assessed as reduction in ILbeta secretion in presence of ATP";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"MDM";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5214989";"1";"Scientific Literature";"J Med Chem";"2022";"None";"";"INHIBITOR";""
"CHEMBL5219690";"";"None";"363.46";"0";"2.63";"8";"O=C(Nc1c2c(cc3c1CCC3)CCC2)NS(=O)(=O)c1nccs1";"IC50";"'='";"3660.0";"nM";"5.44";"";"";"UO_0000065";"14.96";"0.31";"2.81";"6.17";"0";"CHEMBL5217806";"Inhibition of NLRP3 inflammasome activation in LPS and nigericin-stimulated human PBMC cells assessed as reduction in IL-1beta release preincubated with LPS for 3 hrs followed by compound addition for 30 mins and further stimulated with nigericin for 1.5 hrs by ELISA analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5214989";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 2.0 hr";"INHIBITOR";""
"CHEMBL5218811";"";"None";"487.58";"0";"1.46";"22";"COC1CN([C@@H]2COc3c(S(=O)(=O)NC(=O)Nc4c5c(cc6c4CCC6)CCC5)cnn3C2)C1";"IC50";"'='";"12.0";"nM";"7.92";"";"";"UO_0000065";"16.25";"0.32";"6.46";"6.90";"0";"CHEMBL5217806";"Inhibition of NLRP3 inflammasome activation in LPS and nigericin-stimulated human PBMC cells assessed as reduction in IL-1beta release preincubated with LPS for 3 hrs followed by compound addition for 30 mins and further stimulated with nigericin for 1.5 hrs by ELISA analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5214989";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 2.0 hr";"INHIBITOR";""
"CHEMBL5184899";"";"None";"432.89";"0";"3.36";"7";"O=C(Nc1c2c(cc3c1CCC3)CCC2)NS(=O)(=O)c1ccc(Cl)c2nonc12";"IC50";"'='";"146.0";"nM";"6.84";"";"";"UO_0000065";"15.79";"0.32";"3.48";"5.99";"0";"CHEMBL5122649";"Inhibition of NLRP3 inflammasome activation in PMA differentiated LPS-primed human THP-1 cells assessed as reduction in nigericin-induced IL-1beta level pretreated for 2 hrs followed by nigericin addition and measured after 30 mins by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"THP-1";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5120824";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"TIME = 2.5 hr";"INHIBITOR";""
"CHEMBL5184563";"";"None";"483.55";"0";"2.55";"7c";"O=C(Nc1c2c(cc3c1CCC3)CCC2)NS(=O)(=O)c1ccc(N2CCOCC2)c2nonc12";"IC50";"'='";"108.0";"nM";"6.97";"";"";"UO_0000065";"14.41";"0.28";"4.42";"5.50";"0";"CHEMBL5122649";"Inhibition of NLRP3 inflammasome activation in PMA differentiated LPS-primed human THP-1 cells assessed as reduction in nigericin-induced IL-1beta level pretreated for 2 hrs followed by nigericin addition and measured after 30 mins by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"THP-1";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5120824";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"TIME = 2.5 hr";"INHIBITOR";""
"CHEMBL5184600";"";"None";"297.31";"0";"2.55";"26";"COc1ccc(CC(=O)Nc2ccc3c(c2)C(=O)OC3)cc1";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5138374";"Inhibition of NLRP3 inflammasome activation in LPS/nigericin-stimulated PMA-differentiated human THP-1 macrophages assessed as reduction in pyroptosis pretreated with LPS followed by compound treatment for 30 mins then stimulation with nigericin and measured after 3 hrs by MTT assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"THP-1";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5137000";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"TIME = 3.5 hr";"";""
"CHEMBL4792478";"";"None";"430.53";"0";"3.61";"2";"CC(C)(O)c1coc(/C=C/S(=O)(=O)NC(=O)Nc2c3c(cc4c2CCC4)CCC3)c1";"IC50";"'='";"208.0";"nM";"6.68";"";"";"UO_0000065";"15.52";"0.30";"3.07";"6.15";"0";"CHEMBL4671767";"Inhibition of NLRP3 in human THP1 cells assessed as inhibition of IL-1beta production";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"THP-1";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4665838";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"";"INHIBITOR";""
"CHEMBL4778164";"";"None";"479.65";"0";"3.51";"15";"CC[S+]([O-])Cc1csc(/C=C/S(=O)(=O)NC(=O)Nc2c3c(cc4c2CCC4)CCC3)n1";"IC50";"'='";"243.0";"nM";"6.61";"";"";"UO_0000065";"13.79";"0.29";"3.10";"5.95";"0";"CHEMBL4671767";"Inhibition of NLRP3 in human THP1 cells assessed as inhibition of IL-1beta production";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"THP-1";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4665838";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"";"INHIBITOR";""
"CHEMBL4748040";"";"None";"377.37";"0";"3.28";"25";"O=C(Nc1ccccc1C(F)(F)F)NS(=O)(=O)/C=C/c1nccs1";"IC50";"'>'";"1000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4671767";"Inhibition of NLRP3 in human THP1 cells assessed as inhibition of IL-1beta production";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"THP-1";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4665838";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"";"";""
"CHEMBL4782757";"";"None";"365.48";"0";"3.50";"26";"Cc1cc(C)c(C)c(NC(=O)NS(=O)(=O)/C=C/c2nccs2)c1C";"IC50";"'>'";"1000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4671767";"Inhibition of NLRP3 in human THP1 cells assessed as inhibition of IL-1beta production";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"THP-1";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4665838";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"";"";""
"CHEMBL5183540";"";"None";"503.53";"1";"3.92";"7f";"O=C(Nc1c2c(cc3c1CCC3)CCC2)NS(=O)(=O)c1ccc(NC2CC(F)(F)C2)c2nonc12";"IC50";"'='";"247.0";"nM";"6.61";"";"";"UO_0000065";"13.12";"0.26";"2.69";"5.23";"0";"CHEMBL5122649";"Inhibition of NLRP3 inflammasome activation in PMA differentiated LPS-primed human THP-1 cells assessed as reduction in nigericin-induced IL-1beta level pretreated for 2 hrs followed by nigericin addition and measured after 30 mins by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"THP-1";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5120824";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"TIME = 2.5 hr";"INHIBITOR";""
"CHEMBL5207651";"";"None";"427.51";"0";"3.74";"22";"COc1ccc(Cc2cc(=O)n3nc(Nc4c5c(cc6c4CCC6)CCC5)nc3[nH]2)cc1";"IC50";"'='";"3000.0";"nM";"5.52";"";"";"UO_0000065";"12.92";"0.24";"1.78";"6.55";"0";"CHEMBL5149834";"Inhibition of NLRP3 inflammasome in LPS-pretreated PBMC (unknown origin) assessed as reduction in IL-1beta release pretreated for 30 mins followed by ATP stimulated and measured after 1 hr by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5143747";"1";"Scientific Literature";"ACS Med Chem Lett";"2022";"None";"TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5219688";"";"None";"377.49";"0";"2.94";"9";"Cc1ncc(S(=O)(=O)NC(=O)Nc2c3c(cc4c2CCC4)CCC3)s1";"IC50";"'='";"430.0";"nM";"6.37";"";"";"UO_0000065";"16.87";"0.35";"3.43";"7.22";"0";"CHEMBL5217806";"Inhibition of NLRP3 inflammasome activation in LPS and nigericin-stimulated human PBMC cells assessed as reduction in IL-1beta release preincubated with LPS for 3 hrs followed by compound addition for 30 mins and further stimulated with nigericin for 1.5 hrs by ELISA analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5214989";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 2.0 hr";"INHIBITOR";""
"CHEMBL5192873";"";"None";"422.49";"0";"3.60";"28";"N#Cc1ccc(Cc2cc(=O)n3nc(Nc4c5c(cc6c4CCC6)CCC5)nc3[nH]2)cc1";"IC50";"'='";"1600.0";"nM";"5.80";"";"";"UO_0000065";"13.72";"0.25";"2.20";"5.86";"0";"CHEMBL5149834";"Inhibition of NLRP3 inflammasome in LPS-pretreated PBMC (unknown origin) assessed as reduction in IL-1beta release pretreated for 30 mins followed by ATP stimulated and measured after 1 hr by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5143747";"1";"Scientific Literature";"ACS Med Chem Lett";"2022";"None";"TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5205326";"";"None";"398.47";"0";"3.12";"33";"O=c1cc(Cc2ccncc2)[nH]c2nc(Nc3c4c(cc5c3CCC5)CCC4)nn12";"IC50";"'='";"5800.0";"nM";"5.24";"";"";"UO_0000065";"13.14";"0.24";"2.12";"5.95";"0";"CHEMBL5149834";"Inhibition of NLRP3 inflammasome in LPS-pretreated PBMC (unknown origin) assessed as reduction in IL-1beta release pretreated for 30 mins followed by ATP stimulated and measured after 1 hr by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5143747";"1";"Scientific Literature";"ACS Med Chem Lett";"2022";"None";"TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5205427";"";"None";"405.50";"0";"3.25";"36;NDT-30408";"O=c1cc(CC2CCCCO2)[nH]c2nc(Nc3c4c(cc5c3CCC5)CCC4)nn12";"IC50";"'='";"1900.0";"nM";"5.72";"";"";"UO_0000065";"14.11";"0.26";"2.47";"6.79";"0";"CHEMBL5149834";"Inhibition of NLRP3 inflammasome in LPS-pretreated PBMC (unknown origin) assessed as reduction in IL-1beta release pretreated for 30 mins followed by ATP stimulated and measured after 1 hr by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5143747";"1";"Scientific Literature";"ACS Med Chem Lett";"2022";"None";"TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5185500";"";"None";"421.57";"0";"4.62";"51;NDT-30744";"S=c1cc(CC2CCCCO2)[nH]c2nc(Nc3c4c(cc5c3CCC5)CCC4)nn12";"IC50";"'='";"130.0";"nM";"6.89";"";"";"UO_0000065";"16.33";"0.31";"2.27";"10.24";"0";"CHEMBL5149834";"Inhibition of NLRP3 inflammasome in LPS-pretreated PBMC (unknown origin) assessed as reduction in IL-1beta release pretreated for 30 mins followed by ATP stimulated and measured after 1 hr by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5143747";"1";"Scientific Literature";"ACS Med Chem Lett";"2022";"None";"TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL3183703";"";"None";"404.49";"0";"2.99";"1; MCC950, CRID3, CP-456773";"CC(C)(O)c1coc(S(=O)(=O)NC(=O)Nc2c3c(cc4c2CCC4)CCC3)c1";"IC50";"'='";"29.0";"nM";"7.54";"";"";"UO_0000065";"18.63";"0.37";"4.55";"6.94";"0";"CHEMBL5217806";"Inhibition of NLRP3 inflammasome activation in LPS and nigericin-stimulated human PBMC cells assessed as reduction in IL-1beta release preincubated with LPS for 3 hrs followed by compound addition for 30 mins and further stimulated with nigericin for 1.5 hrs by ELISA analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5214989";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 2.0 hr";"INHIBITOR";""
"CHEMBL5219535";"";"None";"357.44";"0";"2.57";"4";"O=C(Nc1c2c(cc3c1CCC3)CCC2)NS(=O)(=O)c1ccccn1";"IC50";"'='";"1330.0";"nM";"5.88";"";"";"UO_0000065";"16.44";"0.32";"3.31";"6.67";"0";"CHEMBL5217806";"Inhibition of NLRP3 inflammasome activation in LPS and nigericin-stimulated human PBMC cells assessed as reduction in IL-1beta release preincubated with LPS for 3 hrs followed by compound addition for 30 mins and further stimulated with nigericin for 1.5 hrs by ELISA analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5214989";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 2.0 hr";"INHIBITOR";""
"CHEMBL5207612";"";"None";"321.38";"0";"2.45";"4";"Cc1cc2[nH]c(Nc3c4c(cc5c3CCC5)CCC4)nn2c(=O)n1";"IC50";"'>'";"40000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5149834";"Inhibition of NLRP3 inflammasome in LPS-pretreated PBMC (unknown origin) assessed as reduction in IL-1beta release pretreated for 30 mins followed by ATP stimulated and measured after 1 hr by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5143747";"1";"Scientific Literature";"ACS Med Chem Lett";"2022";"None";"TIME = 1.5 hr";"";""
"CHEMBL5171049";"";"None";"431.93";"0";"4.38";"25";"O=c1cc(Cc2ccc(Cl)cc2)[nH]c2nc(Nc3c4c(cc5c3CCC5)CCC4)nn12";"IC50";"'='";"10000.0";"nM";"5.00";"";"";"UO_0000065";"11.58";"0.22";"0.62";"6.66";"0";"CHEMBL5149834";"Inhibition of NLRP3 inflammasome in LPS-pretreated PBMC (unknown origin) assessed as reduction in IL-1beta release pretreated for 30 mins followed by ATP stimulated and measured after 1 hr by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5143747";"1";"Scientific Literature";"ACS Med Chem Lett";"2022";"None";"TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5208022";"";"None";"422.49";"0";"3.60";"27";"N#Cc1cccc(Cc2cc(=O)n3nc(Nc4c5c(cc6c4CCC6)CCC5)nc3[nH]2)c1";"IC50";"'='";"2400.0";"nM";"5.62";"";"";"UO_0000065";"13.30";"0.24";"2.02";"5.68";"0";"CHEMBL5149834";"Inhibition of NLRP3 inflammasome in LPS-pretreated PBMC (unknown origin) assessed as reduction in IL-1beta release pretreated for 30 mins followed by ATP stimulated and measured after 1 hr by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5143747";"1";"Scientific Literature";"ACS Med Chem Lett";"2022";"None";"TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5186769";"";"None";"420.52";"0";"2.01";"40";"CN1CCOC(Cc2cc(=O)n3nc(Nc4c5c(cc6c4CCC6)CCC5)nc3[nH]2)C1";"IC50";"'='";"8800.0";"nM";"5.06";"";"";"UO_0000065";"12.02";"0.22";"3.05";"5.77";"0";"CHEMBL5149834";"Inhibition of NLRP3 inflammasome in LPS-pretreated PBMC (unknown origin) assessed as reduction in IL-1beta release pretreated for 30 mins followed by ATP stimulated and measured after 1 hr by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5143747";"1";"Scientific Literature";"ACS Med Chem Lett";"2022";"None";"TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5197427";"";"None";"401.47";"0";"2.46";"44";"Cn1nccc1Cc1cc(=O)n2nc(Nc3c4c(cc5c3CCC5)CCC4)nc2[nH]1";"IC50";"'='";"2000.0";"nM";"5.70";"";"";"UO_0000065";"14.20";"0.26";"3.24";"6.13";"0";"CHEMBL5149834";"Inhibition of NLRP3 inflammasome in LPS-pretreated PBMC (unknown origin) assessed as reduction in IL-1beta release pretreated for 30 mins followed by ATP stimulated and measured after 1 hr by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5143747";"1";"Scientific Literature";"ACS Med Chem Lett";"2022";"None";"TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5185377";"";"None";"401.47";"0";"2.46";"48";"Cn1cncc1Cc1cc(=O)n2nc(Nc3c4c(cc5c3CCC5)CCC4)nc2[nH]1";"IC50";"'='";"16000.0";"nM";"4.80";"";"";"UO_0000065";"11.95";"0.22";"2.34";"5.16";"0";"CHEMBL5149834";"Inhibition of NLRP3 inflammasome in LPS-pretreated PBMC (unknown origin) assessed as reduction in IL-1beta release pretreated for 30 mins followed by ATP stimulated and measured after 1 hr by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5143747";"1";"Scientific Literature";"ACS Med Chem Lett";"2022";"None";"TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5185500";"";"None";"421.57";"0";"4.62";"51;NDT-30744";"S=c1cc(CC2CCCCO2)[nH]c2nc(Nc3c4c(cc5c3CCC5)CCC4)nn12";"IC50";"'='";"8900.0";"nM";"5.05";"";"";"UO_0000065";"11.98";"0.23";"0.43";"7.51";"0";"CHEMBL5149840";"Inhibition of NLRP3 inflammasome in LPS-pretreated human whole blood assessed as reduction in IL-1beta release pretreated for 30 mins followed by ATP stimulated and measured after 1 hr by HTRF assay";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"Blood";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5143747";"1";"Scientific Literature";"ACS Med Chem Lett";"2022";"None";"TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5200838";"";"None";"398.47";"0";"3.12";"31;NDT-30347";"O=c1cc(Cc2ccccn2)[nH]c2nc(Nc3c4c(cc5c3CCC5)CCC4)nn12";"IC50";"'='";"240.0";"nM";"6.62";"";"";"UO_0000065";"16.61";"0.30";"3.50";"7.53";"0";"CHEMBL5149841";"Inhibition of NLRP3 inflammasome in LPS-pretreated human THP1-ASC-GFP cells assessed as reduction in speck positive cells measured after 30 mins in presence of caspase inhibitor zVAD-FMK by Hoechst 33342 staining based confocal microscopy";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"THP1-ASC-GFP";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5143747";"1";"Scientific Literature";"ACS Med Chem Lett";"2022";"None";"TIME = 0.5 hr";"INHIBITOR";""
"CHEMBL5204151";"";"None";"257.29";"0";"2.58";"32";"COc1ccccc1CC(=O)Nc1cccc(O)c1";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5138374";"Inhibition of NLRP3 inflammasome activation in LPS/nigericin-stimulated PMA-differentiated human THP-1 macrophages assessed as reduction in pyroptosis pretreated with LPS followed by compound treatment for 30 mins then stimulation with nigericin and measured after 3 hrs by MTT assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"THP-1";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5137000";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"TIME = 3.5 hr";"";""
"CHEMBL5169525";"";"None";"321.28";"0";"3.20";"30";"COc1ccc(CC(=O)Nc2ccc3c(c2)OC(F)(F)O3)cc1";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5138374";"Inhibition of NLRP3 inflammasome activation in LPS/nigericin-stimulated PMA-differentiated human THP-1 macrophages assessed as reduction in pyroptosis pretreated with LPS followed by compound treatment for 30 mins then stimulation with nigericin and measured after 3 hrs by MTT assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"THP-1";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5137000";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"TIME = 3.5 hr";"";""
"CHEMBL5187588";"";"None";"283.33";"0";"3.08";"15";"COc1ccc(CC(=O)Nc2cccc(C(C)=O)c2)cc1";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5138374";"Inhibition of NLRP3 inflammasome activation in LPS/nigericin-stimulated PMA-differentiated human THP-1 macrophages assessed as reduction in pyroptosis pretreated with LPS followed by compound treatment for 30 mins then stimulation with nigericin and measured after 3 hrs by MTT assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"THP-1";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5137000";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"TIME = 3.5 hr";"";""
"CHEMBL5187380";"";"None";"266.30";"0";"3.05";"60";"O=C(Cc1cc2ccccc2[nH]1)Nc1cccc(O)c1";"IC50";"'='";"13220.0";"nM";"4.88";"";"";"UO_0000065";"18.32";"0.33";"1.83";"7.49";"0";"CHEMBL5138374";"Inhibition of NLRP3 inflammasome activation in LPS/nigericin-stimulated PMA-differentiated human THP-1 macrophages assessed as reduction in pyroptosis pretreated with LPS followed by compound treatment for 30 mins then stimulation with nigericin and measured after 3 hrs by MTT assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"THP-1";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5137000";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"TIME = 3.5 hr";"INHIBITOR";""
"CHEMBL5192338";"";"None";"286.29";"0";"2.78";"16";"COc1ccc(CC(=O)Nc2cccc([N+](=O)[O-])c2)cc1";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5138374";"Inhibition of NLRP3 inflammasome activation in LPS/nigericin-stimulated PMA-differentiated human THP-1 macrophages assessed as reduction in pyroptosis pretreated with LPS followed by compound treatment for 30 mins then stimulation with nigericin and measured after 3 hrs by MTT assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"THP-1";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5137000";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"TIME = 3.5 hr";"";""
"CHEMBL5204576";"";"None";"255.32";"0";"3.18";"14";"COc1ccc(CC(=O)Nc2cccc(C)c2)cc1";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5138374";"Inhibition of NLRP3 inflammasome activation in LPS/nigericin-stimulated PMA-differentiated human THP-1 macrophages assessed as reduction in pyroptosis pretreated with LPS followed by compound treatment for 30 mins then stimulation with nigericin and measured after 3 hrs by MTT assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"THP-1";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5137000";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"TIME = 3.5 hr";"";""
"CHEMBL5173470";"";"None";"299.37";"0";"3.10";"13";"COc1ccc(CC(=O)Nc2cccc(C(C)(C)O)c2)cc1";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5138374";"Inhibition of NLRP3 inflammasome activation in LPS/nigericin-stimulated PMA-differentiated human THP-1 macrophages assessed as reduction in pyroptosis pretreated with LPS followed by compound treatment for 30 mins then stimulation with nigericin and measured after 3 hrs by MTT assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"THP-1";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5137000";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"TIME = 3.5 hr";"";""
"CHEMBL5179909";"";"None";"568.66";"1";"3.42";"7b";"CC(C)(C)OC(=O)NC1CN(c2ccc(S(=O)(=O)NC(=O)Nc3c4c(cc5c3CCC5)CCC4)c3nonc23)C1";"IC50";"'='";"947.0";"nM";"6.02";"";"";"UO_0000065";"10.59";"0.21";"2.60";"3.87";"0";"CHEMBL5122649";"Inhibition of NLRP3 inflammasome activation in PMA differentiated LPS-primed human THP-1 cells assessed as reduction in nigericin-induced IL-1beta level pretreated for 2 hrs followed by nigericin addition and measured after 30 mins by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"THP-1";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5120824";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"TIME = 2.5 hr";"INHIBITOR";""
"CHEMBL5207305";"";"None";"552.70";"1";"4.02";"7h";"CN(C)[C@@H]1CCCC[C@H]1N(C)c1ccc(S(=O)(=O)NC(=O)Nc2c3c(cc4c2CCC4)CCC3)c2nonc12";"IC50";"'='";"636.0";"nM";"6.20";"";"";"UO_0000065";"11.21";"0.22";"2.18";"5.14";"0";"CHEMBL5122649";"Inhibition of NLRP3 inflammasome activation in PMA differentiated LPS-primed human THP-1 cells assessed as reduction in nigericin-induced IL-1beta level pretreated for 2 hrs followed by nigericin addition and measured after 30 mins by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"THP-1";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5120824";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"TIME = 2.5 hr";"INHIBITOR";""
"CHEMBL5188490";"";"None";"444.54";"0";"3.43";"7i";"CSc1ccc(S(=O)(=O)NC(=O)Nc2c3c(cc4c2CCC4)CCC3)c2nonc12";"IC50";"'='";"61.0";"nM";"7.21";"";"";"UO_0000065";"16.23";"0.33";"3.78";"6.32";"0";"CHEMBL5122649";"Inhibition of NLRP3 inflammasome activation in PMA differentiated LPS-primed human THP-1 cells assessed as reduction in nigericin-induced IL-1beta level pretreated for 2 hrs followed by nigericin addition and measured after 30 mins by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"THP-1";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5120824";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"TIME = 2.5 hr";"INHIBITOR";""
"CHEMBL5180066";"";"None";"294.31";"0";"2.35";"58";"O=C(Cn1ccc2ccccc2c1=O)Nc1cccc(O)c1";"IC50";"'='";"5035.0";"nM";"5.30";"";"";"UO_0000065";"18.00";"0.33";"2.95";"7.43";"0";"CHEMBL5138374";"Inhibition of NLRP3 inflammasome activation in LPS/nigericin-stimulated PMA-differentiated human THP-1 macrophages assessed as reduction in pyroptosis pretreated with LPS followed by compound treatment for 30 mins then stimulation with nigericin and measured after 3 hrs by MTT assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"THP-1";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5137000";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"TIME = 3.5 hr";"INHIBITOR";""
"CHEMBL5201588";"";"None";"271.32";"0";"2.97";"35";"CCOc1ccc(CC(=O)Nc2cccc(O)c2)cc1";"IC50";"'='";"387.3";"nM";"6.41";"";"";"UO_0000065";"23.63";"0.44";"3.44";"10.95";"0";"CHEMBL5138374";"Inhibition of NLRP3 inflammasome activation in LPS/nigericin-stimulated PMA-differentiated human THP-1 macrophages assessed as reduction in pyroptosis pretreated with LPS followed by compound treatment for 30 mins then stimulation with nigericin and measured after 3 hrs by MTT assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"THP-1";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5137000";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"TIME = 3.5 hr";"INHIBITOR";""
"CHEMBL5170851";"";"None";"243.26";"0";"2.28";"34";"O=C(Cc1ccc(O)cc1)Nc1cccc(O)c1";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5138374";"Inhibition of NLRP3 inflammasome activation in LPS/nigericin-stimulated PMA-differentiated human THP-1 macrophages assessed as reduction in pyroptosis pretreated with LPS followed by compound treatment for 30 mins then stimulation with nigericin and measured after 3 hrs by MTT assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"THP-1";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5137000";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"TIME = 3.5 hr";"";""
"CHEMBL5204941";"";"None";"295.26";"0";"3.59";"46";"O=C(Cc1ccc(C(F)(F)F)cc1)Nc1cccc(O)c1";"IC50";"'='";"1083.0";"nM";"5.96";"";"";"UO_0000065";"20.20";"0.39";"2.38";"12.09";"0";"CHEMBL5138374";"Inhibition of NLRP3 inflammasome activation in LPS/nigericin-stimulated PMA-differentiated human THP-1 macrophages assessed as reduction in pyroptosis pretreated with LPS followed by compound treatment for 30 mins then stimulation with nigericin and measured after 3 hrs by MTT assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"THP-1";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5137000";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"TIME = 3.5 hr";"INHIBITOR";""
"CHEMBL5190096";"";"None";"261.71";"0";"3.23";"44";"O=C(Cc1ccc(Cl)cc1)Nc1cccc(O)c1";"IC50";"'='";"3986.0";"nM";"5.40";"";"";"UO_0000065";"20.63";"0.41";"2.17";"10.95";"0";"CHEMBL5138374";"Inhibition of NLRP3 inflammasome activation in LPS/nigericin-stimulated PMA-differentiated human THP-1 macrophages assessed as reduction in pyroptosis pretreated with LPS followed by compound treatment for 30 mins then stimulation with nigericin and measured after 3 hrs by MTT assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"THP-1";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5137000";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"TIME = 3.5 hr";"INHIBITOR";""
"CHEMBL5190030";"";"None";"297.40";"0";"4.31";"41";"CCCCCc1ccc(CC(=O)Nc2cccc(O)c2)cc1";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5138374";"Inhibition of NLRP3 inflammasome activation in LPS/nigericin-stimulated PMA-differentiated human THP-1 macrophages assessed as reduction in pyroptosis pretreated with LPS followed by compound treatment for 30 mins then stimulation with nigericin and measured after 3 hrs by MTT assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"THP-1";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5137000";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"TIME = 3.5 hr";"";""
"CHEMBL5219789";"";"None";"431.52";"0";"1.35";"20; GDC-2394";"CN[C@@H]1COc2c(S(=O)(=O)NC(=O)Nc3c4c(cc5c3CCC5)CCC4)cnn2C1";"IC50";"'='";"17.0";"nM";"7.77";"";"";"UO_0000065";"18.01";"0.35";"6.42";"6.79";"0";"CHEMBL5217844";"Inhibition of NLRP3 inflammasome activation in LPS-stimulated human monocyte-derived macrophage assessed as reduction in ILbeta secretion in presence of CHC";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"MDM";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5214989";"1";"Scientific Literature";"J Med Chem";"2022";"None";"";"INHIBITOR";""
"CHEMBL5178097";"";"None";"297.12";"None";"None";"3";"COc1ccc(CC(=O)Nc2ccc3c(c2)B(O)OC3)cc1";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5138374";"Inhibition of NLRP3 inflammasome activation in LPS/nigericin-stimulated PMA-differentiated human THP-1 macrophages assessed as reduction in pyroptosis pretreated with LPS followed by compound treatment for 30 mins then stimulation with nigericin and measured after 3 hrs by MTT assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"THP-1";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5137000";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"TIME = 3.5 hr";"";""
"CHEMBL5197119";"";"None";"320.37";"0";"1.52";"7";"COc1ccc(CC(=O)Nc2cccc(S(N)(=O)=O)c2)cc1";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5138374";"Inhibition of NLRP3 inflammasome activation in LPS/nigericin-stimulated PMA-differentiated human THP-1 macrophages assessed as reduction in pyroptosis pretreated with LPS followed by compound treatment for 30 mins then stimulation with nigericin and measured after 3 hrs by MTT assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"THP-1";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5137000";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"TIME = 3.5 hr";"";""
"CHEMBL5192251";"";"None";"266.30";"0";"2.80";"66";"O=C(NCc1ccc2cc[nH]c2c1)c1cccc(O)c1";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5138374";"Inhibition of NLRP3 inflammasome activation in LPS/nigericin-stimulated PMA-differentiated human THP-1 macrophages assessed as reduction in pyroptosis pretreated with LPS followed by compound treatment for 30 mins then stimulation with nigericin and measured after 3 hrs by MTT assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"THP-1";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5137000";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"TIME = 3.5 hr";"";""
"CHEMBL5180041";"";"None";"266.30";"0";"3.05";"59; J114";"O=C(Cc1ccc2cc[nH]c2c1)Nc1cccc(O)c1";"IC50";"'='";"58.0";"nM";"7.24";"";"";"UO_0000065";"27.17";"0.49";"4.19";"11.11";"0";"CHEMBL5138378";"Inhibition of NLRP3 inflammasome activation in LPS-primed human THP-1 cells assessed as reduction in IL-18 release in supernatant pretreated for 30 mins followed by nigericin stimulation and measured after 30 mins by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"THP-1";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5137000";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"TIME = 1.0 hr";"INHIBITOR";""
"CHEMBL5207270";"";"None";"398.47";"0";"3.12";"32";"O=c1cc(Cc2cccnc2)[nH]c2nc(Nc3c4c(cc5c3CCC5)CCC4)nn12";"IC50";"'='";"3400.0";"nM";"5.47";"";"";"UO_0000065";"13.72";"0.25";"2.35";"6.22";"0";"CHEMBL5149834";"Inhibition of NLRP3 inflammasome in LPS-pretreated PBMC (unknown origin) assessed as reduction in IL-1beta release pretreated for 30 mins followed by ATP stimulated and measured after 1 hr by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5143747";"1";"Scientific Literature";"ACS Med Chem Lett";"2022";"None";"TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL4757554";"";"None";"394.47";"0";"3.28";"33";"COC(=O)C(Cc1cccc(O)c1)NC(=O)Nc1c2c(cc3c1CCC3)CCC2";"IC50";"'='";"2000.0";"nM";"5.70";"";"";"UO_0000065";"14.45";"0.27";"2.42";"6.50";"0";"CHEMBL4702271";"Inhibition of NLRP3 in human PBMC cells assessed as inhibition of LPS and ATP-induced IL-1beta production";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699510";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"";"INHIBITOR";""
"CHEMBL4795765";"";"None";"403.48";"0";"3.44";"35";"COC(=O)[C@@H](Cc1cccc(C#N)c1)NC(=O)Nc1c2c(cc3c1CCC3)CCC2";"IC50";"'='";"1500.0";"nM";"5.82";"";"";"UO_0000065";"14.43";"0.27";"2.38";"6.38";"0";"CHEMBL4702271";"Inhibition of NLRP3 in human PBMC cells assessed as inhibition of LPS and ATP-induced IL-1beta production";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699510";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"";"INHIBITOR";""
"CHEMBL4740907";"";"None";"379.46";"0";"2.96";"39";"COC(=O)[C@@H](Cc1ccncc1)NC(=O)Nc1c2c(cc3c1CCC3)CCC2";"IC50";"'>'";"20000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4702271";"Inhibition of NLRP3 in human PBMC cells assessed as inhibition of LPS and ATP-induced IL-1beta production";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699510";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"";"";""
"CHEMBL4780624";"";"None";"394.48";"0";"2.75";"44";"CCOC(=O)[C@@H](Cc1ncccn1)NC(=O)Nc1c2c(cc3c1CCC3)CCC2";"IC50";"'='";"33.0";"nM";"7.48";"";"";"UO_0000065";"18.97";"0.35";"4.73";"8.03";"0";"CHEMBL4702274";"Inhibition of NLRP3 in human THP-1 cells assessed as reduction in nigercin-induced ASC speck formation measuring green fluorescent protein aggregation by confocal microscopy";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"THP-1";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699510";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"";"INHIBITOR";""
"CHEMBL5220818";"";"None";"357.44";"0";"2.57";"5";"O=C(Nc1c2c(cc3c1CCC3)CCC2)NS(=O)(=O)c1cccnc1";"IC50";"'='";"1080.0";"nM";"5.97";"";"";"UO_0000065";"16.69";"0.33";"3.40";"6.77";"0";"CHEMBL5217806";"Inhibition of NLRP3 inflammasome activation in LPS and nigericin-stimulated human PBMC cells assessed as reduction in IL-1beta release preincubated with LPS for 3 hrs followed by compound addition for 30 mins and further stimulated with nigericin for 1.5 hrs by ELISA analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5214989";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 2.0 hr";"INHIBITOR";""
"CHEMBL449579";"MICHELIOLIDE";"None";"248.32";"0";"2.36";"5; MCL";"C=C1C(=O)O[C@H]2[C@H]1CCC(C)=C1CC[C@@](C)(O)[C@@H]12";"IC50";"'='";"5900.0";"nM";"5.23";"";"";"UO_0000065";"21.06";"0.40";"2.87";"11.24";"0";"CHEMBL4727731";"Inhibition of NLRP3 inflammasome in human primary glial cells assessed as reduction in LPS-induced IL-1beta release";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Primary neuron";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4725325";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"";"INHIBITOR";""
"CHEMBL3183703";"";"None";"404.49";"0";"2.99";"29; MCC950";"CC(C)(O)c1coc(S(=O)(=O)NC(=O)Nc2c3c(cc4c2CCC4)CCC3)c1";"IC50";"'='";"8.1";"nM";"8.09";"";"";"UO_0000065";"20.00";"0.39";"5.10";"7.45";"1";"CHEMBL4775280";"Inhibition of NLRP3 in human monocyte-derived macrophages";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"Bone marrow";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765468";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"INHIBITOR";""
"CHEMBL5219789";"";"None";"431.52";"0";"1.35";"20; GDC-2394";"CN[C@@H]1COc2c(S(=O)(=O)NC(=O)Nc3c4c(cc5c3CCC5)CCC4)cnn2C1";"IC50";"'='";"17.0";"nM";"7.77";"";"";"UO_0000065";"18.01";"0.35";"6.42";"6.79";"0";"CHEMBL5217845";"Inhibition of NLRP3 inflammasome activation in LPS-stimulated human monocyte-derived macrophage assessed as reduction in IL-18 secretion in presence of ATP";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"MDM";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5214989";"1";"Scientific Literature";"J Med Chem";"2022";"None";"";"INHIBITOR";""
"CHEMBL5196139";"";"None";"414.54";"0";"4.49";"50;NDT-30805";"S=c1cc(Cc2ccccn2)[nH]c2nc(Nc3c4c(cc5c3CCC5)CCC4)nn12";"IC50";"'='";"13.0";"nM";"7.89";"";"";"UO_0000065";"19.02";"0.36";"3.40";"11.12";"0";"CHEMBL5149834";"Inhibition of NLRP3 inflammasome in LPS-pretreated PBMC (unknown origin) assessed as reduction in IL-1beta release pretreated for 30 mins followed by ATP stimulated and measured after 1 hr by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5143747";"1";"Scientific Literature";"ACS Med Chem Lett";"2022";"None";"TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5205427";"";"None";"405.50";"0";"3.25";"36;NDT-30408";"O=c1cc(CC2CCCCO2)[nH]c2nc(Nc3c4c(cc5c3CCC5)CCC4)nn12";"IC50";"'>'";"40000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5149840";"Inhibition of NLRP3 inflammasome in LPS-pretreated human whole blood assessed as reduction in IL-1beta release pretreated for 30 mins followed by ATP stimulated and measured after 1 hr by HTRF assay";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"Blood";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5143747";"1";"Scientific Literature";"ACS Med Chem Lett";"2022";"None";"TIME = 1.5 hr";"";""
"CHEMBL5184988";"";"None";"303.36";"0";"4.24";"42";"O=C(Cc1ccc(-c2ccccc2)cc1)Nc1cccc(O)c1";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5138374";"Inhibition of NLRP3 inflammasome activation in LPS/nigericin-stimulated PMA-differentiated human THP-1 macrophages assessed as reduction in pyroptosis pretreated with LPS followed by compound treatment for 30 mins then stimulation with nigericin and measured after 3 hrs by MTT assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"THP-1";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5137000";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"TIME = 3.5 hr";"";""
"CHEMBL5202880";"";"None";"256.31";"0";"2.46";"6";"COc1ccc(CC(=O)Nc2cccc(N)c2)cc1";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5138374";"Inhibition of NLRP3 inflammasome activation in LPS/nigericin-stimulated PMA-differentiated human THP-1 macrophages assessed as reduction in pyroptosis pretreated with LPS followed by compound treatment for 30 mins then stimulation with nigericin and measured after 3 hrs by MTT assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"THP-1";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5137000";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"TIME = 3.5 hr";"";""
"CHEMBL5182880";"";"None";"333.39";"0";"4.15";"36";"O=C(Cc1ccc(OCc2ccccc2)cc1)Nc1cccc(O)c1";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5138374";"Inhibition of NLRP3 inflammasome activation in LPS/nigericin-stimulated PMA-differentiated human THP-1 macrophages assessed as reduction in pyroptosis pretreated with LPS followed by compound treatment for 30 mins then stimulation with nigericin and measured after 3 hrs by MTT assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"THP-1";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5137000";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"TIME = 3.5 hr";"";""
"CHEMBL5206185";"";"None";"297.31";"0";"2.55";"27";"COc1ccc(CC(=O)Nc2ccc3c(c2)COC3=O)cc1";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5138374";"Inhibition of NLRP3 inflammasome activation in LPS/nigericin-stimulated PMA-differentiated human THP-1 macrophages assessed as reduction in pyroptosis pretreated with LPS followed by compound treatment for 30 mins then stimulation with nigericin and measured after 3 hrs by MTT assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"THP-1";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5137000";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"TIME = 3.5 hr";"";""
"CHEMBL5175503";"";"None";"282.30";"0";"3.02";"23";"COc1ccc(CC(=O)Nc2ccc3ncoc3c2)cc1";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5138374";"Inhibition of NLRP3 inflammasome activation in LPS/nigericin-stimulated PMA-differentiated human THP-1 macrophages assessed as reduction in pyroptosis pretreated with LPS followed by compound treatment for 30 mins then stimulation with nigericin and measured after 3 hrs by MTT assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"THP-1";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5137000";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"TIME = 3.5 hr";"";""
"CHEMBL5186980";"";"None";"257.29";"0";"2.58";"8";"COc1ccc(CC(=O)Nc2cccc(O)c2)cc1";"IC50";"'='";"239.2";"nM";"6.62";"";"";"UO_0000065";"25.73";"0.48";"4.04";"11.31";"0";"CHEMBL5138374";"Inhibition of NLRP3 inflammasome activation in LPS/nigericin-stimulated PMA-differentiated human THP-1 macrophages assessed as reduction in pyroptosis pretreated with LPS followed by compound treatment for 30 mins then stimulation with nigericin and measured after 3 hrs by MTT assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"THP-1";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5137000";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"TIME = 3.5 hr";"INHIBITOR";""
"CHEMBL5198440";"";"None";"401.47";"0";"2.46";"46";"Cn1cc(Cc2cc(=O)n3nc(Nc4c5c(cc6c4CCC6)CCC5)nc3[nH]2)cn1";"IC50";"'='";"4900.0";"nM";"5.31";"";"";"UO_0000065";"13.23";"0.24";"2.85";"5.72";"0";"CHEMBL5149834";"Inhibition of NLRP3 inflammasome in LPS-pretreated PBMC (unknown origin) assessed as reduction in IL-1beta release pretreated for 30 mins followed by ATP stimulated and measured after 1 hr by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5143747";"1";"Scientific Literature";"ACS Med Chem Lett";"2022";"None";"TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5176441";"";"None";"335.41";"0";"2.70";"12";"CCc1cc(=O)n2nc(Nc3c4c(cc5c3CCC5)CCC4)nc2[nH]1";"IC50";"'='";"8700.0";"nM";"5.06";"";"";"UO_0000065";"15.09";"0.28";"2.36";"6.74";"0";"CHEMBL5149834";"Inhibition of NLRP3 inflammasome in LPS-pretreated PBMC (unknown origin) assessed as reduction in IL-1beta release pretreated for 30 mins followed by ATP stimulated and measured after 1 hr by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5143747";"1";"Scientific Literature";"ACS Med Chem Lett";"2022";"None";"TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5189790";"";"None";"390.49";"0";"2.61";"19";"O=c1cc(C2CCCNC2)[nH]c2nc(Nc3c4c(cc5c3CCC5)CCC4)nn12";"IC50";"'>'";"40000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5149834";"Inhibition of NLRP3 inflammasome in LPS-pretreated PBMC (unknown origin) assessed as reduction in IL-1beta release pretreated for 30 mins followed by ATP stimulated and measured after 1 hr by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5143747";"1";"Scientific Literature";"ACS Med Chem Lett";"2022";"None";"TIME = 1.5 hr";"";""
"CHEMBL5200838";"";"None";"398.47";"0";"3.12";"31;NDT-30347";"O=c1cc(Cc2ccccn2)[nH]c2nc(Nc3c4c(cc5c3CCC5)CCC4)nn12";"IC50";"'>'";"40000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5149840";"Inhibition of NLRP3 inflammasome in LPS-pretreated human whole blood assessed as reduction in IL-1beta release pretreated for 30 mins followed by ATP stimulated and measured after 1 hr by HTRF assay";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"Blood";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5143747";"1";"Scientific Literature";"ACS Med Chem Lett";"2022";"None";"TIME = 1.5 hr";"";""
"CHEMBL5187589";"";"None";"504.47";"None";"None";"13b";"CN(C)c1ccc(S(=O)(=O)NC(=O)Nc2c3c(cc4c2CCC4)CCC3)c2n[se]nc12";"IC50";"'='";"100.0";"nM";"7.00";"";"";"UO_0000065";"13.88";"None";"None";"None";"0";"CHEMBL5122649";"Inhibition of NLRP3 inflammasome activation in PMA differentiated LPS-primed human THP-1 cells assessed as reduction in nigericin-induced IL-1beta level pretreated for 2 hrs followed by nigericin addition and measured after 30 mins by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"THP-1";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5120824";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"TIME = 2.5 hr";"INHIBITOR";""
"CHEMBL5205443";"";"None";"284.32";"0";"2.53";"51";"CC(=O)Nc1ccc(CC(=O)Nc2cccc(O)c2)cc1";"IC50";"'='";"3625.0";"nM";"5.44";"";"";"UO_0000065";"19.14";"0.35";"2.91";"6.94";"0";"CHEMBL5138374";"Inhibition of NLRP3 inflammasome activation in LPS/nigericin-stimulated PMA-differentiated human THP-1 macrophages assessed as reduction in pyroptosis pretreated with LPS followed by compound treatment for 30 mins then stimulation with nigericin and measured after 3 hrs by MTT assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"THP-1";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5137000";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"TIME = 3.5 hr";"INHIBITOR";""
"CHEMBL5192602";"";"None";"299.33";"0";"2.66";"5";"COC(=O)c1cccc(NC(=O)Cc2ccc(OC)cc2)c1";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5138374";"Inhibition of NLRP3 inflammasome activation in LPS/nigericin-stimulated PMA-differentiated human THP-1 macrophages assessed as reduction in pyroptosis pretreated with LPS followed by compound treatment for 30 mins then stimulation with nigericin and measured after 3 hrs by MTT assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"THP-1";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5137000";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"TIME = 3.5 hr";"";""
"CHEMBL5197222";"";"None";"285.30";"0";"2.57";"4";"COc1ccc(CC(=O)Nc2cccc(C(=O)O)c2)cc1";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5138374";"Inhibition of NLRP3 inflammasome activation in LPS/nigericin-stimulated PMA-differentiated human THP-1 macrophages assessed as reduction in pyroptosis pretreated with LPS followed by compound treatment for 30 mins then stimulation with nigericin and measured after 3 hrs by MTT assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"THP-1";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5137000";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"TIME = 3.5 hr";"";""
"CHEMBL5189326";"";"None";"259.28";"0";"3.02";"17";"COc1ccc(CC(=O)Nc2cccc(F)c2)cc1";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5138374";"Inhibition of NLRP3 inflammasome activation in LPS/nigericin-stimulated PMA-differentiated human THP-1 macrophages assessed as reduction in pyroptosis pretreated with LPS followed by compound treatment for 30 mins then stimulation with nigericin and measured after 3 hrs by MTT assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"THP-1";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5137000";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"TIME = 3.5 hr";"";""
"CHEMBL5169347";"";"None";"271.32";"0";"2.37";"12";"COc1ccc(CC(=O)Nc2cccc(CO)c2)cc1";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5138374";"Inhibition of NLRP3 inflammasome activation in LPS/nigericin-stimulated PMA-differentiated human THP-1 macrophages assessed as reduction in pyroptosis pretreated with LPS followed by compound treatment for 30 mins then stimulation with nigericin and measured after 3 hrs by MTT assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"THP-1";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5137000";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"TIME = 3.5 hr";"";""
"CHEMBL5180006";"";"None";"266.30";"0";"2.99";"63";"O=C(Cn1ccc2ccccc21)Nc1cccc(O)c1";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5138374";"Inhibition of NLRP3 inflammasome activation in LPS/nigericin-stimulated PMA-differentiated human THP-1 macrophages assessed as reduction in pyroptosis pretreated with LPS followed by compound treatment for 30 mins then stimulation with nigericin and measured after 3 hrs by MTT assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"THP-1";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5137000";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"TIME = 3.5 hr";"";""
"CHEMBL5205740";"";"None";"271.27";"0";"2.30";"55";"O=C(Cc1ccc2c(c1)OCO2)Nc1cccc(O)c1";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5138374";"Inhibition of NLRP3 inflammasome activation in LPS/nigericin-stimulated PMA-differentiated human THP-1 macrophages assessed as reduction in pyroptosis pretreated with LPS followed by compound treatment for 30 mins then stimulation with nigericin and measured after 3 hrs by MTT assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"THP-1";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5137000";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"TIME = 3.5 hr";"";""
"CHEMBL5220827";"";"None";"360.44";"0";"1.91";"11";"Cn1nccc1S(=O)(=O)NC(=O)Nc1c2c(cc3c1CCC3)CCC2";"IC50";"'='";"2550.0";"nM";"5.59";"";"";"UO_0000065";"15.52";"0.31";"3.68";"6.01";"0";"CHEMBL5217806";"Inhibition of NLRP3 inflammasome activation in LPS and nigericin-stimulated human PBMC cells assessed as reduction in IL-1beta release preincubated with LPS for 3 hrs followed by compound addition for 30 mins and further stimulated with nigericin for 1.5 hrs by ELISA analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5214989";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 2.0 hr";"INHIBITOR";""
"CHEMBL5169534";"";"None";"390.49";"0";"2.61";"17";"O=c1cc(C2CCNCC2)[nH]c2nc(Nc3c4c(cc5c3CCC5)CCC4)nn12";"IC50";"'>'";"40000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5149834";"Inhibition of NLRP3 inflammasome in LPS-pretreated PBMC (unknown origin) assessed as reduction in IL-1beta release pretreated for 30 mins followed by ATP stimulated and measured after 1 hr by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5143747";"1";"Scientific Literature";"ACS Med Chem Lett";"2022";"None";"TIME = 1.5 hr";"";""
"CHEMBL5177768";"";"None";"431.93";"0";"4.38";"24";"O=c1cc(Cc2cccc(Cl)c2)[nH]c2nc(Nc3c4c(cc5c3CCC5)CCC4)nn12";"IC50";"'='";"2800.0";"nM";"5.55";"";"";"UO_0000065";"12.86";"0.24";"1.17";"7.40";"0";"CHEMBL5149834";"Inhibition of NLRP3 inflammasome in LPS-pretreated PBMC (unknown origin) assessed as reduction in IL-1beta release pretreated for 30 mins followed by ATP stimulated and measured after 1 hr by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5143747";"1";"Scientific Literature";"ACS Med Chem Lett";"2022";"None";"TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5175650";"";"None";"411.51";"0";"4.04";"29";"Cc1ccccc1Cc1cc(=O)n2nc(Nc3c4c(cc5c3CCC5)CCC4)nc2[nH]1";"IC50";"'='";"4000.0";"nM";"5.40";"";"";"UO_0000065";"13.12";"0.24";"1.36";"7.19";"0";"CHEMBL5149834";"Inhibition of NLRP3 inflammasome in LPS-pretreated PBMC (unknown origin) assessed as reduction in IL-1beta release pretreated for 30 mins followed by ATP stimulated and measured after 1 hr by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5143747";"1";"Scientific Literature";"ACS Med Chem Lett";"2022";"None";"TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5203319";"";"None";"415.47";"0";"3.87";"30";"O=c1cc(Cc2ccccc2F)[nH]c2nc(Nc3c4c(cc5c3CCC5)CCC4)nn12";"IC50";"'='";"3700.0";"nM";"5.43";"";"";"UO_0000065";"13.07";"0.24";"1.56";"7.23";"0";"CHEMBL5149834";"Inhibition of NLRP3 inflammasome in LPS-pretreated PBMC (unknown origin) assessed as reduction in IL-1beta release pretreated for 30 mins followed by ATP stimulated and measured after 1 hr by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5143747";"1";"Scientific Literature";"ACS Med Chem Lett";"2022";"None";"TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5207889";"";"None";"457.58";"0";"3.25";"13a";"CN(C)c1ccc(S(=O)(=O)NC(=O)Nc2c3c(cc4c2CCC4)CCC3)c2nsnc12";"IC50";"'='";"49.0";"nM";"7.31";"";"";"UO_0000065";"15.97";"0.32";"4.06";"7.01";"0";"CHEMBL5122649";"Inhibition of NLRP3 inflammasome activation in PMA differentiated LPS-primed human THP-1 cells assessed as reduction in nigericin-induced IL-1beta level pretreated for 2 hrs followed by nigericin addition and measured after 30 mins by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"THP-1";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5120824";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"TIME = 2.5 hr";"INHIBITOR";""
"CHEMBL5181056";"";"None";"278.31";"0";"3.12";"57";"O=C(Cc1ccc2ncccc2c1)Nc1cccc(O)c1";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5138374";"Inhibition of NLRP3 inflammasome activation in LPS/nigericin-stimulated PMA-differentiated human THP-1 macrophages assessed as reduction in pyroptosis pretreated with LPS followed by compound treatment for 30 mins then stimulation with nigericin and measured after 3 hrs by MTT assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"THP-1";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5137000";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"TIME = 3.5 hr";"";""
"CHEMBL5207805";"";"None";"269.34";"0";"3.53";"38";"CCCc1ccc(CC(=O)Nc2cccc(O)c2)cc1";"IC50";"'='";"2208.0";"nM";"5.66";"";"";"UO_0000065";"21.00";"0.39";"2.13";"11.47";"0";"CHEMBL5138374";"Inhibition of NLRP3 inflammasome activation in LPS/nigericin-stimulated PMA-differentiated human THP-1 macrophages assessed as reduction in pyroptosis pretreated with LPS followed by compound treatment for 30 mins then stimulation with nigericin and measured after 3 hrs by MTT assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"THP-1";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5137000";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"TIME = 3.5 hr";"INHIBITOR";""
"CHEMBL5219789";"";"None";"431.52";"0";"1.35";"20; GDC-2394";"CN[C@@H]1COc2c(S(=O)(=O)NC(=O)Nc3c4c(cc5c3CCC5)CCC4)cnn2C1";"IC50";"'='";"490.0";"nM";"6.31";"";"";"UO_0000065";"14.62";"0.29";"4.96";"5.52";"0";"CHEMBL5217842";"Inhibition of NLRP3 inflammasome activation in LPS-stimulated human whole blood assessed as reduction in ILbeta secretion in presence of cholesterol crystal";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"Blood";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5214989";"1";"Scientific Literature";"J Med Chem";"2022";"None";"";"INHIBITOR";""
"CHEMBL5279642";"";"None";"367.38";"0";"3.08";"I-2";"Cc1nc(N[C@@H]2CCCN(C)C2)nnc1-c1ccc(C(F)(F)F)cc1O";"IC50";"'<'";"1.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5260446";"Inhibition of NLRP3 inflammasome activation in PMA-differentiated human THP-1 cells assessed as reduction in IL-1beta secretion preincubated for 20 hrs followed by nigericin addition and measured after 3 hrs by HTRF assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"THP-1";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5257145";"1";"Scientific Literature";"ACS Med Chem Lett";"2023";"None";"TIME = 23.0 hr";"INHIBITOR";""
"CHEMBL5219210";"";"None";"431.52";"0";"1.35";"R-20";"CN[C@H]1COc2c(S(=O)(=O)NC(=O)Nc3c4c(cc5c3CCC5)CCC4)cnn2C1";"IC50";"'='";"1400.0";"nM";"5.85";"";"";"UO_0000065";"13.57";"0.27";"4.50";"5.12";"0";"CHEMBL5217806";"Inhibition of NLRP3 inflammasome activation in LPS and nigericin-stimulated human PBMC cells assessed as reduction in IL-1beta release preincubated with LPS for 3 hrs followed by compound addition for 30 mins and further stimulated with nigericin for 1.5 hrs by ELISA analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5214989";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 2.0 hr";"INHIBITOR";""
"CHEMBL5218858";"";"None";"360.44";"0";"1.91";"13";"Cn1cc(S(=O)(=O)NC(=O)Nc2c3c(cc4c2CCC4)CCC3)cn1";"IC50";"'='";"210.0";"nM";"6.68";"";"";"UO_0000065";"18.53";"0.36";"4.77";"7.17";"0";"CHEMBL5217806";"Inhibition of NLRP3 inflammasome activation in LPS and nigericin-stimulated human PBMC cells assessed as reduction in IL-1beta release preincubated with LPS for 3 hrs followed by compound addition for 30 mins and further stimulated with nigericin for 1.5 hrs by ELISA analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5214989";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 2.0 hr";"INHIBITOR";""
"CHEMBL5172572";"";"None";"403.53";"0";"4.26";"21";"O=c1cc(CC2CCCCC2)[nH]c2nc(Nc3c4c(cc5c3CCC5)CCC4)nn12";"IC50";"'='";"4500.0";"nM";"5.35";"";"";"UO_0000065";"13.25";"0.24";"1.09";"7.12";"0";"CHEMBL5149834";"Inhibition of NLRP3 inflammasome in LPS-pretreated PBMC (unknown origin) assessed as reduction in IL-1beta release pretreated for 30 mins followed by ATP stimulated and measured after 1 hr by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5143747";"1";"Scientific Literature";"ACS Med Chem Lett";"2022";"None";"TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5209496";"";"None";"293.27";"0";"3.17";"48";"O=C(Cc1ccc(OC(F)F)cc1)Nc1cccc(O)c1";"IC50";"'='";"380.3";"nM";"6.42";"";"";"UO_0000065";"21.89";"0.42";"3.25";"10.96";"0";"CHEMBL5138374";"Inhibition of NLRP3 inflammasome activation in LPS/nigericin-stimulated PMA-differentiated human THP-1 macrophages assessed as reduction in pyroptosis pretreated with LPS followed by compound treatment for 30 mins then stimulation with nigericin and measured after 3 hrs by MTT assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"THP-1";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5137000";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"TIME = 3.5 hr";"INHIBITOR";""
"CHEMBL5176442";"";"None";"245.25";"0";"2.71";"43";"O=C(Cc1ccc(F)cc1)Nc1cccc(O)c1";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5138374";"Inhibition of NLRP3 inflammasome activation in LPS/nigericin-stimulated PMA-differentiated human THP-1 macrophages assessed as reduction in pyroptosis pretreated with LPS followed by compound treatment for 30 mins then stimulation with nigericin and measured after 3 hrs by MTT assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"THP-1";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5137000";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"TIME = 3.5 hr";"";""
"CHEMBL5218938";"";"None";"357.44";"0";"2.57";"6";"O=C(Nc1c2c(cc3c1CCC3)CCC2)NS(=O)(=O)c1ccncc1";"IC50";"'='";"1540.0";"nM";"5.81";"";"";"UO_0000065";"16.26";"0.32";"3.24";"6.59";"0";"CHEMBL5217806";"Inhibition of NLRP3 inflammasome activation in LPS and nigericin-stimulated human PBMC cells assessed as reduction in IL-1beta release preincubated with LPS for 3 hrs followed by compound addition for 30 mins and further stimulated with nigericin for 1.5 hrs by ELISA analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5214989";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 2.0 hr";"INHIBITOR";""
"CHEMBL5190221";"";"None";"325.29";"0";"3.78";"21";"COc1ccc(CC(=O)Nc2cccc(OC(F)(F)F)c2)cc1";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5138374";"Inhibition of NLRP3 inflammasome activation in LPS/nigericin-stimulated PMA-differentiated human THP-1 macrophages assessed as reduction in pyroptosis pretreated with LPS followed by compound treatment for 30 mins then stimulation with nigericin and measured after 3 hrs by MTT assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"THP-1";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5137000";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"TIME = 3.5 hr";"";""
"CHEMBL5207084";"";"None";"449.58";"0";"4.39";"15";"CN(C)c1cccc2c(S(=O)(=O)NC(=O)Nc3c4c(cc5c3CCC5)CCC4)cccc12";"IC50";"'='";"9180.0";"nM";"5.04";"";"";"UO_0000065";"11.20";"0.21";"0.65";"6.42";"0";"CHEMBL5122649";"Inhibition of NLRP3 inflammasome activation in PMA differentiated LPS-primed human THP-1 cells assessed as reduction in nigericin-induced IL-1beta level pretreated for 2 hrs followed by nigericin addition and measured after 30 mins by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"THP-1";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5120824";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"TIME = 2.5 hr";"INHIBITOR";""
"CHEMBL5203089";"";"None";"411.51";"0";"3.92";"15";"O=c1cc(CCc2ccccc2)[nH]c2nc(Nc3c4c(cc5c3CCC5)CCC4)nn12";"IC50";"'='";"3400.0";"nM";"5.47";"";"";"UO_0000065";"13.29";"0.24";"1.55";"7.28";"0";"CHEMBL5149834";"Inhibition of NLRP3 inflammasome in LPS-pretreated PBMC (unknown origin) assessed as reduction in IL-1beta release pretreated for 30 mins followed by ATP stimulated and measured after 1 hr by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5143747";"1";"Scientific Literature";"ACS Med Chem Lett";"2022";"None";"TIME = 1.5 hr";"INHIBITOR";""
"CHEMBL5219789";"";"None";"431.52";"0";"1.35";"20; GDC-2394";"CN[C@@H]1COc2c(S(=O)(=O)NC(=O)Nc3c4c(cc5c3CCC5)CCC4)cnn2C1";"IC50";"'='";"5.4";"nM";"8.27";"";"";"UO_0000065";"19.16";"0.38";"6.92";"7.23";"0";"CHEMBL5217806";"Inhibition of NLRP3 inflammasome activation in LPS and nigericin-stimulated human PBMC cells assessed as reduction in IL-1beta release preincubated with LPS for 3 hrs followed by compound addition for 30 mins and further stimulated with nigericin for 1.5 hrs by ELISA analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5214989";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 2.0 hr";"INHIBITOR";""
"CHEMBL5219789";"";"None";"431.52";"0";"1.35";"20; GDC-2394";"CN[C@@H]1COc2c(S(=O)(=O)NC(=O)Nc3c4c(cc5c3CCC5)CCC4)cnn2C1";"IC50";"'='";"380.0";"nM";"6.42";"";"";"UO_0000065";"14.88";"0.29";"5.07";"5.61";"0";"CHEMBL5217841";"Inhibition of NLRP3 inflammasome activation in LPS-stimulated human whole blood assessed as reduction in ILbeta secretion in presence of monosodium urate";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"None";"Blood";"None";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5214989";"1";"Scientific Literature";"J Med Chem";"2022";"None";"";"INHIBITOR";""
"CHEMBL5219660";"";"None";"402.48";"0";"2.15";"17";"O=C(Nc1c2c(cc3c1CCC3)CCC2)NS(=O)(=O)c1cnn2c1OCCC2";"IC50";"'='";"63.0";"nM";"7.20";"";"";"UO_0000065";"17.89";"0.35";"5.05";"7.04";"0";"CHEMBL5217806";"Inhibition of NLRP3 inflammasome activation in LPS and nigericin-stimulated human PBMC cells assessed as reduction in IL-1beta release preincubated with LPS for 3 hrs followed by compound addition for 30 mins and further stimulated with nigericin for 1.5 hrs by ELISA analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5214989";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 2.0 hr";"INHIBITOR";""
"CHEMBL4640151";"";"None";"356.45";"0";"3.17";"3";"O=C(Nc1c2c(cc3c1CCC3)CCC2)NS(=O)(=O)c1ccccc1";"IC50";"'='";"1790.0";"nM";"5.75";"";"";"UO_0000065";"16.12";"0.31";"2.58";"7.64";"0";"CHEMBL5217806";"Inhibition of NLRP3 inflammasome activation in LPS and nigericin-stimulated human PBMC cells assessed as reduction in IL-1beta release preincubated with LPS for 3 hrs followed by compound addition for 30 mins and further stimulated with nigericin for 1.5 hrs by ELISA analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL1741208";"NACHT, LRR and PYD domains-containing protein 3";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5214989";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 2.0 hr";"INHIBITOR";""
